Letters and Comments on Asbestos

PubMed, the National Library of Medicine's index of medical journals, labels every article with its publication type. 1,151 studies in our library are labeled as letters to the editor and comments on other articles. The labels are NLM's, not ours. Each entry links to the study on PubMed and to its journal's page in our library, where you can read the abstract.

2020s

• Banned here, sold elsewhere: globalization, e-commerce and the continuing circulation of asbestos-containing products. A.F. Gualtieri, A. Cavallo. Environmental Health 2026;25(1). Letter PubMed · Publisher · Free full text

• Editorial Note: Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma. PLOS One Editors. PloS One 2026;21(7):e0353725. Comment · Editorial PubMed · Publisher · Free full text

• Editorial Note: In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma. PLOS One Editors. PloS One 2026;21(7):e0353915. Comment · Editorial PubMed · Publisher · Free full text

• Optimal follow-up duration for nonspecific pleuritis: how long is long enough?. S. Ozyavuz, G. Ak, S. Metintas, et al. ERJ Open Research 2026;12(2). Letter PubMed · Publisher · Free full text

• Pleural plaques and interstitial lung abnormalities in AGES-Reykjavik study. Y. Ko, G. Gudmundsson, T. Fukuda, et al. ERJ Open Research 2026;12(5). Letter PubMed · Publisher · Free full text

• Reply: Optimal follow-up duration for nonspecific pleuritis: how long is long enough?. A. Sundaralingam, R. Bhatnagar. ERJ Open Research 2026;12(2). Letter PubMed · Publisher · Free full text

• Beyond CT and MRI: terahertz imaging as a frontier tool for early mesothelioma diagnosis. S. Saleem, A. Imtiaz, U.U. Rehman, et al. Annals of Medicine and Surgery 2025;87(12):9169-9170. Letter PubMed · Publisher · Free full text

• Influence of the effectiveness of sarcopenia on postoperative major complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy: a retrospective cohort study. N. Havan, S. Gülmez, A.S. Senger, et al. International Journal of Colorectal Disease 2025;40(1):96. Letter PubMed · Publisher · Free full text

• Letter to the Editor: 'Asbestosis Requiring Lung Transplantation in a Retired Hairdresser: An Occupational Exposure to Comb Through'. E. Anderson, S. Meyler, A. Gallagher, et al. Respirology Case Reports 2025;13(10):e70368. Letter PubMed · Publisher · Free full text

• Primary cardiac pericardial mesothelioma-a rare but deadly disease: a case description. M. Meter, D. Glavaš, D. Radović, et al. Quantitative Imaging in Medicine and Surgery 2025;15(11):11689-11694. Letter PubMed · Publisher · Free full text

• Reply to 'Letter to the Editor: "Asbestosis Requiring Lung Transplantation in a Retired Hairdresser: An Occupational Exposure to Comb Through"'. R. Bu, L. Puttagunta, A. Hirji. Respirology Case Reports 2025;13(10):e70370. Letter · Comment PubMed · Publisher · Free full text

• Risk of cancer associated with residential exposure to asbestos insulation: updated evidence. H.D. Law, M. Clements, N. Lazarevic, et al. The Lancet Regional Health. Western Pacific 2025;63:101699. Letter PubMed · Publisher · Free full text

• The effect of pirfenidone on disease progression in asbestosis patients: a real-world Dutch cohort study. I. Smesseim, A.E. Wind, J.R. Miedema, et al. ERJ Open Research 2025;11(6). Letter PubMed · Publisher · Free full text

• WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome. Z.N. Berneman, M. De Laere, P. Germonpré, et al. Journal of Hematology & Oncology 2025;18(1):9. Letter PubMed · Publisher · Free full text

• A cluster of mesotheliomas reported in a case series does not implicate chrysotile asbestos-containing friction products as the cause of mesotheliomas. S.J. Geyer. American Journal of Industrial Medicine 2024;67(1):81-82. Letter PubMed · Publisher

• A WHO-led global strategy to control greenhouse gas emissions: a call for action. M.F. Chersich, N. Brink, M.H. Craig, et al. Globalization and Health 2024;20(1):4. Letter PubMed · Publisher · Free full text

• Commentary: The role of single nucleotide polymorphisms related to iron homeostasis in mesothelioma susceptibility after asbestos exposure: a genetic study on autoptic samples. G. Tagarakis, F. Tsolaki, I. Tagarakis. Frontiers in Public Health 2024;12:1336545. Comment PubMed · Publisher · Free full text

• Response to the editor-Environmental Research this letter is a critique of the paper by Roggli et al. (1) regarding chronological trends of the fiber burden in mesothelioma cases. V.L. Roggli, E.N. Pavlisko, C.H. Glass, et al. Environmental Research 2024;251(Pt 1):118620. Letter · Comment PubMed · Publisher

• To the Editor-environmental research this letter is a critique of the paper by regarding chronological trends of the fiber burden in mesothelioma cases. A.L. Frank. Environmental Research 2024;251(Pt 1):117352. Letter · Comment PubMed · Publisher

• Commentary on "Mechanisms of asbestos-induced carcinogenesis" published in 2009. S. Toyokuni. Nagoya Journal of Medical Science 2023;85(1):13-15. Comment PubMed · Publisher · Free full text

• Commentary: Case report: Mesothelioma and BAP1 tumor predisposition syndrome: implications for public health. C. Sassorossi, M. Chiappetta, M.T. Congedo, et al. Frontiers in Oncology 2023;13:1279786. Comment PubMed · Publisher · Free full text

• Comments on "Monitoring of airborne asbestos fibers in an urban ambient air of Shahryar City, Iran: levels, spatial distribution, seasonal variations, and health risk assessment" by Taghizadeh et al., https://doi.org/10.1007/s11356-018-4029-0. C.I. Yavuz. Environmental Science and Pollution Research International 2023;30(58):122972-122973. Letter PubMed · Publisher

• Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?. M. Carbone, H. Yang, H.I. Pass, et al. Journal of Thoracic Oncology 2023;18(6):694-697. Editorial · Comment PubMed · Publisher

• Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?. A. Nakamura, K. Kuribayashi. Translational Lung Cancer Research 2023;12(2):193-196. Editorial · Comment PubMed · Publisher · Free full text

• Is mesothelioma related to "initial dose" rather than to "cumulative dose"? Critical remarks on Maghin et al. Assessment protocol of mesothelioma and relevance of SEM-EDS analysis through a case studies of legal medicine of Brescia (Italy). Legal Medicine 2022;57:102076. P.G. Barbieri, D. Consonni, C. Magnani, et al. Legal Medicine 2023;63:102262. Letter · Comment PubMed · Publisher

• Lung cancer: Removing toxic dust from our environment. N. van Zandwijk, H.M. Marshall, K.M. Fong. Respirology 2023;28(6):511-512. Editorial · Comment PubMed · Publisher

• Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma. M. Lapidot, R. Bueno. Translational Lung Cancer Research 2023;12(2):190-192. Editorial · Comment PubMed · Publisher · Free full text

• Response to Letter to the Editor regarding "The prevalences and levels of occupational exposure to dusts and/or fibres (silica, asbestos and coal): A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury". V. Schlünssen, B. Ádám, N.C. Momen, et al. Environment International 2023;179:108165. Letter · Comment PubMed · Publisher

• Response to the Letter to the Editor From Jeffrey Brent, MD, PhD. Re: Mesothelioma Associated With the Use of Cosmetic Talc. J. Moline. Journal of Occupational and Environmental Medicine 2023;65(5):e361. Comment · Letter PubMed · Publisher

• Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma. K. Branch, P.S. Adusumilli, M.G. Zauderer. Translational Lung Cancer Research 2023;12(2):187-189. Editorial · Comment PubMed · Publisher · Free full text

• Spare the lung: surgical treatment approach for malignant pleural mesothelioma. N. Fujimoto. Translational Lung Cancer Research 2023;12(2):197-199. Editorial · Comment PubMed · Publisher · Free full text

• Surgical series in mesothelioma: navigating between biases. J. Raskin, P.E. Van Schil, J.P.V. Meerbeeck. Translational Lung Cancer Research 2023;12(2):184-186. Editorial · Comment PubMed · Publisher · Free full text

• A (Controlled) Spill of IL2 for Localized Treatment of Mesothelioma. R. Palanki, K.L. Swingle, M.J. Mitchell. Clinical Cancer Research 2022;28(23):5010-5012. Editorial · Comment PubMed · Publisher · Free full text

• Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology. T. Meirson, V. Nardone, F. Pentimalli, et al. Journal of Translational Medicine 2022;20(1):593. Letter PubMed · Publisher · Free full text

• ASO Author Reflections: Co-Localization of Synchronous Gastrointestinal Stromal Tumors (GISTs) and Peritoneal Mesothelioma (PM): A Case Series. A.S. Courelli, A.K. Sharma, J.K. Sicklick. Annals of Surgical Oncology 2022;29(12):7549-7550. Comment PubMed · Publisher · Free full text

• Authors' response to the letter to the editor on "characterization of asbestos exposures associated with the use of facial makeups". M. Holton, J. Ellis, E. Anderson. Risk Analysis 2022;42(10):2142-2144. Letter PubMed · Publisher

• Commentary: A return trip to MARS: Less may be more when treating mesothelioma. C.M. Griffin, V.H. van Berkel. The Journal of Thoracic and Cardiovascular Surgery 2022;163(6):1948-1949. Editorial · Comment PubMed · Publisher

• Commentary: Surgical standardization in mesothelioma trials. V.W. Rusch. The Journal of Thoracic and Cardiovascular Surgery 2022;163(6):1949-1950. Editorial · Comment PubMed · Publisher

• Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion. X. Xie, M. You, E. Meng, et al. Journal of Cancer Research and Clinical Oncology 2022;148(9):2561-2566. Case report · Letter PubMed · Publisher · Free full text

• Concerns re Harris et al.: Low-dose CT-detected interstitial lung abnormalities in a population with low asbestos exposure. R.G. Sangani, A.J. Ghio, J.E. Parker. American Journal of Industrial Medicine 2022;65(5):425-426. Letter PubMed · Publisher

• Cytological diagnosis of mesothelioma in situ versus invasive mesothelioma. A. Churg, F. Galateau-Salle, L. Tan, et al. Pathology 2022;54(1):133-136. Case report · Letter PubMed · Publisher

• Does the Amount of Asbestos Exposure Influence Prognosis?. H. Yang, G. Gaudino, F. Bardelli, et al. Journal of Thoracic Oncology 2022;17(8):949-952. Editorial · Comment PubMed · Publisher

• Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link. G. Brandi, K. Straif, D. Mandrioli, et al. Annals of Global Health 2022;88(1):41. Review · Letter PubMed · Publisher · Free full text

• Holton et al., Characterization of asbestos exposures associated with the use of facial makeups. Risk Analysis, 42, 2129-2139. M.M. Finkelstein. Risk Analysis 2022;42(10):2140-2141. Letter PubMed · Publisher

• Invited Perspective: Eliminating Toxics to Prevent Disease: Asbestos Leads the Way. D. Kriebel, D.J. Myers. Environmental Health Perspectives 2022;130(5):51305. Comment PubMed · Publisher · Free full text

• Isolated pancreatic metastasis from a malignant pleural mesothelioma diagnosed using endoscopic ultrasonography-guided fine needle aspiration biopsy. Y. Ishikawa-Kakiya, H. Maruyama, K. Tanoue, et al. Hepatobiliary & Pancreatic Diseases International 2022;21(2):196-198. Letter PubMed · Publisher

• Malignant mesothelioma: health care awareness and preparedness. E.M. Capitani, E. Algranti. Jornal Brasileiro de Pneumologia 2022;48(5):e20220349. In English, Portuguese. Editorial · Comment PubMed · Publisher · Free full text

• Mesothelioma among vehicle mechanics: a controversy?. P.A. Hessel. Thorax 2022;77(5):426-427. Editorial · Comment PubMed · Publisher

• Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations. Y.L. Liu, K.A. Cadoo, S. Mukherjee, et al. Cancer Epidemiology, Biomarkers & Prevention 2022;31(2):362-371. Comment PubMed · Publisher · Free full text

• Re: Comment to "Relationship between exposure to ionizing radiation and mesothelioma risk: A systematic review of the scientific literature and meta-analysis": Cancer Med. 2022 Feb;11(3):778-789. doi:10.1002/cam4.4436. Epub 2022 Jan 14: Cancer Med. 2022 Feb;11(3):778-789. doi:10.1002/cam4.4436. Epub 2022 Jan 14. G. Visci, C. Zunarelli, P. Boffetta, et al. Cancer Medicine 2022;11(24):5035-5036. Letter · Comment PubMed · Publisher · Free full text

• Response to "Revisiting 'BAP1ness' in Malignant Pleural Mesothelioma". O.D. Røe, J. Creaney, BAP1 Study Group. Journal of Thoracic Oncology 2022;17(8):e69-e70. Letter · Comment PubMed · Publisher

• The Role of Real-World Evidence to Support Treatment Choices in Malignant Pleural Mesothelioma. P. Wheatley-Price, S. Moore, C.W. Lee. JTO Clinical and Research Reports 2022;3(4):100300. Editorial · Comment PubMed · Publisher · Free full text

• A reply to "managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy". G.L. Ceresoli, P. Ghirardelli, D. Franceschini, et al. Lung Cancer 2021;157:165-166. Letter · Comment PubMed · Publisher

• Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis". A. Marinaccio, D. Consonni, C. Mensi, et al. Scandinavian Journal of Work, Environment & Health 2021;47(1):87-89. Letter · Comment PubMed · Publisher · Free full text

• Benefit with first-line ICIs in mesothelioma. D. Romero. Nature Reviews. Clinical Oncology 2021;18(4):194. Comment PubMed · Publisher

• CAR T cells show promise in mesothelioma. D. Killock. Nature Reviews. Clinical Oncology 2021;18(9):541. Comment PubMed · Publisher

• Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal Mesothelioma. K. Raghav, S. Liu, M. Overman, et al. JAMA Network Open 2021;4(8):e2119934. Letter PubMed · Publisher · Free full text

• Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy". H. Yang, S.R.R. Hall, B. Sun, et al. British Journal of Cancer 2021;124(6):1177-1178. Letter · Comment PubMed · Publisher · Free full text

• Commentary: Acute kidney injury after intrapleural cisplatin: Minimizing collateral damage. M.I. Ebright. The Journal of Thoracic and Cardiovascular Surgery 2021;161(4):1522-1523. Editorial · Comment PubMed · Publisher

• Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma. S.S. Groth, R.T. Ripley. The Journal of Thoracic and Cardiovascular Surgery 2021;161(4):1519-1520. Editorial · Comment PubMed · Publisher

• Commentary: SARS-CoV-2 and Asbestos Exposure: Can Our Experience With Mesothelioma Patients Help Us Understand the Psychological Consequences of COVID-19 and Develop Interventions?. D. Di Basilio, J. Shigemura, F. Guglielmucci. Frontiers in Psychology 2021;12:720160. Comment PubMed · Publisher · Free full text

• Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma. A. Bribriesco. The Journal of Thoracic and Cardiovascular Surgery 2021;161(4):1520-1522. Editorial · Comment PubMed · Publisher

• Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis. G. Mezei, E.T. Chang, F.S. Mowat, et al. Scandinavian Journal of Work, Environment & Health 2021;47(1):85-86. Letter · Comment PubMed · Publisher · Free full text

• Complete pathological response after ceritinib for anaplastic lymphoma kinase-rearranged epithelioid peritoneal mesothelioma. S. Sakata, H. Rees, S. Parke, et al. ANZ Journal of Surgery 2021;91(3):475-476. Letter PubMed · Publisher

• Independent lung ventilation using a piston-driven anesthesia machine to ventilate the affected lung during resection of the visceral pleura for malignant pleural mesothelioma: A case series. T. Kida, T. Kobashi, T. Takei, et al. Journal of Clinical Anesthesia 2021;75:110456. Letter PubMed · Publisher

• Is Mesothelioma Unrelated to the Lung Asbestos Burden? Comment on Visonà et al. Inorganic Fiber Lung Burden in Subjects with Occupational and/or Anthropogenic Environmental Asbestos Exposure in Broni (Pavia, Northern Italy): An SEM-EDS Study on Autoptic Samples. Int. J. Environ. Res. Public Health 2021, 18, 2053. D. Mirabelli, A. Angelini, P.G. Barbieri, et al. International Journal of Environmental Research and Public Health 2021;18(13). Comment PubMed · Publisher · Free full text

• L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well-differentiated papillary mesothelial tumours and malignant mesotheliomas. G. Karpathiou, F. Casteillo, M. Dridi, et al. Histopathology 2021;79(2):272-274. Letter PubMed · Publisher

  In plain English

  This was a short research letter by pathologists at university hospitals in Saint-Etienne, France, and Ioannina, Greece. They looked back at tissue from 57 consecutive cystic mesothelial lesions, which are fluid-filled lesions of the lining of body cavities. Of these, 47 were in the peritoneum (abdominal lining) and 10 in the pericardium (lining around the heart). They stained the tissue for a protein called L1CAM. For comparison, they also stained 18 adenomatoid tumours and 7 well-differentiated papillary mesothelial tumours, both benign, and 24 malignant mesotheliomas, all pleural and epithelioid. None of the 57 cystic lesions and none of the 24 malignant mesotheliomas showed L1CAM. The protein was found in 13 of the 18 adenomatoid tumours (focal in 6) and in 3 of the 7 papillary tumours (mild and focal). The authors concluded that L1CAM is not found in cystic mesothelial lesions, which probably suggests these lesions arise differently from the two benign tumours. They also said L1CAM staining should be interpreted with caution when used for diagnosis, partly because the antibody they used detects L1CAM least often of the available antibodies. The article does not discuss asbestos exposure.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• Letter to the Editor: Comment on 'Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions'. Lung Cancer 2021;159:127. Letter PubMed · Publisher

• Managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy. A.R. Barsky, N. Yegya-Raman, S.I. Katz, et al. Lung Cancer 2021;157:163-164. Letter · Comment PubMed · Publisher

• New and old treatments for malignant mesothelioma: not just immunotherapy. A.K. Nowak. The Lancet. Respiratory Medicine 2021;9(6):547-549. Comment PubMed · Publisher

• Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests. X. Baur, A.L. Frank. Journal of Occupational Medicine and Toxicology 2021;16(1):6. Letter PubMed · Publisher · Free full text

• Personalized Prognostication in Malignant Pleural Effusion: The Next Step?. D.N. Addala, N.M. Rahman, F. Maldonado. Chest 2021;160(3):805-806. Editorial · Comment PubMed · Publisher

• Post-thoracotomy neuralgic amyotrophy in a patient with BAP1 tumor predisposition syndrome: Multimodality longitudinal follow-up. N. Jazebi, N. Dargah-Zada, K. Alter, et al. Muscle & Nerve 2021;64(3):E7-E9. Case report · Letter PubMed · Publisher · Free full text

• Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinib. A. Petit, S. Lantuejoul, A. Mc Leer, et al. Pediatric Blood & Cancer 2021;68(2):e28666. Case report · Letter PubMed · Publisher

• Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment. O. Arponen, V. Salo, A. Lönnberg, et al. Acta Oncologica 2021;60(5):687-691. Case report · Letter PubMed · Publisher

• Prognostic Role of PD-L1 in Malignant Pleural Mesothelioma: Unraveling the Complexity of the Tumor Microenvironment in Mesothelioma. M. de Perrot. The Annals of Thoracic Surgery 2021;112(5):1583-1584. Comment PubMed · Publisher

• Re: 'High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients'. A. Hara, M. Matsuda, A. Ishii, et al. European Journal of Cancer 2021;153:265-266. Letter · Comment PubMed · Publisher

• Re: Comments on 'High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients'. L. Cantini, F. Pecci, F. Dammeijer, et al. European Journal of Cancer 2021;153:267-269. Letter · Comment PubMed · Publisher

• Re: Dutheil et al. Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis. P. Boffetta, N. Franco, A. Gullino, et al. The Permanente Journal 2021;25. Letter · Comment PubMed · Publisher · Free full text

• Reply to Mirabelli et al. Is Mesothelioma Unrelated to the Lung Asbestos Burden? Comment on "Visonà et al. Inorganic Fiber Lung Burden in Subjects with Occupational and/or Anthropogenic Environmental Asbestos Exposure in Broni (Pavia, Northern Italy): An SEM-EDS Study on Autoptic Samples. Int. J. Environ. Res. Public Health 2021, 18, 2053". S.D. Visonà, S. Capella, S. Bodini, et al. International Journal of Environmental Research and Public Health 2021;18(13). Comment PubMed · Publisher · Free full text

• Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy". M.G. White, O.S. Eng. British Journal of Cancer 2021;124(6):1179-1180. Letter · Comment PubMed · Publisher · Free full text

• SMART: logical radiotherapy and surgery beyond MARS. H.I. Pass. The Lancet. Oncology 2021;22(2):156-157. Comment PubMed · Publisher

• 'Compositional data analysis' by Barabesi and Sartorelli: Authors' response. R. Kaarteenaho, E. Keskitalo. Occupational and Environmental Medicine 2020;77(5):351. Letter · Comment PubMed · Publisher

• ALK positive malignant peritoneal mesothelioma mimicking inflammatory myofibroblastic tumour: a diagnostic pitfall. A. Louw, C. Wallace, S.M. Chai, et al. Pathology 2020;52(6):719-722. Case report · Letter PubMed · Publisher

• An appropriate choice for immunotherapy in malignant pleural mesothelioma. N. Fujimoto. EBioMedicine 2020;62:103057. Letter PubMed · Publisher · Free full text

• Asbestos, Pleural Plaques, and Lung Cancer: Untangling the Relationships. P. Harber. American Journal of Respiratory and Critical Care Medicine 2020;201(1):4-6. Editorial · Comment PubMed · Publisher · Free full text

• Author's response to 'Re: Exposure to asbestos and the risk of colorectal cancer mortality: a systematic review and meta-analysis by Kwak et al'. K. Kwak, D. Paek, K.E. Zoh. Occupational and Environmental Medicine 2020;77(9):656-657. Letter · Comment PubMed · Publisher

• Authors' Response to "Evidence Does Not Support Exposure to Cosmetic Talc as a Cause of Malignant Mesothelioma". J. Moline, K. Bevilacqua, R.E. Gordon. Journal of Occupational and Environmental Medicine 2020;62(2):e85-e86. Letter · Comment PubMed · Publisher

• Authors' response to "malignant mesothelioma following exposure to cosmetic talc: Association, not causation". T.S. Emory, J.C. Maddox, R.L. Kradin. American Journal of Industrial Medicine 2020;63(7):651-652. Letter · Comment PubMed · Publisher

• Cancer in the time of COVID-19: expert opinion on how to adapt current practice. J. Raskin, M. Lebeer, C. De Bondt, et al. The European Respiratory Journal 2020;55(5). Letter PubMed · Publisher · Free full text

• Comment on "EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach". W.T. Vigneswaran, M. Kittaneh. Translational Lung Cancer Research 2020;9(6):2508-2510. Editorial · Comment PubMed · Publisher · Free full text

• Comment on Małgorzata Krówczyńska and Ewa Wilk. Environmental and Occupational Exposure to Asbestos as a Result of Consumption and Use in Poland. Int. J. Environ. Res. Public Health 2019, 16, 2611. B. Świątkowska, W. Hanke. International Journal of Environmental Research and Public Health 2020;17(5). Comment PubMed · Publisher · Free full text

• Commentary: A journey of a thousand miles begins with a single step. T.F. Chen-Yoshikawa. The Journal of Thoracic and Cardiovascular Surgery 2020;159(5):2092-2093. Editorial · Comment PubMed · Publisher

• Commentary: Biphasic malignant mesothelioma-Survival of the fittest. L.M. Felmly, B.C. Gibney. The Journal of Thoracic and Cardiovascular Surgery 2020;159(4):1596-1597. Editorial · Comment PubMed · Publisher

• Commentary: Filling up my truck from an oil tanker: Can big 'omic' data influence our clinical decisions?. R.T. Ripley. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1086-1087. Editorial · Comment PubMed · Publisher

• Commentary: Focused attention on proactive identification of deep venous thrombosis after pleurectomy/decortication for malignant pleural mesothelioma. S.S. Groth, R.T. Ripley, P.W. Carrott, et al. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1075-1076. Editorial · Comment PubMed · Publisher

• Commentary: Go small or go home. A.W. Kim, U. Ahmad. The Journal of Thoracic and Cardiovascular Surgery 2020;160(3):e173-e174. Editorial · Comment PubMed · Publisher

• Commentary: Is thoracic cage volume a new parameter for clinical staging in mesothelioma?. M. de Perrot. The Journal of Thoracic and Cardiovascular Surgery 2020;159(6):2520-2521. Editorial · Comment PubMed · Publisher

• Commentary: Know your enemy-Understanding futility in the battle against malignant pleural mesothelioma. A.E. Giles, B. Kidane. The Journal of Thoracic and Cardiovascular Surgery 2020;159(6):2523-2524. Editorial · Comment PubMed · Publisher

• Commentary: Local chemotherapy with nanoparticles: A ray of light in the dark?. S. Nakamura, T.F. Chen-Yoshikawa. The Journal of Thoracic and Cardiovascular Surgery 2020;160(3):e169-e170. Editorial · Comment PubMed · Publisher

• Commentary: Mesothelioma: The Guinness world record holder in thromboembolism. R.B. Cameron. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1074-1075. Editorial · Comment PubMed · Publisher

• Commentary: Not only SMART clinically, but translationally!. H.I. Pass. The Journal of Thoracic and Cardiovascular Surgery 2020;159(5):2094-2095. Editorial · Comment PubMed · Publisher

• Commentary: One nano-step for murinekind, one giant leap for mesothelioma. J.S. Dutcher, J. D'Cunha. The Journal of Thoracic and Cardiovascular Surgery 2020;160(3):e170-e171. Editorial · Comment PubMed · Publisher

• Commentary: Picking the winners-Leaning into selection bias. E. Wakeam, B. Kidane. The Journal of Thoracic and Cardiovascular Surgery 2020;159(4):1594-1595. Editorial · Comment PubMed · Publisher

• Commentary: Surgeon versus mesothelioma in a thoracic cage match. C.D. Hoang. The Journal of Thoracic and Cardiovascular Surgery 2020;159(6):2522-2523. Editorial · Comment PubMed · Publisher

• Commentary: Tasting individual ingredients of meso soup: Can 'omics bring out the flavor?. H.I. Pass. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1084-1085. Editorial · Comment PubMed · Publisher

• Commentary: To scan or not to scan: No longer the question for mesothelioma patients after pleurectomy. E.A. David, S.M. Atay. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1076-1077. Editorial · Comment PubMed · Publisher

• Compositional data analysis. L. Barabesi, P. Sartorelli. Occupational and Environmental Medicine 2020;77(5):352. Letter · Comment PubMed · Publisher

• Evidence Does Not Support Exposure to Cosmetic Talc as Cause of Malignant Mesothelioma. S.J. Geyer. Journal of Occupational and Environmental Medicine 2020;62(2):e83-e84. Letter · Comment PubMed · Publisher

• Ferrante et al respond. D. Ferrante, D. Mirabelli, S. Silvestri, et al. American Journal of Industrial Medicine 2020;63(9):836-837. Letter · Comment PubMed · Publisher

• Follow-Up of the Libby, Montana Screening Cohort: A 17-Year Mortality Study: Likely Underestimation of Nonmalignant Asbestos-Related Disease. A. Miller, G.M. Loewen, J. Szeinuk. Journal of Occupational and Environmental Medicine 2020;62(5):e233-e234. Letter · Comment PubMed · Publisher

• Identification of the prognostic and immunotherapeutic potential of L antigen family member 3 in malignant pleural mesothelioma. X. Dong, J. Song, M. He, et al. Clinical and Translational Medicine 2020;10(7):e207. Letter PubMed · Publisher · Free full text

• IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade. M.P. Pistillo, R. Carosio, B. Banelli, et al. Cellular & Molecular Immunology 2020;17(4):410-411. Letter PubMed · Publisher · Free full text

• In Reply. A.G. Nicholson, J.L. Sauter, F. Galateau-Salle. Journal of Thoracic Oncology 2020;15(6):e94-e95. Letter · Comment PubMed · Publisher

• In Response. F. Dutheil, L. Zaragoza-Civale, B. Pereira, et al. The Permanente Journal 2020;25:1. Letter · Comment PubMed · Publisher

• Inhalation unit risk (IUR) of asbestos based on available science. A. Korchevskiy, J.O. Rasmuson, E.J. Rasmuson, et al. Inhalation Toxicology 2020;32(9-10):372-374. Letter PubMed · Publisher

• Is the Deciduoid Variant of Pleural Mesothelioma Significant?. A. Aujayeb, L. Taylor. Journal of Thoracic Oncology 2020;15(6):e94. Letter · Comment PubMed · Publisher

• Letter to Editor regarding Franzblau et al. 2020: Asbestos-containing materials in abandoned residential dwellings in Detroit, Science of Total Environment, v714,1-8. A.L. Frank. The Science of the Total Environment 2020;739:139129. Letter · Comment PubMed · Publisher

• Letter to the Editor regarding Bullock 2020. D. Egilman, B. Castleman, T. Bird. Critical Reviews in Toxicology 2020;50(10):953-954. Letter · Comment PubMed · Publisher

• Letter to the Editor: Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA. D.J. Lauer, K.A. Mundt, W.J. Thompson, et al. World Journal of Surgery 2020;44(12):4279-4280. Letter · Comment PubMed · Publisher

• Low-Dosage Apatinib as Rescuing Treatment in Advanced Malignant Pleural Mesothelioma. Y.Y. Liu, W.Y. Zhang, D.X. Zeng. American Journal of Therapeutics 2020;27(3):e326-e327. Case report · Letter PubMed · Publisher

• Malignant mesothelioma following exposure to cosmetic talc: Association, not causation. S.J. Geyer. American Journal of Industrial Medicine 2020;63(7):649-650. Letter · Comment PubMed · Publisher

• Malignant mesothelioma presenting as a solitary perifissural nodule. L. Mo, B. Adler, C. Green, et al. Internal Medicine Journal 2020;50(12):1592-1594. Letter PubMed · Publisher

• Malignant peritoneal mesothelioma presenting as a splenic mass. M. Podberezin, M.J. Fitzpatrick, L.P. Hariri, et al. Pathology, Research and Practice 2020;216(12):153273. Case report · Letter PubMed · Publisher

• Mediastinal and pleuropulmonary myeloid sarcoma with HBME1 and podoplanin expression. A diagnostic pitfall. D. Suárez-Vilela, F.M. Izquierdo. APMIS 2020;128(1):65-68. Case report · Letter PubMed · Publisher

• Mesothelioma in the age of "Omics": Before and after The Cancer Genome Atlas. D.T. Severson, A. De Rienzo, R. Bueno. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1078-1083.e2. Editorial · Comment PubMed · Publisher · Free full text

• Natriuretic peptides in pleural effusions: Beyond a diagnosis of heart failure. J.M. Porcel. Respirology 2020;25(10):1021-1022. Editorial · Comment PubMed · Publisher

• New Information on Talc and Mesothelioma. J.B. Shrager. The Annals of Thoracic Surgery 2020;110(3):1099. Letter · Comment PubMed · Publisher

• Not just a research method: If used with caution, can job-exposure matrices be a useful tool in the practice of occupational medicine and public health?. M. Fadel, B.A. Evanoff, J.H. Andersen, et al. Scandinavian Journal of Work, Environment & Health 2020;46(5):552-553. Letter · Comment PubMed · Publisher · Free full text

• Occupational lung disease: the need for a global surveillance system. K. Asanati, S.H. Al Jassasi, A. Sherafat, et al. Occupational and Environmental Medicine 2020;77(7):506-507. Letter · Comment PubMed · Publisher

• Oncolytic Viral Therapy for Malignant Pleural Mesothelioma. H. Yang, D. Xu, Y. Gao, et al. Journal of Thoracic Oncology 2020;15(7):e111-e113. Letter · Comment PubMed · Publisher

• Personalized Oncolytic Therapy: The Next Step Toward the Successful Clinical Application of Vaccine-Strain Measles Viruses for Cancer Therapy?. T. Peikert. Journal of Thoracic Oncology 2020;15(5):689-691. Editorial · Comment PubMed · Publisher

• Pleural sarcomatoid mesothelioma with an interstitial growth pattern. K. Miyakawa, M. Yamamoto, N. Akiyama, et al. Pathology International 2020;70(2):126-128. Case report · Letter PubMed · Publisher

• Prognostication in malignant pleural effusion: One size does not fit all. A. Dipper, N. Maskell. Respirology 2020;25(12):1229-1230. Editorial · Comment PubMed · Publisher

• Re Ferrante et al (2020). Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study. J. Schüz, H. Kromhout. American Journal of Industrial Medicine 2020;63(9):834-835. Letter · Comment PubMed · Publisher

• Re: Exposure to asbestos and the risk of colorectal cancer mortality: a systematic review and meta-analysis by Kwak et al. P. Boffetta. Occupational and Environmental Medicine 2020;77(9):655. Letter · Comment PubMed · Publisher

• Regulated Asbestos Analysis: EPA Polarized Light Microscopy Method and the Implications for Reported Fiber Sizes. T.G. Laubenthal. New Solutions 2020;30(2):83-85. Letter PubMed · Publisher

• Reply to Comment on Małgorzata Krówczyńska and Ewa Wilk. Environmental and Occupational Exposure to Asbestos as a Result of Consumption and Use in Poland. Int. J. Environ. Res. Public Health 2019, 16, 2611. M. Krówczyńska, E. Wilk. International Journal of Environmental Research and Public Health 2020;17(6). Comment PubMed · Publisher · Free full text

• Reply to Waller et al. Standardizing Surgical Treatment for Mesothelioma. J.S. Friedberg, M.J. Culligan, A.S. Tsao, et al. Journal of Thoracic Oncology 2020;15(5):e75-e77. Letter · Comment PubMed · Publisher

• Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma. D. Jean, T. Delaunay, C. Meiller, et al. Journal of Thoracic Oncology 2020;15(7):e113-e116. Letter · Comment PubMed · Publisher

• Response to 'Follow-Up of the Libby, Montana Screening Cohort: A 17-year Mortality Study: Likely Underestimation of Nonmalignant Asbestos-Related Disease'. T.C. Larson, L. Williamson, V.C. Antao. Journal of Occupational and Environmental Medicine 2020;62(5):e235. Letter · Comment PubMed · Publisher · Free full text

• Response to Letter to Editor by Cornelissen et al. R. Hassan, M. Miettinen. Journal of Thoracic Oncology 2020;15(10):e169-e170. Letter · Comment PubMed · Publisher · Free full text

• Response to Letter to the Editor by Yang et al. R. Hassan, M. Sengupta, J. Murai, et al. Journal of Thoracic Oncology 2020;15(6):e91. Letter · Comment PubMed · Publisher

• Response to Letter to the Editor from Egilman, Castleman and Bird (2020) concerning Bullock (2020), Perspectives on the knowledge of asbestos disease in the United States - what was known, by whom and when. W.H. Bullock. Critical Reviews in Toxicology 2020;50(10):955-956. Letter · Comment PubMed · Publisher

• Response to Letter to the Editor regarding Franzblau et al., Asbestos-containing materials in abandoned residential dwellings in Detroit, from Prof. Arthur Frank, MD, PhD. A. Franzblau, A.H. Demond, S.K. Sayler, et al. The Science of the Total Environment 2020;739:139165. Letter · Comment PubMed · Publisher

• Response to Roggli et al. (2020) "Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation". T. Tran, D. Egilman, M. Rigler. Ultrastructural Pathology 2020;44(3):314-315. Comment PubMed · Publisher

• Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back. P. Astoul. Translational Lung Cancer Research 2020;9(4):1613-1616. Editorial · Comment PubMed · Publisher · Free full text

• Second primary malignancies in patients with hidradenocarcinoma: a US national database study. A. Loya, V. Ramachandran, H.P. Nguyen. Clinical and Experimental Dermatology 2020;45(4):453-455. Letter PubMed · Publisher

• Standardizing Surgical Treatment of Malignant Pleural Mesothelioma. D.A. Waller, R. Bilancia, A. Bille, et al. Journal of Thoracic Oncology 2020;15(5):e73-e74. Letter · Comment PubMed · Publisher

• The Association of BAP1 Loss-of-Function With the Defect in Homologous Recombination Repair and Sensitivity to PARP-Targeted Therapy. H. Yang, D. Xu, Y. Gao, et al. Journal of Thoracic Oncology 2020;15(6):e88-e90. Letter · Comment PubMed · Publisher

• The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma. H.J. Lee, T. Pham, M.T. Chang, et al. Cancer Research 2020;80(8):1656-1668. Comment PubMed · Publisher · Free full text

• Transitional Mesothelioma and Artificial Intelligence: Do We Need One More Subtype? and Do We Need Computers to Identify Them?. M. Carbone. Journal of Thoracic Oncology 2020;15(6):884-887. Editorial · Comment PubMed · Publisher

• Tumour Treating Fields for mesothelioma - Authors' reply. G.L. Ceresoli, L. Gianoncelli, F. Grosso, et al. The Lancet. Oncology 2020;21(1):e10. Letter · Comment PubMed · Publisher

• Tumour Treating Fields for mesothelioma. C.J. de Gooijer, J.A. Burgers. The Lancet. Oncology 2020;21(1):e9. Letter · Comment PubMed · Publisher

• Tumour Treating Fields for mesothelioma. M. Barbarino, M. Bottaro, L. Luzzi, et al. The Lancet. Oncology 2020;21(1):e8. Letter · Comment PubMed · Publisher

• Utility of highly expressed EZH2 in pleural effusion cytology for the diagnosis of mesothelioma. M. Yoshimura, M. Hamasaki, Y. Kinoshita, et al. Pathology International 2020;70(10):831-833. Letter PubMed · Publisher

2010s

• 3D Culture Models of Malignant Mesothelioma Reveal a Powerful Interplay Between Photodynamic Therapy and Kinase Suppression Offering Hope to Reduce Tumor Recurrence. B.Q. Spring, D. Kessel. Photochemistry and Photobiology 2019;95(1):462-463. Comment PubMed · Publisher

• A better AI-based tool for mesothelioma. D. Romero. Nature Reviews. Clinical Oncology 2019;16(12):722. Comment PubMed · Publisher

• A case of malignant mesothelioma pleural effusion with MOC-31, BerEP4, and calretinin expression. P. Zhao. Diagnostic Cytopathology 2019;47(12):1321-1323. Case report · Letter PubMed · Publisher

• A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. M.M. Finkelstein. Toxicology and Applied Pharmacology 2019;371:1-2. Letter PubMed · Publisher

• A thinner peel to peel: Pleural thickness is prognostic in mesothelioma. S.S. Groth, R.T. Ripley, B.M. Burt. The Journal of Thoracic and Cardiovascular Surgery 2019;157(1):414-415. Editorial · Comment PubMed · Publisher

• An unexpected cause of dysphagia: pleural mesothelioma. S.M. Santos Seoane, R. Yano Escudero, V. Arenas García. Revista Española de Enfermedades Digestivas 2019;111(6):494-495. Case report · Letter PubMed · Publisher

• Asbestos-related Diseases in Turkey: Caused Not Only by Naturally Occurring Fibers but Also by Industrial Exposures. M. Bayram, D. Özkan, E. Hayat, et al. American Journal of Respiratory and Critical Care Medicine 2019;199(5):656-659. Letter PubMed · Publisher

• ASO Author Reflections: Postoperative Radiotherapy for Patients with Mesothelioma-Past, Present, and Future. G.D. Lewis, B.S. Teh. Annals of Surgical Oncology 2019;26(Suppl 3):635-636. Comment PubMed · Publisher

• Beyond Stanton and Pott hypothesis; carbon nanotubes-induced malignant mesothelioma as a disease of gene loss. G.J. Yoshida. Journal of Occupational Health 2019;61(2):203-205. Letter PubMed · Publisher · Free full text

• Cause of Asbestos-Induced Pleurisy Forgotten. E. Böhm. Deutsches Ärzteblatt International 2019;116(37):615. Comment PubMed · Publisher · Free full text

• Checkpoint inhibitors in mesothelioma: hope for the future?. A. Bibby, N. Maskell. The Lancet. Oncology 2019;20(2):172-174. Comment PubMed · Publisher

• Comment on the paper 'Boffetta et al. Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy. Ann Oncol 2018; 29(2): 484-489'. D. Consonni, C. Mensi. Annals of Oncology 2019;30(2):340-341. Letter · Comment PubMed · Publisher

• Comment on: "Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos". E.J.A. Harris, A.W. Musk, N. DeKlerk, et al. Lung Cancer 2019;136:148-149. Letter PubMed · Publisher

• Comment on: "Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos". F. Barbone, F. Barbiero, G. Fasola. Lung Cancer 2019;136:150. Letter PubMed · Publisher

• Comment on: Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure. E. Oddone, B. Terracini, D. Mirabelli, et al. Carcinogenesis 2019;40(3):488-489. Letter · Comment PubMed · Publisher

• Commentary: Adjuvant intensity-modulated radiation therapy for malignant pleural mesothelioma: Suspension of intention. S.S. Groth, B.M. Burt, R.T. Ripley. The Journal of Thoracic and Cardiovascular Surgery 2019;158(3):932-933. Editorial · Comment PubMed · Publisher

• Commentary: Return to intended radiation therapy-Criteria for resection?. J. Dux, R. Grosser, P.S. Adusumilli. The Journal of Thoracic and Cardiovascular Surgery 2019;158(3):930-931. Editorial · Comment PubMed · Publisher · Free full text

• Comments on "Dimensions of elongated mineral particles with implications for pathogenicity and classification as asbestiform versus cleavage fragments". M.M. Finkelstein. Ultrastructural Pathology 2019;43(6):326-329. Letter · Comment PubMed · Publisher

• Comments on Vimercati et al., 2019, "Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register". G. Mezei, E.T. Chang, F.S. Mowat, et al. Environmental Health 2019;18(1):111. Letter PubMed · Publisher · Free full text

• Contextualising the policy decision to ban asbestos. B. Terracini. The Lancet. Planetary Health 2019;3(8):e331-e332. Comment PubMed · Publisher

• Does Chromothripsis Make Mesothelioma an Immunogenic Cancer?. M. Carbone, H. Yang, G. Gaudino. Journal of Thoracic Oncology 2019;14(2):157-159. Editorial · Comment PubMed · Publisher · Free full text

• Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion. M. Yamazoe, H. Ozasa, Y.H. Kim. Journal of Thoracic Oncology 2019;14(11):e251-e253. Case report · Letter PubMed · Publisher

• Expert Review Under Attack: Glyphosate, Talc, and Cancer. J.M. Samet. American Journal of Public Health 2019;109(7):976-978. Comment PubMed · Publisher · Free full text

• Fatal Anti-Ma2 Encephalitis Related to Treatment of Malignant Pleural Mesothelioma With a Combination of Anti-Programmed Death 1 and Anti-Cytotoxic T-Lymphocyte Associated Protein 4 Antibodies. P. Du Rusquec, A. Peyre, F. Toulgoat, et al. Journal of Thoracic Oncology 2019;14(8):e174-e176. Letter PubMed · Publisher

• Health inequalities in former asbestos workers. F. Chirico, N. Magnavita. Epidemiologia e Prevenzione 2019;43(1):5. Letter PubMed · Publisher

• Idiopathic pulmonary fibrosis and asbestos use. C.M. Barber, D. Fishwick. BMJ 2019;364:l1041. Letter · Comment PubMed · Publisher

• IGG4-Related Pleural Bridging Fibrosis, Retrosternal Fibrosclerosis and Retroperitoneal Fibrosis in an Asbestos-Exposed Patient. P.P.T.E.S. Torres, L.B.M. Fonseca, K.S. Teixeira, et al. Archivos de Bronconeumología 2019;55(9):496-497. In English, Spanish. Case report · Letter PubMed · Publisher

• Immunotherapy trials in mesothelioma - promising results, but don't stop here. A.K. Nowak, P.M. Forde. Nature Reviews. Clinical Oncology 2019;16(12):726-728. Comment PubMed · Publisher

• In Reply to "Malignant Mesothelioma and Its Nonasbestos Causes". R.L. Attanoos, A. Churg, F. Galateau-Salle, et al. Archives of Pathology & Laboratory Medicine 2019;143(8):911-914. Letter · Comment PubMed · Publisher

• Letter concerning: Burns AM, Barlow CA, Banducci AM, Unice KM, Sahmel J. Potential Airborne Asbestos Exposure and Risk Associated with the Historical Use of Cosmetic Talcum Powder Products. M.M. Finkelstein. Risk Analysis 2019;39(12):2601-2603. Letter PubMed · Publisher

• Letter concerning: Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration of latency period by Gary M. Marsh et al. (Inhal Toxicol. 2019 Aug 5:1-11. doi:10.1080/08958378.2019.1645768). M.M. Finkelstein. Inhalation Toxicology 2019;31(13-14):429-431. Letter · Comment PubMed · Publisher

• Letter to the Editor on "Chrysotile and rock wool fibers induce chromosome aberrations and DNA damage in V79 lung fibroblast cells". J.G. Hadley, A.E. Crane. Environmental Science and Pollution Research International 2019;26(3):3091-3093. Letter · Comment PubMed · Publisher · Free full text

• Letter to the editor re: Dragani et al. (2018), 'Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure'. A. Farioli, S. Mattioli, S. Curti, et al. Carcinogenesis 2019;40(3):487. Letter · Comment PubMed · Publisher

• Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma. M. Ladanyi, F. Sanchez Vega, M. Zauderer. Genome Medicine 2019;11(1):18. Comment PubMed · Publisher · Free full text

• Malignant Mesothelioma and Its Nonasbestos Causes. M.M. Finkelstein. Archives of Pathology & Laboratory Medicine 2019;143(6):659-660. Letter · Comment PubMed · Publisher

• Malignant Mesothelioma and Its Nonasbestos Causes: Talcum Powder Does Not Create Occult Asbestos Exposure. S.J. Geyer. Archives of Pathology & Laboratory Medicine 2019;143(12):1439. Letter · Comment PubMed · Publisher

• Molecular and Ultrastructural Features of Diffuse Intrapulmonary Malignant Mesothelioma. B.T. Larsen, M.L. Smith, A.C. Roden, et al. The American Journal of Surgical Pathology 2019;43(1):147-150. Letter PubMed · Publisher

• MUC4 Staining in Sarcomatoid Carcinomas. K.B. Berg, D. Ionescu, A.M. Churg. Modern Pathology 2019;32(1):157. Letter · Comment PubMed · Publisher

• Nivo-lution in Mesothelioma. A.S. Mansfield, M.G. Zauderer. Clinical Cancer Research 2019;25(18):5438-5440. Comment PubMed · Publisher · Free full text

• Nonexpandable Lung: More Than Just a Call from Radiology. D. Feller-Kopman. Annals of the American Thoracic Society 2019;16(10):1240-1242. Editorial · Comment PubMed · Publisher

• On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016). E. Pira, P. Boffetta, C. Ciocan. Tumori 2019;105(4):359-360. Letter PubMed · Publisher

• Palliative care in mesothelioma: Are current services RESPECT-able enough?. N. Kumar, D. Alrifai, I. Psallidas. Thorax 2019;74(4):326-327. Editorial · Comment PubMed · Publisher

• Paraneoplastic Migratory Oligoarthritis in a Patient With Malignant Mesothelioma. M. Eidenschink, A. Beard, D. Ewart. The American Journal of Medicine 2019;132(11):e801-e802. Case report · Letter PubMed · Publisher

• Potential Problems with Determining Elongate Mineral Particle (EMP) Potency (Comments on article entitled, "A Comparison of Asbestos Fiber Potency and Elongate Mineral Particle (EMP) Potency for Mesothelioma in Humans"). J.H. Mandel, N.U. Odo, B.H. Alexander. Toxicology and Applied Pharmacology 2019;370:131-132. Comment PubMed · Publisher

• Public Health and Independent Risk Assessment. P. Vineis. American Journal of Public Health 2019;109(7):978-980. Comment PubMed · Publisher · Free full text

• Re: Comments on Egilman's response to Hessel regarding the health hazards of brake dust and his reflections on corporate behavior. D. Paustenbach. American Journal of Industrial Medicine 2019;62(7):616-624. Letter · Comment PubMed · Publisher

• Refining classification of malignant pleural mesothelioma reveals its Achilles' heel. I.S. Pateras. EBioMedicine 2019;48:3-4. Letter PubMed · Publisher · Free full text

• Reimagining Our System for Public Health Protection. D. Michaels. American Journal of Public Health 2019;109(7):975-976. Comment PubMed · Publisher · Free full text

• Reliance, Not Responsibility: Relations Between Science and Industry. H. Rodenberg. American Journal of Public Health 2019;109(7):980-981. Comment PubMed · Publisher · Free full text

• Reply to 'MUC4 staining in sarcomatoid carcinomas' by Berg et al. V.J. Amatya, K. Kushitani, A.S. Mawas, et al. Modern Pathology 2019;32(1):158. Letter · Comment PubMed · Publisher

• Reply to letters to the editor by Brentisci et al. and Consonni and Mensi. P. Boffetta, L. Righi, C. Ciocan, et al. Annals of Oncology 2019;30(2):341. Letter · Comment PubMed · Publisher

• Response to comment on: "Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos". P. Maisonneuve, S. Iavicoli, G. Veronesi. Lung Cancer 2019;136:151-152. Letter PubMed · Publisher

• Response to comments on 'Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure' by Farioli et al. and Oddone et al. T.A. Dragani, F. Colombo, E.N. Pavlisko, et al. Carcinogenesis 2019;40(3):490-491. Letter · Comment PubMed · Publisher

• Response to letter by Farioli et al. A. Reid, P. Franklin, G. Berry, et al. Occupational and Environmental Medicine 2019;76(5):356. Letter · Comment PubMed · Publisher

• Response to the "Letter to the Editor" by Gabor Mezei et al., Comments on Vimercati et al., 2019, "Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (Southern Italy) mesothelioma register". L. Vimercati, D. Cavone, M.C. Delfino, et al. Environmental Health 2019;18(1):112. Letter PubMed · Publisher · Free full text

• Response to: 'Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom' by Reid et al. A. Farioli, P. Boffetta, S. Curti, et al. Occupational and Environmental Medicine 2019;76(5):355. Letter · Comment PubMed · Publisher

• Shining Light on Pleural Biopsy in Mesothelioma: Is It Time to Get "Smart"?. E.O. Bedawi, N.M. Rahman. Chest 2019;156(4):643-644. Editorial · Comment PubMed · Publisher

• SMARCA4 Loss Is Very Rare in Thoracic Mesothelioma. M.S. Ahadi, A.J. Gill. The American Journal of Surgical Pathology 2019;43(8):1154-1155. Letter · Comment PubMed · Publisher

• Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma. A. Napolitano. EBioMedicine 2019;39:7-8. Comment PubMed · Publisher · Free full text

• The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression. V. Fontana, A. Vigani, M.P. Pistillo, et al. Journal of Thoracic Oncology 2019;14(5):e92-e94. Letter PubMed · Publisher

• The future of mesothelioma treatment: time to shift gear. M. Maio, L. Calabrò. The Lancet. Respiratory Medicine 2019;7(7):554-555. Comment PubMed · Publisher

• To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma. B.M. Burt, R.T. Ripley, S.S. Groth. The Journal of Thoracic and Cardiovascular Surgery 2019;157(2):767-768. Editorial · Comment PubMed · Publisher

• Tumour Treating Fields for mesothelioma: controversy versus opportunity. D.A. Fennell. The Lancet. Oncology 2019;20(12):1623-1625. Comment PubMed · Publisher

• A case of cytokeratin-negative sarcomatoid malignant pleural mesothelioma. K. Inafuku, Y. Tsuura, T. Morohoshi, et al. Pathology International 2018;68(6):391-393. Case report · Letter PubMed · Publisher

• A patient with malignant pleural mesothelioma carrying BRAF V600E mutation responding to vemurafenib. Y. Chen, B. Chen, X. Zhu, et al. Lung Cancer 2018;116:96-98. Case report · Letter PubMed · Publisher

• Asbestos-related lung cancers are rarely associated with ALK, ROS1 and RET rearrangements. M. Uguen, J.D. Dewitte, B. Loddé, et al. The European Respiratory Journal 2018;51(3). Letter · Comment PubMed · Publisher

• ASO Author Reflections: C-Reactive Protein/Albumin Ratio as a Prognostic Factor in Patients with Malignant Pleural Mesothelioma: What Does the Novel Index Represent?. S. Takamori, M. Takenoyama. Annals of Surgical Oncology 2018;25(Suppl 3):958-959. Comment PubMed · Publisher

• ASO Author Reflections: Long-Term Survival Is Feasible After Complete CRS/HIPEC for Biphasic Peritoneal Mesothelioma. K. Chouliaras, K.I. Votanopoulos. Annals of Surgical Oncology 2018;25(Suppl 3):770-771. Comment PubMed · Publisher

• ASO Author Reflections: Management of Malignant Peritoneal Mesothelioma. T.R. Cushman, V. Verma, C.B. Simone. Annals of Surgical Oncology 2018;25(Suppl 3):767-768. Comment PubMed · Publisher

• Author reply: 'Response to: Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features' by Araki et al. T. Araki, G.M. Hunninghake, D.C. Christiani, et al. Occupational and Environmental Medicine 2018;75(1):77-78. Letter · Comment PubMed · Publisher

• Authors' response (April 30, 2018) to the letter to the editor concerning the paper "Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany". I.S. Feder, A. Theile, A. Tannapfel. International Journal of Occupational Medicine and Environmental Health 2018;31(6):849-851. Letter · Comment PubMed · Publisher

• Authors' response (March 14, 2018) to the letter to the Editor concerning the paper "Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany". I.S. Feder, A. Theile, A. Tannapfel. International Journal of Occupational Medicine and Environmental Health 2018;31(6):841-843. Letter · Comment PubMed · Publisher

• Biomarkers in malignant pleural mesothelioma: current status and future directions. T. Ahmadzada, G. Reid, S. Kao. Journal of Thoracic Disease 2018;10(Suppl 9):S1003-S1007. Editorial · Comment PubMed · Publisher · Free full text

• Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis. P. Smeele, S.M. d'Almeida, C. Meiller, et al. Molecular Cancer 2018;17(1):148. Letter PubMed · Publisher · Free full text

• Breast Metastasis from Malignant Pleural Mesothelioma: A Rare Challenging Entity. A. Catino, D. La Forgia, A. Scattone, et al. Journal of Thoracic Oncology 2018;13(7):e117-e118. Case report · Letter PubMed · Publisher

• Comment on 'Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy'. C. Brentisci, M. Gangemi, E. Migliore, et al. Annals of Oncology 2018;29(12):2395-2396. Letter · Comment PubMed · Publisher

• Commentary on "Assessment of Health Risk From Historical Use of Cosmetic Talcum Powder". D. Egilman, J. Steffen. New Solutions 2018;28(3):400-409. Comment PubMed · Publisher

• Commentary to the article lung function not affected by asbestos exposure in workers with normal Computed Tomography scan, by Schikowsky, Felten, et al., 2017. X. Baur, B. Terracini, F. Belpoggi, et al. American Journal of Industrial Medicine 2018;61(4):351-354. Letter · Comment PubMed · Publisher

• Commentary: Asbestos exposure and mesothelioma risk. A. Krupoves. International Journal of Epidemiology 2018;47(6):1758-1759. Comment PubMed · Publisher

• Commentary: Past and current asbestos exposure and future mesothelioma risks in Britain. B. Terracini. International Journal of Epidemiology 2018;47(6):1756-1757. Comment PubMed · Publisher

• Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience. M.C. Ambrogi, P. Bertoglio, V. Aprile, et al. The Journal of Thoracic and Cardiovascular Surgery 2018;155(4):1857-1866.e2. Comment PubMed · Publisher

• Discussion. The Journal of Thoracic and Cardiovascular Surgery 2018;155(6):2732-2733. Comment PubMed · Publisher

• Dose-time response association between occupational asbestos exposure and pleural mesothelioma: authors' response. A. Lacourt, E. Leveque, M. Goldberg, et al. Occupational and Environmental Medicine 2018;75(2):161-162. Letter · Comment PubMed · Publisher

• Evaluation of RET Gene Rearrangement by Fluorescence In Situ Hybridization in Malignant Mesothelioma. S. Salvi, J.L. Ravetti, G. Arena, et al. Journal of Thoracic Oncology 2018;13(1):e12-e14. Letter PubMed · Publisher

• Immuno-oncology in malignant pleural mesothelioma. P. Baas, M. Disselhorst. The Lancet. Respiratory Medicine 2018;6(6):408-410. Comment PubMed · Publisher

• In Reply. L. Brcic, G. Vlacic, F. Quehenberger, et al. Archives of Pathology & Laboratory Medicine 2018;142(11):1311-1312. Letter · Comment PubMed · Publisher

• Letter concerning: 'Response to: 'The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure' by Marinaccio et al'. A. Marinaccio, M. Corfiati, A. Binazzi, et al. Occupational and Environmental Medicine 2018;75(11):844-845. Letter · Comment PubMed · Publisher

• Letter Concerning: Glynn ME, Keeton KA, Gaffney SH, Sahmel J. Ambient Asbestos Fiber Concentrations and Long-Term Trends in Pleural Mesothelioma Incidence Between Urban and Rural Areas in the United States (1973-2012). Risk Analysis 2018;38(3):454-471. M.M. Finkelstein. Risk Analysis 2018;38(8):1521-1523. Letter · Comment PubMed · Publisher

• Letter to the Editor (April 4, 2018) concerning the paper "Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany". P.J. Landrigan, R.A. Lemen, O.B.O.T. Collegium Ramazzini. International Journal of Occupational Medicine and Environmental Health 2018;31(6):845-847. Letter · Comment PubMed · Publisher

• Letter to the Editor (February 14, 2018) concerning the paper "Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany". X. Baur, F. Belpoggi, L.T. Budnik, et al. International Journal of Occupational Medicine and Environmental Health 2018;31(6):837-839. Letter · Comment PubMed · Publisher

• Long-term continuous erector spinae plane block for palliative pain control in a patient with pleural mesothelioma. J. Ramos, P. Peng, M. Forero. Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie 2018;65(7):852-853. Case report · Letter PubMed · Publisher

• Malignant Pleural Mesothelioma: The Last 8 Years of Experience in Our Area. J.C. Benítez, M. Campayo, S. Call, et al. Archivos de Bronconeumología 2018;54(12):637-638. In English, Spanish. Letter PubMed · Publisher

• Mediastinal and Pleural MR Imaging in Daily Practice. A.M. Priola, A. Veltri, S.M. Priola. Radiographics 2018;38(3):981-982. Comment PubMed · Publisher

• Mesothelioma risk genes revealed. P. Sidaway. Nature Reviews. Clinical Oncology 2018;15(11):655. Comment PubMed · Publisher

• Minimally invasive, ionizing-free, and ultrasound-guided technique to biopsy anterior mediastinal masses: first 60 cases. B. Lorenzati, R. Cristofori, A. Landi, et al. Panminerva Medica 2018;60(3):132-133. Letter PubMed · Publisher

• Molecular Characterization of Malignant Mesothelioma: Time for New Targets?. C. Aggarwal, S.M. Albelda. Cancer Discovery 2018;8(12):1508-1510. Comment PubMed · Publisher

• National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma. Z.M. Abdelsattar, S.A. Saddoughi, S.H. Blackmon. Journal of Thoracic Oncology 2018;13(4):e64-e65. Letter · Comment PubMed · Publisher

• Pemetrexed-induced painful erythematous nodules in both legs in a patient with recurrent mesothelioma. M. Llamas-Velasco, E. Ovejero-Merino, J. Fraga, et al. Journal of Cutaneous Pathology 2018;45(2):184-186. Case report · Letter PubMed · Publisher

• Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma. D.A. Fennell. Journal of Thoracic Oncology 2018;13(10):1436-1437. Editorial · Comment PubMed · Publisher

• Reanalysis of non-occupational exposure to asbestos and the risk of pleural mesothelioma. M.M. Finkelstein. Occupational and Environmental Medicine 2018;75(6):472-473. Letter · Comment PubMed · Publisher

• Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping: Methodologic Issue. M. Naderi, S. Sabour. Archives of Pathology & Laboratory Medicine 2018;142(11):1311. Letter · Comment PubMed · Publisher

• Response to Baur et al. (2017). C. Schikowsky, M.K. Felten, C. Eisenhawer, et al. American Journal of Industrial Medicine 2018;61(4):355-357. Letter · Comment PubMed · Publisher

• Response to Letter to the Editor Regarding "Ambient Asbestos Fiber Concentrations and Long-Term Trends in Pleural Mesothelioma Incidence Between Urban and Rural Areas in the United States (1973-2012)" by Finkelstein. K.A. Keeton, M.E. Glynn, S.H. Gaffney, et al. Risk Analysis 2018;38(8):1524-1528. Letter · Comment PubMed · Publisher

• Response to letters regarding "Cosmetic talc as a risk factor for pleural mesothelioma: a weight of evidence evaluation of the epidemiology". B.L. Finley, S.M. Benson, G.M. Marsh. Inhalation Toxicology 2018;30(1):1-4. Letter · Comment PubMed · Publisher

• Response to: 'Dose-time-response association between occupational asbestos exposure and pleural mesothelioma' by Lacourt et al. P. Boffetta, E. Pira, C. Romano, et al. Occupational and Environmental Medicine 2018;75(2):160. Letter · Comment PubMed · Publisher

• Response to: 'Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features' by Araki et al. A. Franzblau, V.C. Antao, G. Pinheiro, et al. Occupational and Environmental Medicine 2018;75(1):77. Letter · Comment PubMed · Publisher · Free full text

• Response to: 'Reanalysis of non-occupational exposure to asbestos and the risk of pleural mesothelioma' by Finkelstein. G.M. Marsh, A.S. Riordan, K.A. Keeton, et al. Occupational and Environmental Medicine 2018;75(6):473-474. Letter · Comment PubMed · Publisher

• Response to: 'The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure' by Marinaccio et al. M.M. Finkelstein. Occupational and Environmental Medicine 2018;75(11):844. Letter · Comment PubMed · Publisher

• Revised Modified RECIST Criteria in Malignant Pleural Mesothelioma (Version 1.1): A Step Forward in a Long Race. A.S. Tsao, G.W. Gladish, R.R. Gill. Journal of Thoracic Oncology 2018;13(7):871-873. Editorial · Comment PubMed · Publisher

• Surgery for mesothelioma: Less is more, more or less. S. Milman, T. Ng. The Journal of Thoracic and Cardiovascular Surgery 2018;155(4):1867-1868. Editorial · Comment PubMed · Publisher

• Targeting the tumour vasculature in mesothelioma. D.A. Fennell. The Lancet. Oncology 2018;19(6):723-724. Comment PubMed · Publisher

• The C-Reactive Protein/Albumin Ratio May Predict the Long-Term Outcome in Patients with Malignant Pleural Mesothelioma. N. Yoshida, H. Baba. Annals of Surgical Oncology 2018;25(6):1471-1472. Editorial · Comment PubMed · Publisher

• Therapeutic R2 resection for pleural mesothelioma. D. Nguyen, D.J. Sugarbaker, B.M. Burt. The Journal of Thoracic and Cardiovascular Surgery 2018;155(6):2734-2735. Editorial · Comment PubMed · Publisher

• Treat it or Leave it: Immuno-Oncology in Mesothelioma Observed by the Eyes of Argus. C.J. de Gooijer, P. Baas. Journal of Thoracic Oncology 2018;13(11):1619-1622. Editorial · Comment PubMed · Publisher

• Ultrasound guided continuous erector spinae plane block for pain management in pulmonary malignancy. T. Aydın, O. Balaban, A. Acar. Journal of Clinical Anesthesia 2018;46:63-64. Case report · Letter PubMed · Publisher

• Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment. A. Vigani, M.P. Pistillo, V. Fontana, et al. Journal of Thoracic Oncology 2018;13(8):e143-e145. Case report · Letter PubMed · Publisher

• Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. X. Baur, H.J. Woitowitz, L.T. Budnik, et al. American Journal of Industrial Medicine 2017;60(5):411-421. Comment PubMed · Publisher

• Asbestos. Laryngeal cancer. L. Sánchez Galán. Acta Otorrinolaringologica Española 2017;68(4):250. In English, Spanish. Letter PubMed · Publisher

• Author's response to: "Letter to the Editor" regarding content of "Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States" by R. A. Lemen, Journal of Toxicology and Environmental Health, Part B 2016; 19: 250-265. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 2017;20(8):389. Letter · Comment PubMed · Publisher

• Comment on "Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States" by R A Lemen, Journal of Toxicology and Environmental Health, Part B 2016;19:250-265. C. Magnani, D. Mirabelli, B. Terracini. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 2017;20(8):387-388. Letter · Comment PubMed · Publisher

• Comment on "pleural plaques and lung function in the Marysville worker cohort: a re-analysis" by Zu et al. (2016). J.E. Lockey, K. Dunning, T.J. Hilbert, et al. Inhalation Toxicology 2017;29(2):43-45. Letter · Comment PubMed · Publisher

• Concern: Improving the Accuracy of Mesothelioma Diagnosis in China. Y. Wang. Journal of Thoracic Oncology 2017;12(8):e131. Letter · Comment PubMed · Publisher

• Correspondence regarding the article "The asbestos fibre burden in human lungs: new insights into the chrysotile debate". L.C. Oliver, F. Belpoggi, L.T. Budnik, et al. The European Respiratory Journal 2017;50(6). Letter · Comment PubMed · Publisher

• Correspondence regarding the article "The asbestos fibre burden in human lungs: new insights into the chrysotile debate". I.S. Feder, I. Tischoff, A. Theile, et al. The European Respiratory Journal 2017;50(6). Letter · Comment PubMed · Publisher

• Correspondence regarding the article "The asbestos fibre burden in human lungs: new insights into the chrysotile debate". P. Sartorelli. The European Respiratory Journal 2017;50(6). Letter · Comment PubMed · Publisher

• CTLA-4 blockade in mesothelioma: ineffective or reason for optimism?. A. Thomas, R. Hassan. The Lancet. Oncology 2017;18(9):1150-1151. Comment PubMed · Publisher

• Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours. M. Yoshimura, Y. Kinoshita, M. Hamasaki, et al. Histopathology 2017;71(6):1011-1014. Letter PubMed · Publisher

• Extrapleural Pneumonectomy Is Not Shown to Be Clinically Effective in the Treatment of Malignant Pleural Mesothelioma. G. Cardillo, T. Treasure. Annals of Surgery 2017;265(4):e53. Letter PubMed · Publisher

• FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma. S. Salvi, S. Varesano, S. Boccardo, et al. Journal of Thoracic Oncology 2017;12(8):e116-e118. Letter PubMed · Publisher

• Hazards of residential exposure to household asbestos. N. de Klerk, A. Reid. The Lancet. Public Health 2017;2(11):e490-e491. Comment PubMed · Publisher

• Immune checkpoint inhibitors in malignant pleural mesothelioma. G.L. Ceresoli, A. Mantovani. The Lancet. Oncology 2017;18(5):559-561. Comment PubMed · Publisher

• Improving the Accuracy of Mesothelioma Diagnosis in China. M. Carbone, Z. Guo, W. Mao. Journal of Thoracic Oncology 2017;12(8):e132. Letter · Comment PubMed · Publisher

• In reference to Asbestos exposure and laryngeal cancer mortality. M.M. Finkelstein. The Laryngoscope 2017;127(3):E114. Comment PubMed · Publisher

• In response to Sharing different perspectives to understand asbestos-induced carcinogenesis: A comment to Jiang et al. (2016) by Alessandro Francesco Gualtieri (2017). S. Toyokuni, L. Jiang. Cancer Science 2017;108(5):1089-1090. Letter · Comment PubMed · Publisher · Free full text

• Is Mesothelioma in China Rare or Misdiagnosed?. T. John, P.A. Russell, B. Thapa. Journal of Thoracic Oncology 2017;12(4):607-609. Editorial · Comment PubMed · Publisher

• Letter on: "Cosmetic talc as a risk factor for pleural mesothelioma: a weight of evidence evaluation of the epidemiology". D. Mirabelli. Inhalation Toxicology 2017;29(8):341. Letter · Comment PubMed · Publisher

• Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib. N. Agatsuma, Y. Yasuda, H. Ozasa. Journal of Thoracic Oncology 2017;12(9):e141-e143. Case report · Letter PubMed · Publisher

• Malignant pleural mesothelioma in a young adult with no known exposure to asbestos. Can asbestos exposure be truly ruled out?. J. Ferrer, J. Sampol, M.J. Cruz. Archivos de Bronconeumología 2017;53(8):469. In English, Spanish. Letter · Comment PubMed · Publisher

• Mesothelioma: Identical Routes to Malignancy from Asbestos and Carbon Nanotubes. J. Port, D.J. Murphy. Current Biology 2017;27(21):R1173-R1176. Comment PubMed · Publisher

• Metastatic primary peritoneal malignant mesothelioma mimicking primary diffuse gastric carcinoma: a rare encounter in gastric biopsy. Y. Yang, D. Gunawardane, D. Moffat, et al. Pathology 2017;49(3):317-319. Case report · Letter PubMed · Publisher

• miR-16: expanding the range of molecular targets in mesothelioma. D. Fennell. The Lancet. Oncology 2017;18(10):1296-1297. Comment PubMed · Publisher

• Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma. N. Sobhani, G. Roviello, S.P. Corona, et al. Lung Cancer 2017;114:103-105. Letter · Comment PubMed · Publisher

• New Keywords in the Treatment of Malignant Pleural Mesothelioma. P. Bertoglio, M. Lucchi, A. Mussi. The Annals of Thoracic Surgery 2017;104(4):1434. Letter · Comment PubMed · Publisher

• PD-L1 Testing for Immune Checkpoint Inhibitors in Mesothelioma: For Want of Anything Better?. S. Lantuejoul, N. Le Stang, F. Damiola, et al. Journal of Thoracic Oncology 2017;12(5):778-781. Editorial · Comment PubMed · Publisher

• Pleural IMRT after Lung-Sparing Cytoreduction for Mesothelioma: Mature Enough to Randomize. H.I. Pass. Journal of Thoracic Oncology 2017;12(6):919-921. Editorial · Comment PubMed · Publisher

• Pleural mesothelioma and asbestos exposure: a case-control study with quantitative risk assessment-response to Marsh and Benson's letter. D. Ferrante, D. Mirabelli, S. Tunesi, et al. Occupational and Environmental Medicine 2017;74(2):157-158. Letter · Comment PubMed · Publisher

• Quantifying asbestos in lung tissue: what debate?. B. Nemery, V. Nuyts, K. Nackaerts. The European Respiratory Journal 2017;49(6). Editorial · Comment PubMed · Publisher

• Re: Brent L. Finley, Stacey M. Benson & Gary M. Marsh (2017): Cosmetic talc as a risk factor for pleural mesothelioma: a weight of evidence evaluation of the epidemiology, Inhalation Toxicology, DOI: 10.1080/08958378.2017.1336187. M.M. Finkelstein. Inhalation Toxicology 2017;29(9):387-388. Letter · Comment PubMed · Publisher

• Recurrent diaphoresis, acute confusional state, and pleural mesothelioma. R.O. Domínguez, E.M. Cárdenas, Y.H.S. Marulanda, et al. Neurología 2017;32(7):484-485. In English, Spanish. Case report · Letter PubMed · Publisher

• Response to Hessel. D. Egilman. American Journal of Industrial Medicine 2017;60(10):915-920. Letter PubMed · Publisher

• Response to: 'Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment' by Ferrante et al. G.M. Marsh, S.M. Benson. Occupational and Environmental Medicine 2017;74(2):156-157. Letter · Comment PubMed · Publisher

• Sharing different perspectives to understand asbestos-induced carcinogenesis: A comment to Jiang et al. (2016). A.F. Gualtieri. Cancer Science 2017;108(1):156-157. Letter · Comment PubMed · Publisher · Free full text

• Successful desensitization of pemetrexed-induced anaphylaxis in a patient with malignant mesothelioma. J. Youk, H. Park, K.N. Jin, et al. The Korean Journal of Internal Medicine 2017;32(3):563-565. Case report · Letter PubMed · Publisher · Free full text

• Where is the "Corruption?". P.A. Hessel. American Journal of Industrial Medicine 2017;60(10):911-912. Comment PubMed · Publisher

• A new standard for malignant pleural mesothelioma. M.G. Zauderer. Lancet 2016;387(10026):1352-1354. Comment PubMed · Publisher · Free full text

• Asbestos and product defence science. Response to: Boffetta and La Vecchia. B. Terracini, D. Mirabelli. International Journal of Epidemiology 2016;45(5):1692-1693. Letter · Comment PubMed · Publisher

• Authors' response to Finkelstein's letter to the editor regarding our recent review of ambient airborne asbestos concentrations (Abelmann et al., 2015). A. Abelmann, M.E. Glynn, J.S. Pierce, et al. Inhalation Toxicology 2016;28(13):581-582. Letter · Comment PubMed · Publisher

• Authors's response: Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment. D. Ferrante, D. Mirabelli, S. Tunesi, et al. Occupational and Environmental Medicine 2016;73(10):713-4. Letter · Comment PubMed · Publisher

• Collegium Ramazzini response to 'Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations'. Collegium Ramazzini. Scandinavian Journal of Work, Environment & Health 2016;42(1):91-4. Letter · Comment PubMed · Publisher

• Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases. Y. Metaxas, R. Cathomas, M. Mark, et al. Lung Cancer 2016;102:136-138. Case report · Letter PubMed · Publisher

• Comment on "Exposure-response modeling of non-cancer effects in humans exposed to Libby Amphibole Asbestos; update" by Benson et al. (2015). J.E. Goodman, K. Zu, G. Tao, et al. Regulatory Toxicology and Pharmacology 2016;80:268-9. Letter · Comment PubMed · Publisher

• Comment on Shvedova et al. (2016), "gender differences in murine pulmonary responses elicited by cellulose nanocrystals". J.A. Shatkin, G. Oberdörster. Particle and Fibre Toxicology 2016;13(1):59. Letter · Comment PubMed · Publisher · Free full text

• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma. M.C. Russell, C.A. Staley. Journal of Oncology Practice 2016;12(10):938-939. Comment PubMed · Publisher

• Discussion. D. Rice, D. Sugarbaker, R. Flores, et al. The Journal of Thoracic and Cardiovascular Surgery 2016;151(2):473-5. Comment PubMed · Publisher

• EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-EGFR and Anti-MET Therapies. S. Salvi, S. Varesano, S. Boccardo, et al. Journal of Thoracic Oncology 2016;11(6):e78-80. Letter PubMed · Publisher

• Endobronchial Diagnosis of a Malignant Mesothelioma. H.S. Yap, S. Klebe, A. Rose. Journal of Bronchology & Interventional Pulmonology 2016;23(3):e30-2. Case report · Letter PubMed · Publisher

• Estimating Lifetime Asbestos Exposure in Patients With Idiopathic Pulmonary Fibrosis. C.M. Barber, R.E. Wiggans, D. Fishwick. The Annals of Occupational Hygiene 2016;60(5):649-50. Letter · Comment PubMed · Publisher · Free full text

• Estimating Occupational Exposure to Asbestos in Australia. M. Kottek, D.J. Kilpatrick. The Annals of Occupational Hygiene 2016;60(4):531-2. Letter · Comment PubMed · Publisher

• Genetic Basis of Mesothelioma--More Than Asbestos Exposure. D. Lee. Journal of Thoracic Oncology 2016;11(2):e27-8. Letter · Comment PubMed · Publisher

• Health Surveillance in Italian workers formerly exposed to asbestos: a call to action for policy makers. F. Chirico. Annali di Igiene 2016;28(5):373-5. Comment PubMed · Publisher

• Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?. A. Rimner, C.B. Simone, M.G. Zauderer, et al. The Lancet. Oncology 2016;17(2):e43-e44. Letter · Comment PubMed · Publisher

• Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power? - Authors' reply. O. Riesterer, W. Weder, R. Stahel. The Lancet. Oncology 2016;17(2):e44-e45. Letter · Comment PubMed · Publisher

• Historical ambient airborne asbestos concentrations in the United States. M.M. Finkelstein. Inhalation Toxicology 2016;28(10):429-30. Comment PubMed · Publisher

• Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations. B.S. Sheffield, J. Lorette, Y. Shen, et al. Archives of Pathology & Laboratory Medicine 2016;140(5):391. Letter PubMed · Publisher

• Mesothelioma in iron ore (taconite) miners. D. Mirabelli. Occupational and Environmental Medicine 2016;73(4):217-8. Comment PubMed · Publisher

• MET Gene Status in Malignant Mesothelioma Using Fluorescent In Situ Hybridization. S. Varesano, S. Salvi, S. Boccardo, et al. Journal of Thoracic Oncology 2016;11(2):e28-30. Letter · Comment PubMed · Publisher

• New standard for assessing asbestos exposure and its consequences?. L.C. Oliver, L. Welch, A.L. Frank, et al. Occupational and Environmental Medicine 2016;73(10):709-10. Letter · Comment PubMed · Publisher

• Para-occupational exposures to asbestos: lessons learned from Casale Monferrato, Italy. L.T. Stayner. Occupational and Environmental Medicine 2016;73(3):145-6. Comment PubMed · Publisher

• Pemetrexed and interstitial lung disease. B. Adhikari, R.M. Dongol, D. Baral, et al. Acta Oncologica 2016;55(4):521-2. Letter PubMed · Publisher

• Podoplanin is Positive Not Only on Follicular Dendritic Cells and Their Tumoral Counterparts, But Also on Reticular Fibroblasts and in Some Tumors of Reticular Fibroblasts. D. Suárez-Vilela, F.M. Izquierdo. Applied Immunohistochemistry & Molecular Morphology 2016;24(2):e11. Letter · Comment PubMed · Publisher

• Prophylactic radiotherapy to prevent procedure-tract metastases. D. Landau, E. Lim. The Lancet. Oncology 2016;17(10):e418. Letter · Comment PubMed · Publisher

• Prophylactic radiotherapy to prevent procedure-tract metastases. G. Zalcman, S. Brosseau, A. Scherpereel. The Lancet. Oncology 2016;17(10):e417. Letter · Comment PubMed · Publisher

• Pulmonary acantholytic squamous cell carcinoma with focal signet ring cell morphology mimicking malignant mesothelioma on fine needle aspiration cytology: a case report. S.E. Choi, H.S. Park. Cytopathology 2016;27(2):131-3. Case report · Letter PubMed · Publisher

• Radiotherapy to intervention sites in mesothelioma: no more?. G.L. Ceresoli, V. Vavassori. The Lancet. Oncology 2016;17(8):1025-1027. Comment PubMed · Publisher

• Re: Asbestos and product defence science. P. Boffetta, C. La Vecchia. International Journal of Epidemiology 2016;45(5):1690-1691. Letter · Comment PubMed · Publisher

• Re: Comments on the causation of malignant mesothelioma: Rebutting the false concept that recent exposures to asbestos do not contribute to causation of mesothelioma. B. Terracini, D. Mirabelli, X. Baur, et al. American Journal of Industrial Medicine 2016;59(12):1180-1182. Comment PubMed · Publisher

• Re: Terracini et al. Comments on the causation of malignant mesothelioma: Rebutting the false concept that recent exposures to asbestos do not contribute to causation of mesothelioma. Am J Ind Med 2016;59:506-507. P. Boffetta. American Journal of Industrial Medicine 2016;59(12):1177-1179. Comment PubMed · Publisher

• Response by the organizers of the Helsinki criteria updates 2014: Criteria for asbestos-related diseases need periodic updates. H. Wolff, T. Vehmas, P. Oksa, et al. Scandinavian Journal of Work, Environment & Health 2016;42(1):95-6. Letter · Comment PubMed · Publisher

• Response to comment on "Exposure-response modeling of non-cancer effects in humans exposed to Libby Amphibole Asbestos; update" by Benson et al. (2015) submitted by Goodman et al. (2016). R. Benson, D. Berry, J. Lockey, et al. Regulatory Toxicology and Pharmacology 2016;80:270-1. Letter · Comment PubMed · Publisher

• Response to Kay Teschke. Re: Mesothelioma among Motor Vehicle Mechanics: An Updated Review and Meta-analysis. D.H. Garabrant, D.D. Alexander, P.E. Miller, et al. The Annals of Occupational Hygiene 2016;60(8):1036-7. Letter · Comment PubMed · Publisher

• Response to Kottek and Kilpatrick, 'Estimating Occupational Exposure to Asbestos in Australia'. S. Peters, S.C. van Oyen, H. Alfonso, et al. The Annals of Occupational Hygiene 2016;60(4):533-5. Letter · Comment PubMed · Publisher

• Response to the letter to editors concerning "Validity of mesothelin in occupational medicine practice". P. Smolková, M. Nakládalová, J. Zapletalová. International Journal of Occupational Medicine and Environmental Health 2016;29(6):881. Comment · Letter PubMed · Publisher

• Response to: Pleural mesothelioma, and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment. P. Boffetta. Occupational and Environmental Medicine 2016;73(10):712. Letter · Comment PubMed · Publisher

• Resveratrol and cisplatin in a malignant mesothelioma cell model. S. Chirumbolo, G. Bjørklund. Food and Chemical Toxicology 2016;98(Pt B):308-309. Letter PubMed · Publisher

• Setting new standards for epidemiological research on mesothelioma. P. Boffetta, C. La Vecchia. Occupational and Environmental Medicine 2016;73(5):289. Comment PubMed · Publisher

• SMART or simply bold?. V.W. Rusch, A. Rimner, P.S. Adusumilli. The Journal of Thoracic and Cardiovascular Surgery 2016;151(2):476-7. Editorial · Comment PubMed · Publisher

• The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma. H.L. Kindler. Journal of Oncology Practice 2016;12(10):936-937. Comment PubMed · Publisher

• The mesothelioma surgery shift. R.M. Flores. The Journal of Thoracic and Cardiovascular Surgery 2016;151(2):485-6. Editorial · Comment PubMed · Publisher

• The staging of malignant pleural mesothelioma: are we any nearer to squaring the circle?. D.A. Waller. European Journal of Cardio-thoracic Surgery 2016;49(6):1648-9. Editorial · Comment PubMed · Publisher

• Thinking about Occupation-Response and Exposure-Response Relationships: Vehicle Mechanics, Chrysotile, and Mesothelioma. K. Teschke. The Annals of Occupational Hygiene 2016;60(4):528-30. Letter PubMed · Publisher

• Unreliable proposed 'new standard' for assessing asbestos exposure. D. Egilman, X. Baur, C.L. Soskolne. Occupational and Environmental Medicine 2016;73(10):709. Letter · Comment PubMed · Publisher

• Validity of mesothelin in occupational medicine practice. D. Taeger, K. Gawrych, T. Brüning. International Journal of Occupational Medicine and Environmental Health 2016;29(6):879-880. Letter · Comment PubMed · Publisher

• A lesson from vorinostat in pleural mesothelioma. M.C. Garassino, S. Marsoni. The Lancet. Oncology 2015;16(4):359-60. Comment PubMed · Publisher

• A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma. S.C. Kao, M. Fulham, K. Wong, et al. American Journal of Respiratory and Critical Care Medicine 2015;191(12):1467-9. Case report · Letter PubMed · Publisher

• Amplification of MET in a Patient with Malignant Pleural Mesothelioma. S. Varesano, S. Salvi, S. Boccardo, et al. Journal of Thoracic Oncology 2015;10(10):e103-4. Case report · Letter PubMed · Publisher

• An unjustified prognosis of the number of asbestos-related lung cancer cases caused by an increase in airborne asbestos concentrations as a result of removing of asbestos-cement products. N. Szeszenia-Dąbrowska, B. Świątkowska. TheScientificWorldJournal 2015;2015:264568. Letter · Comment PubMed · Publisher · Free full text

• Asbestos fibres in the lungs of an American mechanic who drilled, riveted, and ground brake linings: a case report and discussion. M.M. Finkelstein. The Annals of Occupational Hygiene 2015;59(4):525-7. Case report · Letter PubMed · Publisher

• Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. R. Lee, D. Van Orden. International Journal of Occupational and Environmental Health 2015;21(4):337-41. Letter · Comment PubMed · Publisher · Free full text

• ASIA: asbestos stop in Asia. P. Baas, S. Burgers. Respirology 2015;20(4):521. Editorial · Comment PubMed · Publisher

• Author's response: Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies. J. Creaney, B.W. Robinson. Thorax 2015;70(4):374-5. Letter · Comment PubMed · Publisher

• Authors' response: A systematic review of the association between pleural plaques and changes in lung function. L. Kopylev, K.Y. Christensen, J.W. Brown, et al. Occupational and Environmental Medicine 2015;72(9):685-6. Letter · Comment PubMed · Publisher · Free full text

• Benign cystic mesothelioma in a boy: An uncommon case mimicking a lymphangioma. P. Fernandez Eire, M.X. Lemos Bouzas, J.A. Ortiz Rey, et al. Journal of Paediatrics and Child Health 2015;51(8):841-2. Case report · Letter PubMed · Publisher

• Benign multicystic mesothelioma causing bilateral pneumothoraces. M. Oks, T. He, A. Palkar, et al. Annals of the American Thoracic Society 2015;12(7):1106-9. Case report · Letter PubMed · Publisher

• Closing the stable door before the horse leaves. V. Acton. The Journal of Thoracic and Cardiovascular Surgery 2015;149(5):1467. Letter · Comment PubMed · Publisher

• Comment on "A systematic review of the association between pleural plaques and changes in lung function" by Kopylev et al (2014). J.E. Goodman, L.E. Kerper, K. Zu, et al. Occupational and Environmental Medicine 2015;72(9):684-5. Letter · Comment PubMed · Publisher

• Comment on "HRCT/CT and Associated Spirometric Effects of Low Libby Amphibole Asbestos Exposure" by Lockey et al (2015). G. Tao, K. Zu, L.E. Kerper, et al. Journal of Occupational and Environmental Medicine 2015;57(7):e80. Letter · Comment PubMed · Publisher

• Comments on the recently published "Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma". A. Hjerpe, K. Dobra. Cancer Cytopathology 2015;123(8):449-53. Comment PubMed · Publisher

• CTLA4 blockade in patients with malignant mesothelioma. B.M. Burt. The Lancet. Respiratory Medicine 2015;3(4):261-3. Comment PubMed · Publisher

• Cystic mesothelioma of the gallbladder: MR imaging findings. S. Mezghani, H. Mhalla, L. Bouallegue, et al. Diagnostic and Interventional Imaging 2015;96(2):221-3. Case report · Letter PubMed · Publisher

• Discussion. The Journal of Thoracic and Cardiovascular Surgery 2015;149(6):1546-7. Comment PubMed · Publisher

• Epidemics of asbestos-related diseases--something old, something new. H. Vainio. Scandinavian Journal of Work, Environment & Health 2015;41(1):1-4. Editorial · Comment PubMed · Publisher

• Erionite and cancer in a Mexican village. R. Saracci. Occupational and Environmental Medicine 2015;72(3):163-4. Editorial · Comment PubMed · Publisher

• Extrapleural Pneumonectomy and Pleurectomy Decortication: Can We Really Compare Their Survival?. P. Bertoglio, S. Korasidis. The Annals of Thoracic Surgery 2015;100(4):1508-9. Letter · Comment PubMed · Publisher

• Fibrinogen concentrate as first-line therapy in children undergoing cardiac surgery: Promising perspectives. D. Faraoni. The Journal of Thoracic and Cardiovascular Surgery 2015;149(5):1466-7. Letter · Comment PubMed · Publisher

• Fifteen years in the evaluation of extrapleural pneumonectomy: Lessons to be learned. T. Treasure, F. Macbeth. The Journal of Thoracic and Cardiovascular Surgery 2015;149(5):1382-3. Editorial · Comment PubMed · Publisher

• Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Applicable to all and by all?. R. Haas, P. Baas. Journal of Medical Imaging and Radiation Oncology 2015;59(3):353-4. Editorial · Comment PubMed · Publisher

• In Response. A. Billè, L. Porcu. Journal of Thoracic Oncology 2015;10(9):e93-e94. Letter · Comment PubMed · Publisher

• Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies. K.G. Blyth. Thorax 2015;70(4):374. Letter · Comment PubMed · Publisher

• Into another dimension: Assessing novel therapeutics in a more lifelike microenvironment. M.B. Antonoff. The Journal of Thoracic and Cardiovascular Surgery 2015;149(5):1426-7. Editorial · Comment PubMed · Publisher

• Invited commentary. V.W. Rusch. The Annals of Thoracic Surgery 2015;99(5):1780. Comment PubMed · Publisher

• Invited commentary. L. Lang-Lazdunski. The Annals of Thoracic Surgery 2015;99(2):481. Comment PubMed · Publisher

• Invited Commentary. B.M. Burt. The Annals of Thoracic Surgery 2015;100(5):1874. Comment PubMed · Publisher

• Jejunal Perforation by Metastasis of Malignant Pleural Mesothelioma. M.I. Navarro García, A. Sánchez Pérez, J.L. Vázquez Rojas. Archivos de Bronconeumología 2015;51(7):366-7. In English, Spanish. Case report · Letter PubMed · Publisher

• Knowledge and attitude towards asbestos hazards among asbestos workers in India. R.R. Tiwari, A. Saha. The International Journal of Occupational and Environmental Medicine 2015;6(1):58-60. Letter PubMed · Publisher · Free full text

• Malignant peritoneal mesothelioma diagnosed by EUS-guided tissue acquisition. D. Mohri, Y. Nakai, H. Isayama, et al. Endoscopic Ultrasound 2015;4(4):353-4. Letter PubMed · Publisher · Free full text

• Mesothelioma cells breaking bad: loss of integrin α7 promotes cell motility and poor clinical outcomes in patients. D.J. Burkin, T.M. Fontelonga. The Journal of Pathology 2015;237(3):282-4. Comment PubMed · Publisher

• Mesothelioma with superior vena cava obstruction in young female following short latency of asbestos exposure. A. Patra, S. Kundu, A. Pal, et al. Journal of Cancer Research and Therapeutics 2015;11(4):940-2. Case report · Letter PubMed · Publisher

• Meta-Analysis of Different Procedures: The Importance of Recognizing the Spectrum of Pleurectomy/Decortication Techniques. C. Cao, D.H. Tian, H. Wolfenden, et al. The Annals of Thoracic Surgery 2015;100(3):1133. Letter · Comment PubMed · Publisher

• Multimodal treatment for malignant pleural mesothelioma. R.C. Rintoul, T. Treasure, F. Macbeth. The Lancet. Oncology 2015;16(16):1576-7. Comment PubMed · Publisher

• No Increased Risk for Mesothelioma in Relation to Natural-Occurring Asbestos in Southern Nevada. P.S. Pinheiro, H. Jin. Journal of Thoracic Oncology 2015;10(7):e62-3. Letter · Comment PubMed · Publisher · Free full text

• Non-asbestos Causes of mesothelioma and translocation of asbestos fibres. J.H. Lange, L. Cegolon. Singapore Medical Journal 2015;56(6):361. Letter · Comment PubMed · Publisher · Free full text

• Pleural plaques in smoking-associated fibrosis and pulmonary asbestosis. R.G. Sangani, A.J. Ghio, J.E. Parker. International Journal of Chronic Obstructive Pulmonary Disease 2015;10:869-70. Letter · Comment PubMed · Publisher · Free full text

• Povidone iodine: the new solution for mesothelioma?. V.W. Rusch. The Journal of Thoracic and Cardiovascular Surgery 2015;149(2):567-8. Editorial · Comment PubMed · Publisher

• Pseudomesotheliomatous small-cell neuroendocrine carcinoma of the lung with calretinin expression. G.D. Exarchos, R.L. Attanoos. Histopathology 2015;66(6):895-6. Case report · Letter PubMed · Publisher

• Re: Bias in the proportionate mortality ratio analysis of small study populations: A case on analyses of radiation and mesothelioma. M.J. Hein, M.K. Schubauer-Berigan. International Journal of Radiation Biology 2015;91(11):908-10. Letter · Comment PubMed · Publisher

• Re: Fitzgerald et al. "Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals". A. Descatha, S. Ollivier, T. Despreaux. Scandinavian Journal of Work, Environment & Health 2015;41(4):417-8. Letter · Comment PubMed · Publisher

• Recent insights emerging from malignant mesothelioma genome sequencing. M. Carbone, G. Gaudino, H. Yang. Journal of Thoracic Oncology 2015;10(3):409-11. Editorial · Comment PubMed · Publisher · Free full text

• Reply to "No Increased Risk for Mesothelioma in Relation to Natural-Occurring Asbestos in Southern Nevada". F. Baumann, B.J. Buck, R.V. Metcalf, et al. Journal of Thoracic Oncology 2015;10(7):e64-5. Letter · Comment PubMed · Publisher · Free full text

• Reply: To PMID 24726598. L. Spaggiari, G. Marulli, G.L. Pariscenti, et al. The Annals of Thoracic Surgery 2015;100(2):770-1. Letter · Comment PubMed · Publisher

• Reply: To PMID 25534527. R.M. Flores, E. Taioli, A.S. Wolf. The Annals of Thoracic Surgery 2015;100(3):1133-4. Letter · Comment PubMed · Publisher

• Reply: To PMID 25534527. E. Taioli, A.S. Wolf, R.M. Flores. The Annals of Thoracic Surgery 2015;100(4):1509. Letter · Comment PubMed · Publisher

• Response to Comment on "HRCT/CT and Associated Spirometric Effects of Low Libby Amphibole Asbestos Exposure" by Lockey et al (2015). J.E. Lockey, K. Dunning, T.J. Hilbert, et al. Journal of Occupational and Environmental Medicine 2015;57(7):e80-2. Letter · Comment PubMed · Publisher

• Response to Hein and Schubauer-Berigan. J.Y. Zhou. International Journal of Radiation Biology 2015;91(11):911-2. Letter · Comment PubMed · Publisher

• Response to RE: Gordon R, Fitzgerald S, and Millette J. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 2014;20(4):318-332. R.E. Gordon. International Journal of Occupational and Environmental Health 2015;21(4):342-6. Letter · Comment PubMed · Publisher · Free full text

• Retroperitoneal fibrosis and asbestosis--a plausible association?. R.D. Swartz. American Journal of Kidney Diseases 2015;65(3):378-80. Editorial · Comment PubMed · Publisher

• Sarcomatoid pleural mesothelioma with osteosarcomatous, chondrosarcomatous and rhabdomyoblastic elements: an extremely rare autopsy case. Y. Tsukamoto, H. Hao, N. Kajimoto, et al. Pathology International 2015;65(1):51-3. Case report · Letter PubMed · Publisher

• Spontaneous Regression of Malignant Pleural Mesothelioma in a Patient with New-Onset Inflammatory Arthropathy. J.C. Moser, T. Peikert, A.C. Roden, et al. Annals of the American Thoracic Society 2015;12(9):1416-7. Case report · Letter PubMed · Publisher

• Status of the ban on asbestos use in Spain and Latin America. R.A. Accinelli Tanaka, L.M. López Oropeza. Archivos de Bronconeumología 2015;51(3):152. In English, Spanish. Letter PubMed · Publisher

• Surgery and Survival of Patients with Diagnosis of Malignant Pleural Mesothelioma. C. Carbonelli, C. Rapicetta, A. Cesario. Journal of Thoracic Oncology 2015;10(9):e92-e93. Letter · Comment PubMed · Publisher

• Surgical Strategy for Malignant Pleural Mesothelioma: Where Are We Going and What Are We Missing?. F. Lococo, M. Paci, T. Ricchetti, et al. The Annals of Thoracic Surgery 2015;100(2):769-70. Letter · Comment PubMed · Publisher

• The evolving role of effusion cytology in the diagnosis of malignant mesothelioma. A. Paintal. Cytopathology 2015;26(3):137-8. Editorial · Comment PubMed · Publisher

• The mesothelioma enigma. R.M. Flores. The Journal of Thoracic and Cardiovascular Surgery 2015;149(6):1548-9. Editorial · Comment PubMed · Publisher

• Ultra-low-dose chest computer tomography screening of an asbestos-exposed population in Western Australia. F.J. Brims, C.P. Murray, N. de Klerk, et al. American Journal of Respiratory and Critical Care Medicine 2015;191(1):113-6. Letter PubMed · Publisher

• "Not your grandfather's pleural disease": rapid progression, ventilatory impairment, and chronic pleuritic pain from Libby vermiculite/amphibole. A. Miller. American Journal of Industrial Medicine 2014;57(11):1195-6. Comment PubMed · Publisher

• A critique of a review on the relationship between asbestos exposure and the risk of mesothelioma: reply. C. La Vecchia, P. Boffetta. European Journal of Cancer Prevention 2014;23(5):494-6. Letter · Comment PubMed · Publisher

• A critique to a review on the relationship between asbestos exposure and the risk of mesothelioma. B. Terracini, D. Mirabelli, C. Magnani, et al. European Journal of Cancer Prevention 2014;23(5):492-4. Letter · Comment PubMed · Publisher

• Advantages of thoracic ultrasound-guided fine-needle aspiration biopsy in lung cancer and mesothelioma. M. Sperandeo, L. Dimitri, C. Pirri, et al. Chest 2014;146(5):e178-e179. Letter · Comment PubMed · Publisher

• An exception that proves the rule: recurrence free survival five years after extrapleural pneumonectomy for malignant pleural mesothelioma. T. Treasure, F. Macbeth. Journal of Cardiothoracic Surgery 2014;9:181. Comment PubMed · Publisher · Free full text

• Analysing health data from rare occupational cohorts. T.F. Bateson. Occupational and Environmental Medicine 2014;71(11):742-3. Comment PubMed · Publisher

• Asbestos exposure during home renovation in New South Wales. R.A. Lemen, A.L. Frank, C.L. Soskolne, et al. The Medical Journal of Australia 2014;200(6):315. Letter · Comment PubMed · Publisher

• Asbestos exposure during home renovation in New South Wales. A.R. Johnson, D.H. Yates. The Medical Journal of Australia 2014;200(6):315. Letter · Comment PubMed · Publisher

• Asbestos, asbestosis, smoking, and lung cancer: study bias and confounding issues that complicate the interpretation of the results. S.J. Geyer. American Journal of Respiratory and Critical Care Medicine 2014;189(1):115-6. Letter · Comment PubMed · Publisher

• Asbestosis, not asbestos exposure, is the primary risk factor for lung cancer. R. Ross. American Journal of Respiratory and Critical Care Medicine 2014;189(1):114-5. Letter · Comment PubMed · Publisher

• Biomarkers for immune checkpoint inhibitors--authors' reply. L. Calabrò, M. Maio. The Lancet. Oncology 2014;15(1):e1-2. Letter · Comment PubMed · Publisher

• Biomarkers for immune checkpoint inhibitors. L.A. Lievense, J.P. Hegmans, J.G. Aerts. The Lancet. Oncology 2014;15(1):e1. Letter · Comment PubMed · Publisher

• CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma: an expanded analysis of the data. S.J. Geyer. Diagnostic Cytopathology 2014;42(8):734. Letter · Comment PubMed · Publisher

• Coexistence of diffuse malignant peritoneal mesothelioma and Candida norvegensis peritonitis. E. Virgilio, P. Mercantini, M. Ferri, et al. Surgical Infections 2014;15(5):660-1. Case report · Letter PubMed · Publisher

• Colonic invasion induced by malignant peritoneal mesothelioma. S.B. Cao, S. Jin, J.Y. Cao, et al. International Journal of Colorectal Disease 2014;29(7):891-2. Case report · Letter PubMed · Publisher

• Comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'. S.C. Kao, N. van Zandwijk, S. Clarke. British Journal of Cancer 2014;111(12):2376. Letter · Comment PubMed · Publisher · Free full text

• Comment on 'The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)'. D. Mirabelli, D. Zugna. British Journal of Cancer 2014;111(8):1675. Letter · Comment PubMed · Publisher · Free full text

• Comment on 'The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)': methodological problems with case-only survival analysis. D. Consonni, F. Barone-Adesi, C. Mensi. British Journal of Cancer 2014;111(8):1674. Letter · Comment PubMed · Publisher · Free full text

• Comment on 'The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)': the effect of left censoring. A. Farioli, S. Mattioli, S. Curti, et al. British Journal of Cancer 2014;111(11):2197-8. Comment PubMed · Publisher · Free full text

• Comments on the introduction of the paper "Overview of the biochemical and genetic processes in malignant mesothelioma". A. Eduardo. Jornal Brasileiro de Pneumologia 2014;40(5):584-5. In English, Portuguese. Letter · Comment PubMed · Publisher · Free full text

• CT scan procedure for lung cancer screening in asbestos-exposed workers. M. Ollier, J.M. Garcier, G. Naughton, et al. Chest 2014;146(2):e76-e77. Letter · Comment PubMed · Publisher

• Discussion. The Journal of Thoracic and Cardiovascular Surgery 2014;147(1):516. Comment PubMed · Publisher

• Firefighters and cancer: where are we and where to now?. L. Fritschi, D.C. Glass. Occupational and Environmental Medicine 2014;71(8):525-6. Comment PubMed · Publisher

• Gibb et al. respond. H. Gibb, K. Fulcher, S. Nagarajan, et al. American Journal of Public Health 2014;104(2):e1-2. Letter · Comment PubMed · Publisher · Free full text

• Incorrect analyses of radiation and mesothelioma. J. Zhou. American Journal of Public Health 2014;104(2):e1. Letter · Comment PubMed · Publisher · Free full text

• Invited commentary. B.C. Tong. The Annals of Thoracic Surgery 2014;98(5):1754. Comment PubMed · Publisher

• Invited commentary. S.C. Murthy. The Annals of Thoracic Surgery 2014;98(3):1024-5. Comment PubMed · Publisher

• Invited commentary. R.M. Flores. The Annals of Thoracic Surgery 2014;97(6):1865-6. Comment PubMed · Publisher

• Malignant mesothelioma of tunica vaginalis. A. Stradella, E. Conde-Gallego, C.A. Escalera-Almendros, et al. Actas Urologicas Españolas 2014;38(1):68-9. In English, Spanish. Case report · Letter PubMed · Publisher

• Malignant pleural mesothelioma mimicking the intrapulmonary growth pattern of epithelioid hemangioendothelioma. Y. Muramatsu, K. Isobe, K. Sugino, et al. Pathology International 2014;64(7):358-60. Case report · Letter PubMed · Publisher

• Mesothelial proliferations: useful marker is not the same as a diagnostic one. A.N. Husain. American Journal of Clinical Pathology 2014;141(2):152-3. Editorial · Comment PubMed · Publisher

• Not so WEE: targeting G₂/M to kill mesothelioma cells. P. Dent. Cancer Biology & Therapy 2014;15(4):351-2. Comment PubMed · Publisher · Free full text

• Other causative factors for lung diseases in populations exposed to asbestos. J.H. Lange, W.C. Heymann, L. Cegolon. The Clinical Respiratory Journal 2014;8(2):253-4. Letter · Comment PubMed · Publisher

• Paratesticular malignant mesothelioma in a patient exposed to asbestos for more than 50 years. L.N. Hsu, M.T. Sung, P.H. Chiang. The Kaohsiung Journal of Medical Sciences 2014;30(10):537-8. Letter · Comment PubMed · Publisher · Free full text

• Pleurodesis to prevent mesothelioma. V. Acton. The Journal of Thoracic and Cardiovascular Surgery 2014;147(3):1111. Letter · Comment PubMed · Publisher

• Preventing pleural mesothelioma in patients with recognizable asbestos-related pleural plaques. V. Acton. The Journal of Thoracic and Cardiovascular Surgery 2014;148(4):1763. Letter · Comment PubMed · Publisher

• Regional delivery of oncolytic vaccinia virus: it's time for clinical trials. S. Downs-Canner, D.L. Bartlett. Annals of Surgical Oncology 2014;21(7):2127-8. Editorial · Comment PubMed · Publisher · Free full text

• Reply to the editor. W.T. Vigneswaran. The Journal of Thoracic and Cardiovascular Surgery 2014;148(4):1763-4. Letter · Comment PubMed · Publisher

• Reply: To PMID 23590275. S. Markowitz, A. Morabia, A. Miller. American Journal of Respiratory and Critical Care Medicine 2014;189(1):116-7. Letter · Comment PubMed · Publisher

• Response to comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'. T.M. Meniawy, J. Creaney, R.A. Lake, et al. British Journal of Cancer 2014;111(12):2377. Letter · Comment PubMed · Publisher · Free full text

• Response to comment on 'The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)'. G. Frost. British Journal of Cancer 2014;111(11):2198-9. Comment PubMed · Publisher · Free full text

• Response. R. Thomas, Y.C.G. Lee. Chest 2014;146(3):e111-e112. Letter · Comment PubMed · Publisher

• Simultaneous acute myeloid leukemia and mesothelioma diagnoses in a long-term survivor of the 1984 Bhopal gas leak. J.Y. Law, J.A. Duong, D.E. Gerber, et al. Acta Oncologica 2014;53(7):984-8. Case report · Letter PubMed · Publisher

• Stage distribution and performance status of newly diagnosed patients in a UK regional mesothelioma centre. S. Khan, M. Evison, M. Alaloul, et al. Lung Cancer 2014;85(1):99-100. Letter PubMed · Publisher

• Staphylococcus aureus bio-products: new biological roles for a pleurodesis agent. I. Psallidas, G.T. Stathopoulos. Respirology 2014;19(7):948-9. Editorial · Comment PubMed · Publisher

• The challenge of malignant pleural mesothelioma: new directions. V.W. Rusch, A. Rimner, L.M. Krug. Journal of Thoracic Oncology 2014;9(3):271-2. Editorial · Comment PubMed · Publisher

• The development of MM is strongly correlated with exposure to asbestos and erionite, as well as to simian virus 40”. L.D. Assis, M.C. Isoldi. Jornal Brasileiro de Pneumologia 2014;40(5):586-7. In English, Portuguese. Comment PubMed · Publisher · Free full text

• To seed or not to seed: the open question of mesothelioma intervention tract metastases. L. Bertolaccini, A. Viti, A. Terzi. Chest 2014;146(3):e111. Letter · Comment PubMed · Publisher

• Translational immunotherapeutics: chemoimmunotherapy for malignant pleural mesothelioma. P.S. Adusumilli. Cancer 2014;120(21):3268-71. Editorial · Comment PubMed · Publisher · Free full text

• "One marker does not fit all": additional translational and validation studies are needed to identify faithful predictors of pemetrexed activity in mesothelioma. E. Giovannetti, G.J. Peters, P.A. Zucali. Journal of Thoracic Oncology 2013;8(8):e79-80. Letter · Comment PubMed · Publisher

• Accurate diagnosis of mesothelioma: more important than ever. T.C. Allen. Archives of Pathology & Laboratory Medicine 2013;137(5):601-2. Editorial · Comment PubMed · Publisher

• Asbestos and lung cancer: what we know. J.R. Balmes. American Journal of Respiratory and Critical Care Medicine 2013;188(1):8-9. Editorial · Comment PubMed · Publisher

• Asbestos-induced mesothelioma: is fiber biopersistence really a critical factor?. E. Kagan. The American Journal of Pathology 2013;183(5):1378-1381. Comment PubMed · Publisher

• Authors' reply. Why countries ban asbestos: the roots of political will. J. Bahk, Y. Choi, S. Lim, et al. International Journal of Occupational and Environmental Health 2013;19(2):137-8. Comment PubMed · Publisher

• CD40 therapy and surgery: a potential immunologic partnership. K.T. Byrne, R.H. Vonderheide. Journal of Immunotherapy 2013;36(7):359-61. Comment PubMed · Publisher · Free full text

• Comment on 'estimating the asbestos-related lung cancer burden from mesothelioma mortality' - IARC and chrysotile risks. R.A. Lemen, A.L. Frank, C.L. Soskolne, et al. British Journal of Cancer 2013;109(3):823-5. Letter · Comment PubMed · Publisher · Free full text

• Commentary on 'evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature', Donovan et al.1. D.S. Egilman, N.M. Druar. International Journal of Occupational and Environmental Health 2013;19(3):163-8. Editorial · Comment PubMed · Publisher

• Commentary on: Comparison of chest digital tomosynthesis and chest radiography for detection of asbestos-related pleuropulmonary disease. I. Vlahos. Clinical Radiology 2013;68(4):336-7. Comment PubMed · Publisher

• Deciduoid pleural mesothelioma in an adolescent. E. Arango-Tomás, F.J. Algar-Algar, A. Salvatierra Velázquez. Archivos de Bronconeumología 2013;49(5):218-9. In English, Spanish. Case report · Letter PubMed · Publisher

• Detection of mesothioloma remains a conundrum. R. Kratzke. Journal of the National Cancer Institute 2013;105(4):254-5. Editorial · Comment PubMed · Publisher

• Does miR-1 play a role in malignant pleural mesothelioma development and progression?. C.M. Wright, M.B. Kirschner, N. van Zandwijk, et al. Chest 2013;144(6):1971. Letter · Comment PubMed · Publisher

• Extrapulmonary small cell carcinoma mimicking malignant pleural mesothelioma. K. Noguchi, N. Fujimoto, M. Asano, et al. Journal of Clinical Pathology 2013;66(5):450-1. Case report · Letter PubMed · Publisher

• Fibulin-3 as a biomarker for pleural mesothelioma. K. Hollevoet, E. Sharon. The New England Journal of Medicine 2013;368(2):189. Letter · Comment PubMed · Publisher · Free full text

• Fibulin-3 as a biomarker for pleural mesothelioma. H.I. Pass, C. Goparaju. The New England Journal of Medicine 2013;368(2):190. Letter · Comment PubMed · Publisher

• Fibulin-3 as a biomarker for pleural mesothelioma. K. Lamote, P. Baas, J.P. van Meerbeeck. The New England Journal of Medicine 2013;368(2):189-90. Letter · Comment PubMed · Publisher

• I feel it in my bones: a rare presentation of idiopathic sclerosing orbital inflammation with hyperostosis. S.T. Ho, M. Lakey, B. Crawford, et al. Clinical & Experimental Ophthalmology 2013;41(3):304-5. Case report · Letter PubMed · Publisher

• Immunological checkpoint inhibitors enter adolescence. A.K. Nowak. The Lancet. Oncology 2013;14(11):1035-1037. Letter · Comment PubMed · Publisher

• Invited commentary. J.S. Donington. The Annals of Thoracic Surgery 2013;95(4):1188. Comment PubMed · Publisher

• Letter concerning the paper by Finley and colleagues: dx.doi.org/10.1016/j.yrtph.2012.05.015. M.M. Finkelstein. Regulatory Toxicology and Pharmacology 2013;65(1):178-9. Letter · Comment PubMed · Publisher

• Letter to the editor on commentary: malignant mesothelioma incidence among talc miners and millers in New York state by M M Finkelstein. R.P. Nolan, J.F. Gamble, G.W. Gibbs. American Journal of Industrial Medicine 2013;56(9):1116-8. Letter · Comment PubMed · Publisher

• Letter to the Editor re Bernstein et al: Health risk of chrysotile revisited. Crit Rev Toxicol, 2013; 43(2): 154-183. M.M. Finkelstein. Critical Reviews in Toxicology 2013;43(8):707-8. Letter · Comment PubMed · Publisher

• Lung-sparing total pleurectomy: the surgical option of choice in malignant pleural mesothelioma?. D.A. Waller. European Journal of Cardio-thoracic Surgery 2013;44(1):123-4. Comment PubMed · Publisher

• Malignant biphasic peritoneal mesothelioma in a child: consideration of other diagnostic possibilities. S.J. Geyer. Diagnostic Cytopathology 2013;41(7):658. Letter · Comment PubMed · Publisher

• MARS: a sense of perspective and an inconvenient truth. T. Treasure, M. Utley, K. O'Byrne. Journal of Thoracic Oncology 2013;8(5):e48-9. Letter · Comment PubMed · Publisher

• MARS: a sense of perspective and an inconvenient truth. V.W. Rusch, H.L. Kindler. Journal of Thoracic Oncology 2013;8(5):e49-50. Letter · Comment PubMed · Publisher

• Mesothelin and osteopontin. G. Hillerdal. The European Respiratory Journal 2013;42(2):557. Letter · Comment PubMed · Publisher

• Mesothelin and osteopontin. I. Pantazopoulos, T. Xanthos, P. Boura, et al. The European Respiratory Journal 2013;42(2):557-8. Letter · Comment PubMed · Publisher

• Mesothelioma: closer to the target?. H.I. Pass. The Lancet. Oncology 2013;14(6):448-9. Comment PubMed · Publisher

• Nervous system metastases from malignant mesothelioma. N.M. Martinez, I.T. Gavrilovic, C. Grommes. Clinical Oncology 2013;25(1):74. Letter PubMed · Publisher · Free full text

• No indication that mineral wool causes mesothelioma. J.P. Bonde. American Journal of Respiratory and Critical Care Medicine 2013;188(7):873. Letter · Comment PubMed · Publisher

• Obtaining expert opinions in diagnostically difficult cases. C. Hemmings. Pathology 2013;45(1):80. Letter · Comment PubMed · Publisher

• Quality of evidence must guide risk assessment of asbestos, by Lenters, V; Burdorf, A; Vermeulen, R; Stayner, L; Heederik, D. J.T. Hodgson. The Annals of Occupational Hygiene 2013;57(5):670-4. Letter · Comment PubMed · Publisher

• Quality of evidence must guide risk assessment of asbestos, by Lenters, V; Burdorf, A; Vermeulen, R; Stayner, L; Heederik, D. D.W. Berman, B.W. Case. The Annals of Occupational Hygiene 2013;57(5):667-9. Letter · Comment PubMed · Publisher

• Recurrence of malignant pleural mesothelioma at the resection borders--local or distant recurrence?. S. Bölükbas, M. Eberlein, J. Schirren. Journal of Thoracic Oncology 2013;8(7):e65. Letter · Comment PubMed · Publisher

• Recurrence of malignant pleural mesothelioma at the resection borders--local or distant recurrence?. D. Gomez, A. Tsao, D. Rice. Journal of Thoracic Oncology 2013;8(7):e65-6. Letter · Comment PubMed · Publisher

• Reply to letter by Nolan and colleagues--re: the carcinogenicity of New York state talc dusts in humans. M. Finkelstein. American Journal of Industrial Medicine 2013;56(9):1119-24. Letter · Comment PubMed · Publisher

• Reply to the editor. M. Baud, P. Forgez, D. Damotte, et al. The Journal of Thoracic and Cardiovascular Surgery 2013;146(4):990-1. Letter · Comment PubMed · Publisher

• Reply: comment on 'estimating the asbestos-related lung cancer burden from mesothelioma mortality'. V. McCormack, J. Peto, G. Byrnes, et al. British Journal of Cancer 2013;109(3):825-6. Letter · Comment PubMed · Publisher · Free full text

• Reply: No indication that mineral wool causes mesothelioma. A. Lacourt. American Journal of Respiratory and Critical Care Medicine 2013;188(7):873-4. Letter · Comment PubMed · Publisher

• Reply: response to the letter by Drs Berman and Case. D. Heederik, V. Lenters, R. Vermeulen. The Annals of Occupational Hygiene 2013;57(5):675-7. Letter · Comment PubMed · Publisher

• Response to a letter to the editor by Dr. Murray M. Finkelstein regarding the article by Finley et al. (2012). B.L. Finley, J.S. Pierce, D.J. Paustenbach, et al. Regulatory Toxicology and Pharmacology 2013;65(1):180-1. Letter · Comment PubMed · Publisher

• Response to Murray M. Finkelstein, letter to the editor re Bernstein et al: Health risk of chrysotile revisited. Crit Rev Toxicol, 2013; 43(2): 154-183. D. Bernstein, J. Dunnigan, T. Hesterberg, et al. Critical Reviews in Toxicology 2013;43(8):709-10. Letter · Comment PubMed · Publisher

• Response. Y. Xu, M. Zheng, A. Khuong, et al. Chest 2013;144(6):1971-1972. Letter · Comment PubMed · Publisher

• Statement in response to asbestos industry efforts to prevent a ban on asbestos in Pakistan: chrysotile asbestos use is not safe and must be banned. G. Aguilar Madrid, M. Beaudry, W. Bell, et al. Archives of Environmental & Occupational Health 2013;68(4):243-9. Letter PubMed · Publisher

• The dog didn't bark. V. Acton. The Journal of Thoracic and Cardiovascular Surgery 2013;146(4):990. Letter · Comment PubMed · Publisher

• The importance of scientific debate. D.S. Egilman. International Journal of Occupational and Environmental Health 2013;19(3):157-9. Editorial · Comment PubMed · Publisher

• The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma. F. Mairinger, C. Vollbrecht, T. Mairinger, et al. Journal of Thoracic Oncology 2013;8(8):e80-2. Letter · Comment PubMed · Publisher

• The usefulness of expert opinion in medicolegal referrals of malignant mesothelioma. D.L. Dixon, K.M. Griggs, M. Ely, et al. Pathology 2013;45(5):523-5. Letter PubMed · Publisher

• Tomotherapy after pleurectomy or decortication or biopsy for malignant pleural mesothelioma. M. Trovo, E. Minatel. Journal of Thoracic Oncology 2013;8(5):e50-1. Letter · Comment PubMed · Publisher

• Tomotherapy after pleurectomy or decortication or biopsy for malignant pleural mesothelioma. S. Bölükbas, J. Schirren, M. Eberlein. Journal of Thoracic Oncology 2013;8(5):e50. Letter · Comment PubMed · Publisher

• Why countries ban asbestos: some alternative thoughts. A.L. Frank. International Journal of Occupational and Environmental Health 2013;19(2):136. Comment PubMed · Publisher

• A proposed threshold exposure for airborne asbestos. J.H. Lange, G. Mastrangelo, L. Cegolon. Occupational and Environmental Medicine 2012;69(3):227-8. Letter · Comment PubMed · Publisher

• Adjuvant radiotherapy for malignant pleural mesothelioma: challenges and pitfalls. G.L. Ceresoli, U. Ricardi, V. Vavassori, et al. Radiotherapy and Oncology 2012;105(2):271. Letter · Comment PubMed · Publisher

• Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?. M. Andersen, M. Grauslund, M. Muhammad-Ali, et al. APMIS 2012;120(9):767-9. Letter PubMed · Publisher

• China and the US: asbestos in common. A.L. Frank. International Journal of Occupational and Environmental Health 2012;18(3):179-80. Editorial · Comment PubMed · Publisher

• Clinical and pathological features are still the best determinants of prognosis in mesothelioma. A.C. Miller, R. Hassan. Oncology 2012;26(12):1176, 1178, 1180. Comment PubMed · Free full text

• Desmoplastic malignant mesothelioma originating from the peritoneum. H. Takamaru, Y. Arimura, Y. Shinomura. Medical Oncology 2012;29(5):3155-6. Case report · Letter PubMed · Publisher

• Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components--a hitherto undescribed pattern of differentiation. A. Klabatsa, A.G. Nicholson, K. Dulay, et al. Histopathology 2012;60(7):1164-6. Case report · Letter PubMed · Publisher

• Egilman's assessment regarding exposures of auto mechanics to amphiboles is not accurate. D.J. Paustenbach, K.R. White. Inhalation Toxicology 2012;24(9):609-13; author reply 614-8. Letter · Comment PubMed · Publisher

• Estimation with vanishing baseline risk. R.M. Park. Epidemiology 2012;23(6):937-8. Letter PubMed · Publisher · Free full text

• Expression of concern: false claim to be free of conflicts in asbestos biopersistence debate. S.R. Bohme. International Journal of Occupational and Environmental Health 2012;18(2):85-8. Letter PubMed · Publisher

• High association of peroxiredoxins with lung cancer. Y. Soini, V.L. Kinnula. Lung Cancer 2012;78(2):167. Letter · Comment PubMed · Publisher

• Importance of meta-analyses for evaluating carcinogens. M. Kogevinas, N. Pearce. Environmental Health Perspectives 2012;120(4):A145; author reply A146-7. Letter · Comment PubMed · Publisher · Free full text

• In reply to L. Ceresoli et al. "Adjuvant radiotherapy for malignant pleural mesothelioma: challenges and pitfalls". S. Tonoli, S. Magrini, G. Tassi. Radiotherapy and Oncology 2012;105(2):272. Letter · Comment PubMed · Publisher

• Invited commentary. H.I. Pass. The Annals of Thoracic Surgery 2012;94(4):1092-3. Comment PubMed · Publisher

• Ionising radiation and occupational cancer in Britain. C.R. Muirhead, R. Haylock. British Journal of Cancer 2012;107(9):1660-1; author reply 1662. Letter · Comment PubMed · Publisher · Free full text

• Is there a need for expert opinion for biopsy diagnosis of difficult cases of malignant mesothelioma?. S. Klebe, K.M. Griggs, M. Ely, et al. Pathology 2012;44(6):562-3. Letter PubMed · Publisher

• Letter re Marsh et al. M. Finkelstein. Inhalation Toxicology 2012;24(2):139-40; author reply 141-2. Letter · Comment PubMed · Publisher

• Letter to the Editor regarding the Donovan et al. (2011) article. D. Egilman, J.H. Schilling. Critical Reviews in Toxicology 2012;42(2):169-72; author reply 173-83. Letter · Comment PubMed · Publisher

• Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later. A. Gogali, C. Manda-Stachouli, E.E. Ntzani, et al. The European Respiratory Journal 2012;39(1):217-9. Letter PubMed · Publisher

  In plain English

  This research letter updated the authors' earlier reports on malignant mesothelioma in Metsovo, north-west Greece. Households there had used 'luto', a whitewash containing tremolite asbestos. The team followed the Metsovo municipality population (4,417 inhabitants in 2001) and the rest of Ioannina prefecture from 1980 to 2009. None of the patients had an asbestos-related job. Metsovo had 26 cases, a crude rate of 2.04 per 10,000 person-years. Twelve occurred in 1995–2009 (10 pleural, two peritoneal), all in people who had used luto in 1950–1970. The 1995–2009 rate (1.8 per 10,000 person-years) was not statistically different from the 1980–1994 rate (2.2). The last decade's rate (1.1 per 10,000 person-years) was less than half the previous decade's (2.4; p=0.1), which the authors called a trend. Metsovo residents had an estimated 137-fold higher risk than the rest of Ioannina (95% CI 58.2–375.6). This fell from 236-fold in the first 15 years to 86-fold in the second. The authors concluded that abandoning luto had cut incidence to one-half and relative risk to one-third, and that the epidemic may still end by 2020–2030, though no prediction is safe. Rates were not age-adjusted.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• Mesothelioma of the tunica vaginalis with BerEp4 and LeuM1 expression: identification of cytoplasmic tonofilaments by electron microscopy is a key diagnostic feature. D. Shelton, N. Dalal. Journal of Clinical Pathology 2012;65(10):958-9. Case report · Letter PubMed · Publisher

• Pleural mesothelioma secondary to radiotherapy: a rare association. T. Lourido-Cebreiro, V. Leiro-Fernández, A. Fernández-Villar. Archivos de Bronconeumología 2012;48(12):482-3. In English, Spanish. Case report · Letter PubMed · Publisher

• Predicting survival in malignant mesothelioma. J.G. Smith. The European Respiratory Journal 2012;40(3):799. Letter · Comment PubMed · Publisher

• Predicting survival in mesothelioma. A.W. Musk. The European Respiratory Journal 2012;40(6):1582. Letter · Comment PubMed · Publisher

• Primary sarcomatoid malignant mesothelioma of the pericardium. T. Terada. Medical Oncology 2012;29(2):1345-6. Case report · Letter PubMed · Publisher

• Report of a recent "brake" through in the fiber burden-mesothelioma dialogue. D. Egilman. Inhalation Toxicology 2012;24(2):136-7. Letter · Comment PubMed · Publisher

• The asbestos disease epidemic: here today, here tomorrow. P. Cullinan, N. Pearce. Thorax 2012;67(2):98-9. Editorial · Comment PubMed · Publisher

• The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma. T. Li, S.C. Hou, J.H. Mao, et al. Journal of Clinical Pathology 2012;65(9):855-8. Letter PubMed · Publisher · Free full text

• The traveling Libby legacy: Minnesota community exhibits nonoccupational health impacts consistent with asbestos damage. T. Tillett. Environmental Health Perspectives 2012;120(1):A35. News · Comment PubMed · Publisher · Free full text

• Tips for palliative care professionals treating mesothelioma patients. M.Y. Llamas. Journal of Palliative Medicine 2012;15(11):1169. Letter PubMed · Publisher

• Use of meta-analyses by IARC Working Groups. K. Straif, L. Stayner, P.A. Demers, et al. Environmental Health Perspectives 2012;120(9):A342-3. Letter · Comment PubMed · Publisher · Free full text

• Who is driving Mexico's asbestos policy?. L. Kazan-Allen. International Journal of Health Services 2012;42(1):109-18. Comment PubMed · Publisher

• A practical guide to measure "all" malignant pleural mesothelioma tumors by modified RECIST criteria?. K. Nackaerts, J. Vansteenkiste, P. Nafteux. Journal of Thoracic Oncology 2011;6(12):2143-4; author reply 2144-5. Letter · Comment PubMed · Publisher

• A pseudo case of atypical pseudo-Meigs syndrome. D.A. Thaker, P.J. Stride, A. Dettrick. Indian Journal of Cancer 2011;48(3):364-6. Case report · Letter PubMed · Publisher

• An elaboration of "proof" of peritoneal mesothelioma from tremolite free chrysotile. D. Egilman. American Journal of Industrial Medicine 2011;54(8):647. Comment PubMed · Publisher

• Asbestos abatement workers versus asbestos workers: exposure and health-effects differ. J. Lange, G. Mastrangelo, L. Cegolon. International Journal of Occupational Medicine and Environmental Health 2011;24(4):418-9; author reply 420-1. Letter · Comment PubMed · Publisher

• Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?. A.J. Rai, R.M. Flores. Clinical Chemistry and Laboratory Medicine 2011;49(1):5-7. Comment · Editorial PubMed · Publisher

• Benign cystic peritoneal mesothelioma incorrectly diagnosed as an ovarian borderline mucinous tumor of intestinal type at transvaginal preoperative ultrasound evaluation. A.C. Testa, G.F. Zannoni, S. Ferrari, et al. Ultrasound in Obstetrics & Gynecology 2011;37(2):248-50. Case report · Letter PubMed · Publisher

• Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Y. Shi, A. Hollenstein, E. Felley-Bosco, et al. Lung Cancer 2011;71(3):370-1. Letter PubMed · Publisher

• Canadian hypocrisy regarding chrysotile. J. Bridle, J. Hoskins. Lancet 2011;377(9767):720. Letter · Comment PubMed · Publisher

• Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. X. Shi, A. von dem Bussche, R.H. Hurt, et al. Nature Nanotechnology 2011;6(11):714-9. Letter PubMed · Publisher · Free full text

• Clinical report: a patient with primary peritoneal mesothelioma that has improved after taking citric acid orally. A.H. Bucay. Clinics and Research in Hepatology and Gastroenterology 2011;35(3):241. Comment · Letter PubMed · Publisher

• Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma. N. Fujimoto, K. Gemba, T. Kishimoto. Journal of Thoracic Oncology 2011;6(5):971-2. Comment · Letter PubMed · Publisher

• Continued controversy on chrysotile biopersistence. K. Donaldson, G. Oberdörster. International Journal of Occupational and Environmental Health 2011;17(1):98-9; discussion 99-102. Comment · Letter PubMed · Publisher

• eComment: What is the best way to diagnose and stage malignant pleural mesothelioma?. S. Cafarotti, V. Porziella, S. Margaritora, et al. Interactive Cardiovascular and Thoracic Surgery 2011;12(5):811. Comment PubMed · Publisher

• Exposure science will not increase protection of workers from asbestos-caused diseases: NIOSH fails to provide needed public health action and leadership. R.A. Lemen, H. Anderson, J.C. Bailar, et al. Journal of Exposure Science & Environmental Epidemiology 2011;21(1):114-5; author reply 116. Letter · Comment PubMed · Publisher

• Facts, rumours and speculations about the mesothelioma epidemic. J.P. van Meerbeeck, R. Damhuis. Respirology 2011;16(7):1018-9. Editorial · Comment PubMed · Publisher

• Fine needle aspiration cytology in malignant mesothelioma of the tunica vaginalis testis. R. Gupta, P. Dey, R.K. Vasishtha. Cytopathology 2011;22(1):66-8. Case report · Letter PubMed · Publisher

• Germline BAP1 mutations and tumor susceptibility. A.M. Goldstein. Nature Genetics 2011;43(10):925-6. News · Comment PubMed · Publisher · Free full text

• Invited commentary. C.P. Clarke. The Annals of Thoracic Surgery 2011;91(6):1745-6. Comment PubMed · Publisher

• Lack of evidence in malignant pleural mesothelioma surgery. O. Rena, C. Casadio. Interactive Cardiovascular and Thoracic Surgery 2011;12(3):347-8. Comment · Editorial PubMed · Publisher

• Malignant pleural mesothelioma: a therapeutic challenge. G. Dimitrakakis, T. BinEsmael, A. Szafranek, et al. Interactive Cardiovascular and Thoracic Surgery 2011;13(6):691-2. Comment PubMed · Publisher

• Medicolegal aspects of the third wave of asbestos-related disease in Australia. J.R. Gordon, J. Leigh. The Medical Journal of Australia 2011;195(5):247-8. Editorial · Comment PubMed · Publisher

• Mesothelioma and aircraft industry. C. Bianchi, T. Bianchi. American Journal of Industrial Medicine 2011;54(6):494. Comment · Letter PubMed · Publisher

• Mesothelioma in a connecticut friction plant: the need for transparency and exposure information in attribution of risk. M.J. Teta. The Annals of Occupational Hygiene 2011;55(7):817-9; author reply 820-2. Letter · Comment PubMed · Publisher

• No matter how complex the problem, there is always a simple solution--which is wrong!. V. Acton. The Journal of Thoracic and Cardiovascular Surgery 2011;142(2):477. Letter PubMed · Publisher

• Possible relationship between asbestos exposure and bronchial asthma: a need for clarification. M. Toyoshima, K. Chida, T. Suda, et al. American Journal of Respiratory and Critical Care Medicine 2011;183(11):1571-2; author reply 1572. Comment · Letter PubMed · Publisher

• Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. S. Amatori, I. Bagaloni, D. Viti, et al. Lung Cancer 2011;71(1):113-5. Letter PubMed · Publisher

• Re: Paradis G. Ban all production and export of chrysotile asbestos [Editor's Page]. Can J Public Health 2010;101(5):352. M. Greenberg. Canadian Journal of Public Health = Revue Canadienne de Santé Publique 2011;102(1):76. Letter · Comment PubMed · Publisher · Free full text

• Regarding "absence of radiographic asbestosis and the risk of lung cancer among asbestos-cement workers: extended follow-up of a cohort", by Murray Finkelstein, American Journal of Industrial Medicine 2010. R.M. Ross. American Journal of Industrial Medicine 2011;54(6):495-6; author reply 497-8. Letter · Comment PubMed · Publisher

• Renovation and renewal. A. Katelaris. The Medical Journal of Australia 2011;195(5):245. Editorial · Comment PubMed · Publisher

• Respiratory illness in asbestos contaminated sites: the role of environmental exposure. P. Comba, L. Fazzo, A. Zona. The European Respiratory Journal 2011;38(2):248-50. Comment · Editorial PubMed · Publisher

• Should cytology be an acceptable means of diagnosing malignant mesothelioma?. M. Sheaff. Cytopathology 2011;22(1):3-4. Comment · Editorial PubMed · Publisher

• Skin metastasis of pleural epithelioid malignant mesothelioma. T. Terada. Applied Immunohistochemistry & Molecular Morphology 2011;19(1):92-3. Case report · Letter PubMed · Publisher

• Staging malignant pleural mesothelioma: additional investigation may not improve accuracy. D.G. West, W.S. Walker. European Journal of Cardio-thoracic Surgery 2011;39(5):800; author reply 800-1. Letter · Comment PubMed · Publisher

• Surgery for mesothelioma? The debate continues. H.L. Kindler. The Lancet. Oncology 2011;12(8):713-4. Comment PubMed · Publisher

• Techniques of surgery and radiotherapy for multimodal treatment of pleural mesothelioma. P. Bonnette. Journal of Thoracic Oncology 2011;6(12):2146. Letter PubMed · Publisher

• The importance of retaining post mortem tissue--'pseudomesotheliomatous' Merkel cell carcinoma of the pleura. G.D. Leopold, R.L. Attanoos. Histopathology 2011;58(7):1180-2. Case report · Letter PubMed · Publisher

• The MARS feasibility trial: conclusions not supported by data. W. Weder, R.A. Stahel, P. Baas, et al. The Lancet. Oncology 2011;12(12):1093-4; author reply 1094-5. Letter · Comment PubMed · Publisher

• The need for pathological confirmation of the diagnosis of peritoneal malignant mesothelioma. S.J. Geyer. American Journal of Industrial Medicine 2011;54(8):646. Letter · Comment PubMed · Publisher

• The need for randomized trials in mesothelioma: let's walk the talk. T. Treasure, S. Senan. The Oncologist 2011;16(3):261-3. Comment · Editorial PubMed · Publisher · Free full text

• Where there is asbestos, there is mesothelioma: filling in the data blanks. R.C. Haynes. Environmental Health Perspectives 2011;119(4):A177. Comment · News PubMed · Publisher · Free full text

• A repeat call for the banning of asbestos. L.S. Birnbaum, J.C. Schroeder, H.A. Tilson. Environmental Health Perspectives 2010;118(7):A280-1. Comment · Editorial PubMed · Publisher · Free full text

• A worn-out welcome: renewed call for a global ban on asbestos. R.C. Haynes. Environmental Health Perspectives 2010;118(7):A298-303. Comment · News PubMed · Publisher · Free full text

• Asbestos and lung disease. A.R. Brody. American Journal of Respiratory Cell and Molecular Biology 2010;42(2):131-2. Comment · Editorial · Review PubMed · Publisher

• Asbestos exposure and laryngeal cancer. E.M. Sturgis. Ear, Nose, & Throat Journal 2010;89(3):104; author reply 104. Comment · Letter PubMed

• Biomarkers for early detection of mesothelioma in asbestos-exposed subjects. E.K. Park, P.S. Thomas, D.H. Yates. Clinical Chemistry and Laboratory Medicine 2010;48(11):1673-4. Letter PubMed · Publisher

• Chrysotile asbestos and mesothelioma. R.A. Lemen. Environmental Health Perspectives 2010;118(7):A282. Comment · Letter PubMed · Publisher · Free full text

• Does asbestos exposure (asbestosis) cause (clinical) airway obstruction (small airway disease)?. A. Miller, W.N. Rom. American Journal of Respiratory and Critical Care Medicine 2010;182(4):444-5. Comment · Editorial PubMed · Publisher

• Editorial comment May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?. I. Opitz. European Journal of Cardio-thoracic Surgery 2010;38(3):252-3. Comment · Editorial PubMed · Publisher

• Fatal pemetrexed-induced lung injury in patients with advanced mesothelioma: a report of two cases. K. Nagata, R. Kaji, K. Tomii. Journal of Thoracic Oncology 2010;5(10):1714-5. Case report · Letter PubMed · Publisher

• Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected]. P.H. Sugarbaker. Annals of Surgical Oncology 2010;17(6):1710-2; author reply 1713-4. Comment · Letter PubMed · Publisher

• Invited commentary. D. Rice. The Annals of Thoracic Surgery 2010;89(1):210-1. Comment PubMed · Publisher

• Iodopovidone as a pleurodesis agent: setting standards for clinical pleural research. A.H. Diacon. Respirology 2010;15(1):4-5. Editorial · Comment PubMed · Publisher

• Is risk of pleural mesothelioma an environmental risk outside Turkey? A study on immigrants to Sweden. S.M. Mousavi, J. Sundquist, K. Hemminki. Lung Cancer 2010;68(1):125-6. Letter PubMed · Publisher

• Laparoscopic excision of a benign peritoneal cystic mesothelioma. A. Limone, J. Maier, V. Chiantera, et al. Archives of Gynecology and Obstetrics 2010;281(3):577-8. Case report · Letter PubMed · Publisher

• Letter to the editor: "Comparing milled fiber, Quebec ore, and textile factory dust: has another piece of the asbestos puzzle fallen into place?" by D. Wayne Berman. J.M. Dement, L.T. Stayner. Critical Reviews in Toxicology 2010;40(8):749-51; author reply 752-7. Comment · Letter PubMed · Publisher

• Lung cancer in the melt shops of Ontario steelmakers. M.M. Finkelstein. American Journal of Industrial Medicine 2010;53(7):762. Letter PubMed · Publisher

• Mesothelioma risk from chrysotile. J.T. Hodgson, A. Darnton. Occupational and Environmental Medicine 2010;67(6):432. Comment · Letter PubMed · Publisher

• Mesothelioma: an inviting but challenging target for gene therapy. R.G. Crystal. American Journal of Respiratory Cell and Molecular Biology 2010;42(4):383-4. Comment · Editorial PubMed · Publisher

• Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells. H. Tsukiji, Y. Takeshima, V.J. Amatya, et al. Histopathology 2010;56(7):969-74. Letter PubMed · Publisher

• New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma. P.A. Zucali, E. Giovannetti, Y.G. Assaraf, et al. Annals of Oncology 2010;21(7):1560-1561. Letter PubMed · Publisher

• Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?. K. Tamura, Y. Fujiwara. Asia-Pacific Journal of Clinical Oncology 2010;6(4):248-50. Comment · Editorial PubMed · Publisher

• Porcelain factory worker with asbestos-related mesothelioma. C. Mensi, A. Garberi, C. Sieno, et al. Journal of the Formosan Medical Association = Taiwan Yi Zhi 2010;109(5):389. Comment · Letter PubMed · Publisher

• Sarcomatoid localised mesothelioma mimicking intrapulmonary synovial sarcoma: a case report and review of the literature. A. Teo, C. Hemmings, R. Miller. Pathology 2010;42(2):182-4. Case report · Letter PubMed · Publisher

• Solitary fibrous tumors of the pleura: an estimation of population incidence. T. Thorgeirsson, H.J. Isaksson, H. Hardardottir, et al. Chest 2010;137(4):1005-6. Letter PubMed · Publisher

  In plain English

  This short research letter from Iceland used nationwide registries to estimate how often solitary fibrous tumors of the pleura (SFTP), mostly benign tumors of the lining around the lungs, are diagnosed. The authors found every patient with a tissue-confirmed SFTP in Iceland from 1984 to 2007 through a central pathology registry. For comparison, they took mesothelioma cases from the Icelandic Cancer Registry. Eleven patients had SFTP (mean age 60; eight women) and 35 had mesothelioma (mean age 68; four women). The age-standardized rates were 1.4 per million for SFTP (95% CI 0.54 to 2.2) and 4.0 per million for mesothelioma (95% CI 2.6 to 5.4). All 11 SFTPs were benign. Eight were found by chance and three patients had symptoms. All but one were completely removed by surgery; that one was found at autopsy. At a median follow-up of 70 months there was no recurrence or disease-related death. The authors noted the small number of patients. Because many tumors are found by chance on chest imaging, they said Iceland's rate is possibly in the higher range. The letter did not examine asbestos exposure.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• Surgical treatment of malignant peritoneal mesothelioma: past, present, and future. H.R. Alexander. Annals of Surgical Oncology 2010;17(1):21-2. Comment · Editorial PubMed · Publisher · Free full text

• Taking a retrospective look at asbestos-related thoracic disease produces interesting results. E.B. Gottschall. Radiology 2010;255(3):681-2. Editorial · Comment PubMed · Publisher

• The mesothelioma and radical surgery feasibility study. P. Goldstraw. Journal of Thoracic Oncology 2010;5(2):287. Comment · Letter PubMed · Publisher

2000s

• Asbestos and the lung. Diffuse pleural thickening has new definition for claims. J.L. Hoyle, J.K. Walker. BMJ 2009;339:b3953. Letter PubMed · Publisher

• Asbestos related disease investigated. British Dental Journal 2009;206(10):512. Comment · News PubMed · Publisher

• Comments on Asbestos fibre concentrations in the lungs of brake workers: another look. V.L. Roggli, T.A. Sporn, B.W. Case, et al. The Annals of Occupational Hygiene 2009;53(2):191; author reply 192-3. Comment · Letter PubMed · Publisher

• Inaccuracies in article on mesothelioma in brake workers. P.A. Hessel. International Journal of Occupational and Environmental Health 2009;15(2):232-4; author reply 234-8. Comment · Letter PubMed · Publisher

• Mortality among British asbestos workers. B. Sjögren. Occupational and Environmental Medicine 2009;66(12):854-5. Letter · Comment PubMed · Publisher

• MR imaging features of peritoneal adenomatoid mesothelioma: a case report. C.M. Lins, J. Elias, A.F. Cunha, et al. Clinics 2009;64(3):264-9. Case report · Letter PubMed · Publisher · Free full text

• Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. A. Vaglio. Medicine 2009;88(4):208-210. Comment PubMed · Publisher

• South African data on malignant mesothelioma. J.I. Phillips, J. Murray. Industrial Health 2009;47(2):198-9. Comment · Letter PubMed · Publisher

• The upholsterer and the asbestos. C. Mensi, A. Garberi, R. Trinco, et al. Occupational and Environmental Medicine 2009;66(12):855. Case report · Letter PubMed · Publisher

• 'Environment' in cancer causation and etiological fraction: limitations and ambiguities. D. Mirabelli, E. Merler. Carcinogenesis 2008;29(5):1083. Comment · Letter PubMed · Publisher

• Airborne environmental exposure to asbestos. A. Hansell. American Journal of Respiratory and Critical Care Medicine 2008;178(6):556-7. Comment · Editorial PubMed · Publisher

• An electrocautery pleural biopsy for the diagnosis of desmoplastic malignant mesothelioma during semirigid thoracoscopy. S. Sasada, K. Kawahara, T. Iwasaki, et al. Journal of Thoracic Oncology 2008;3(7):803-4. Case report · Letter PubMed · Publisher

• Asbestos awareness. C. Fry. British Dental Journal 2008;204(9):476-7. Letter PubMed · Publisher

• Asbestos dressing. A. Cook. British Dental Journal 2008;204(5):224. Letter PubMed · Publisher

• Asbestos, mesothelioma and the legacy of shipbuilding in Belfast. P.J. Morrison. The Ulster Medical Journal 2008;77(3):145. Comment · Editorial · Historical article PubMed · Free full text

• Asbestos, pleural mesothelioma,and mortality in Italy. R.G. Carbone, B. Terracini, A. Marinaccio, et al. Journal of Occupational and Environmental Hygiene 2008;5(4):D55-6. Letter PubMed · Publisher

• Carcinogenic asbestos. M. Yewe-Dyer. British Dental Journal 2008;204(10):544. Comment · Letter PubMed · Publisher

• Choroid plexus metastases from pleural sarcomatoid mesothelioma. A. Muljono, T. Ng, J. McMaster, et al. Pathology 2008;40(5):530-2. Case report · Letter PubMed · Publisher

• Clarification on mesothelioma rates in Ontario. J. Payne, E. Pichora. International Journal of Occupational and Environmental Health 2008;14(2):157-8. Comment · Letter PubMed · Publisher

• Comments on Dodson et al., A technical comparison of evaluating asbestos concentration by phase contrast microscopy (PCM), scanning electron microscopy (SEM), and analytical transmission electron microscopy (ATEM) as illustrated from data generated from a case report. V.L. Roggli, T.A. Sporn, K.J. Butnor. Inhalation Toxicology 2008;20(12):1113-4; author reply 1115-7. Comment · Letter PubMed · Publisher

• Correction to R. Lemen's review article, 'Asbestos in Brakes: Exposure and Risk of Disease'. J. Turim. American Journal of Industrial Medicine 2008;51(6):475; author reply 476. Comment · Letter PubMed · Publisher

• Environmental asbestos exposure alters the male:female ratio in patients with pleural mesothelioma. E. Gogou, T. Kerenidi, V. Chamos, et al. Respirology 2008;13(6):931. Comment · Letter PubMed · Publisher

• IAOH denies industry influence. S.M. Shanbhag. International Journal of Occupational and Environmental Health 2008;14(2):159. Letter · Comment PubMed · Publisher

• Immunology. How frustration leads to inflammation. L.A. O'Neill. Science 2008;320(5876):619-20. Comment PubMed · Publisher

• Industry influence on IAOH. T.K. Joshi. International Journal of Occupational and Environmental Health 2008;14(1):82. Letter PubMed · Publisher

• Letter to the editor re: "Mesothelioma and asbestos". M.E. Wagner, L.B. Travis. Regulatory Toxicology and Pharmacology 2008;52(3):353-4; author reply 355. Comment · Letter PubMed · Publisher

• Mesothelioma - "not just in the chest". C.E. Bruckner Holt, A.D. Farmer, W. Syn, et al. The Ulster Medical Journal 2008;77(2):133-4. Case report · Letter PubMed · Free full text

• Re: Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. G. Ichihara, V. Castranova, A. Tanioka, et al. The Journal of Toxicological Sciences 2008;33(3):381-2; author reply 382-4. Comment · Letter PubMed · Publisher

• Re: The "Helsinki Criteria" for attribution of lung cancer to asbestos exposure: how robust are the criteria?. V.L. Roggli, S.P. Hammar, J.C. Maddox, et al. Archives of Pathology & Laboratory Medicine 2008;132(9):1386-7; author reply 1387. Comment · Letter PubMed · Publisher

• Records of the Australian Mesothelioma Surveillance Program have been lost!. M. Hendrickx. The Medical Journal of Australia 2008;188(9):552; author reply 552. Letter PubMed · Publisher

• Screening for mesothelioma: more harm than good?. J.P. van Meerbeeck, G. Hillerdal. American Journal of Respiratory and Critical Care Medicine 2008;178(8):781-2. Comment · Editorial PubMed · Publisher

• Thinking longitudinally in a cross-sectional world. G.R. Wagner. American Journal of Respiratory and Critical Care Medicine 2008;177(6):565-6. Comment · Editorial PubMed · Publisher

• Belgium: historical champion in asbestos consumption. T.S. Nawrot, G. Van Kersschaever, E. Van Eycken, et al. Lancet 2007;369(9574):1692. Comment · Letter PubMed · Publisher

• Canada's asbestos legacy. W. Charney. International Journal of Occupational and Environmental Health 2007;13(4):451. Comment · Letter PubMed · Publisher

• Environmental asbestos contamination: What are the risks?. V.L. Roggli. Chest 2007;131(2):336-8. Comment · Editorial PubMed · Publisher

• Malignant mesothelioma in telephone workers. C. Bianchi, T. Bianchi. Journal of Occupational and Environmental Medicine 2007;49(4):359. Comment · Letter PubMed · Publisher

• Mesothelioma: a case report. J. van Brakel, B. van Ouwerkerk, T.J. Cleophas. The Netherlands Journal of Medicine 2007;65(1):43; autho reply 43. Comment · Letter PubMed

• Modelling mesothelioma risk for workers assembling military gas masks. J.W. Cherrie, H.A. Cowie, A.D. Jones. Occupational and Environmental Medicine 2007;64(11):785-6; author reply 785-6. Comment · Letter PubMed · Free full text

• Screening for lung cancer in a high-risk group: but I still haven't found what I'm looking for. G.A. Silvestri. The European Respiratory Journal 2007;29(1):6-7. Comment · Editorial PubMed · Publisher

• Shipyard workers and asbestos: a persistent and international problem. W.S. Beckett. Occupational and Environmental Medicine 2007;64(10):639-41. Comment · Editorial PubMed · Publisher · Free full text

• The "Helsinki Criteria" for attribution of lung cancer to asbestos exposure: how robust are the criteria?. M. Greenberg. Archives of Pathology & Laboratory Medicine 2007;131(11):1630; author reply 1630. Comment · Letter PubMed · Publisher

• The fallout from asbestos. G.R. Wagner. Lancet 2007;369(9566):973-4. Comment PubMed · Publisher

• Asbestos exposure and serum osteopontin. A. Hiraki, K. Aoe, H. Ueoka. The New England Journal of Medicine 2006;354(3):304-5; author reply 304-5. Comment · Letter PubMed

• Asbestos exposure and serum osteopontin. A.W. O'Regan, D. Serlin, J.S. Berman. The New England Journal of Medicine 2006;354(3):304-5; author reply 304-5. Comment · Letter PubMed · Publisher

• Asbestos, smoking, and lung cancer: interaction and attribution. B.W. Case. Occupational and Environmental Medicine 2006;63(8):507-8. Comment PubMed · Publisher · Free full text

• Comments about the proposal to adapt the WASP programme to fibre counting tests. B. Préat. The Annals of Occupational Hygiene 2006;50(1):105. Comment · Letter PubMed · Publisher

• Differential peeky bias. D.S. Egilman, M.A. Billings. International Journal of Occupational and Environmental Health 2006;12(3):294. Letter PubMed · Publisher

• Errors and blunders in the estimation of radiation exposure for the uranium miners of WISMUT in Germany. G.G. Eigenwillig. Health Physics 2006;91(4):390-1; author reply 392. Letter · Comment PubMed · Publisher

• Estimating the number of asbestos-related cancer deaths in Great Britain. M. Greenberg. The Annals of Occupational Hygiene 2006;50(1):107. Letter · Comment PubMed · Publisher

• Malignant mesothelioma: A disease that continues to mystify. D. Bendayan, M.R. Kramer. The Israel Medical Association Journal 2006;8(7):501-2. Comment · Editorial PubMed

• Malignant pleural mesothelioma: occupational and environmental exposure. O. Yetkin. Respiratory Medicine 2006;100(6):1121-2; author reply 1123-4. Comment · Letter PubMed · Publisher

• Proposal to adapt the WASP programme to fibre counting tests. M. Grzebyk, E. Kauffer, L. Fréville. The Annals of Occupational Hygiene 2006;50(4):427. Comment · Letter PubMed · Publisher

• Pulmonary histiocytosis X in a patient with epithelioid mesothelioma. J. Morrison, S. Stamenkovic, W.S. Walker, et al. Histopathology 2006;49(3):320-1. Case report · Letter PubMed · Publisher

• Re: Evaluation of the size and type of free particulates collected from unused asbestos-containing brake components as related to potential for respirability. D.J. Paustenbach, B.L. Finley, P.J. Sheehan, et al. American Journal of Industrial Medicine 2006;49(1):60-1; author reply 62-4. Letter PubMed · Publisher

• Residential proximity to naturally occurring asbestos and mesothelioma risks: further consideration of exposure misclassification and occupational confounding. M.A. Kelsh, D.W. Berman, A.M. Langer. American Journal of Respiratory and Critical Care Medicine 2006;174(12):1400; author reply 1400-1. Comment · Letter PubMed · Publisher

• Residential proximity to naturally occurring asbestos: health risk or ecologic fallacy?. C.A. Brodkin, J.R. Balmes, C.A. Redlich, et al. American Journal of Respiratory and Critical Care Medicine 2006;173(5):573; author reply 573-4. Comment · Letter PubMed · Publisher

• Scientific method questioned. D.J. Paustenbach. International Journal of Occupational and Environmental Health 2006;12(3):290-2; author reply 292-3. Comment · Letter PubMed · Publisher

• Setting the record straight. K. Crump. International Journal of Occupational and Environmental Health 2006;12(2):180-1; author reply 182-6. Comment · Letter PubMed · Publisher

• Smoking rates in asbestos workers. J.H. Lange, J.A. Hoskins, G. Mastrangelo. Occupational Medicine 2006;56(8):581. Comment · Letter PubMed · Publisher

• What is a significant lung asbestos fibre result?. S.K. Suvarna, C. Layton. Histopathology 2006;48(2):203-4. Letter PubMed · Publisher

• 2004 asbestos disease guidelines ignore mass screening abuse. L. Martin. American Journal of Respiratory and Critical Care Medicine 2005;171(6):665; author reply 666-7. Comment · Letter PubMed · Publisher

• Are lung and pleural benign asbestos induced diseases a preliminary step in the pathogenic process of mesothelioma and lung cancer development?. M. Goldberg. Occupational and Environmental Medicine 2005;62(10):663-4. Comment PubMed · Publisher · Free full text

• Asbestos lung residue and asbestosis risk. R. Howie. The Annals of Occupational Hygiene 2005;49(1):95-7. Letter PubMed · Publisher

• Asbestos lung residue and asbestosis risk. A. Rogers. The Annals of Occupational Hygiene 2005;49(4):363-4; author reply 364-5. Comment · Letter PubMed · Publisher

• Can exposure to very low levels of asbestos induce pleural mesothelioma?. M. Goldberg, D. Luce. American Journal of Respiratory and Critical Care Medicine 2005;172(8):939-40. Comment · Editorial · Review PubMed · Publisher

• Can one assess genotoxic and carcinogenic risk of asbestos without mentioning ingested fibres?. C. Varga. Mutation Research 2005;572(1-2):173-4; author reply 175-6. Letter PubMed · Publisher

• Changing trends in US mesothelioma incidence. M. Greenberg. Occupational and Environmental Medicine 2005;62(2):134. Comment · Letter PubMed · Publisher · Free full text

• Diagnosis and initial management of nonmalignant diseases related to asbestos. D. Weill, H. Weill. American Journal of Respiratory and Critical Care Medicine 2005;171(5):527-8; author reply 528-30. Comment · Letter PubMed · Publisher

• Diagnosis and initial management of nonmalignant diseases related to asbestos. D.D. Smith. American Journal of Respiratory and Critical Care Medicine 2005;171(6):665-6; author reply 666-7. Comment · Letter PubMed · Publisher

• Diagnosis and initial management of nonmalignant diseases related to asbestos. A.J. Ghio, V.L. Roggli. American Journal of Respiratory and Critical Care Medicine 2005;171(5):527; author reply 528-30. Letter · Comment PubMed · Publisher

• Lung squeeze: a helpful adjunct in diagnosis. L. Gupta, J. Elder. Cytopathology 2005;16(5):269-70. Case report · Letter PubMed · Publisher

• Monitoring of fluoro-edenite fibre pollution through the study of sheep lymph nodes as a model of a biological indicator. V. Rapisarda, G. Rapisarda, G.D. Vico, et al. Occupational and Environmental Medicine 2005;62(9):656. Letter PubMed · Publisher · Free full text

• Noninvasive mechanical ventilation for asbestos-induced ventilatory failure. X. Munoz, S. Martí, J. Ferrer. American Journal of Respiratory and Critical Care Medicine 2005;172(6):785-6. Comment · Letter PubMed · Publisher

• RE: Asbestos in brakes: exposure and risk of disease. V.L. Roggli, A.M. Langer. American Journal of Industrial Medicine 2005;47(3):276-7; author reply 278-80. Comment · Letter PubMed · Publisher

• Serum osteopontin levels--is it time to screen asbestos-exposed workers for pleural mesothelioma?. M.R. Cullen. The New England Journal of Medicine 2005;353(15):1617-8. Comment · Editorial PubMed · Publisher

• Simultaneous non-Hodgkin's lymphoma and mesothelioma presenting as a collision tumour. L.D. Gudur, M. Munavvar, A. Walsham, et al. Histopathology 2005;47(5):546-8. Case report · Letter PubMed · Publisher

• Asbestos and international organizations. L. Tomatis. Environmental Health Perspectives 2004;112(6):A336-7. Comment · Historical article · Letter PubMed · Publisher · Free full text

• Asbestos exposure and lung cancer. C.S. Lee, W.A. Cooper. Pathology 2004;36(6):513-4. Comment · Editorial PubMed · Publisher

• Asbestos in drinking water does not cause mesothelioma. J.H. Lange, J.A. Hoskins. International Journal of Gynecological Cancer 2004;14(5):1048-9; author reply 1046-7. Comment · Letter PubMed · Publisher

• Asbestos problems in Montana and California. C. Maynard. Environmental Science & Technology 2004;38(3):46A. Comment · Letter PubMed · Publisher

• Changing patterns in asbestos-induced lung disease. P. De Vuyst, P.A. Gevenois, A. Van Muylem, et al. Chest 2004;126(3):999. Letter · Comment PubMed · Publisher

• Coexistent atypical adenomatous hyperplasia, primary lung adenocarcinoma and pleural mesothelioma in an asbestos-exposed subject. D.H. Thomas, R.L. Attanoos, A.R. Gibbs. Histopathology 2004;45(5):540-2. Case report · Letter PubMed · Publisher

• Collision tumour of the pleura composed of small cell carcinoma and malignant mesothelioma. A.H. Lee, I.N. Soomro. Histopathology 2004;45(3):305-6. Case report · Letter · Comment PubMed · Publisher

• Comparison of B readers' interpretations of chest radiographs for asbestos related changes. J.P. Kassirer. Academic Radiology 2004;11(12):1396; author reply 1402-4. Letter · Comment PubMed · Publisher

• Comparison of B readers' interpretations of chest radiographs for asbestos related changes. L.C. Oliver, L.S. Welch, M.R. Harbut. Academic Radiology 2004;11(12):1397-9; author reply 1402-4. Letter · Comment PubMed · Publisher

• Comparison of B readers' interpretations of chest radiographs for asbestos related changes. K.D. Rosenman. Academic Radiology 2004;11(12):1396-7; author reply 1402-4. Letter · Comment PubMed · Publisher

• Comparison of B readers' interpretations of chest radiographs for asbestos related changes. A. Franzblau, B. Gillespie. Academic Radiology 2004;11(12):1400-2; author reply 1402-4. Letter · Comment PubMed · Publisher

• Does asbestos cause laryngeal cancer?. M. El Alami. Clinical Otolaryngology and Allied Sciences 2004;29(3):285. Comment · Letter PubMed · Publisher

• Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads (1900 to present): A "state-of-the-art" review. S.S. Paskal. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 2004;7(6):481-2; author reply 482-3. Comment · Letter PubMed · Publisher

• Failure to prove asbestos exposure produces obstructive lung disease. D.D. Smith. Chest 2004;126(3):1000. Comment · Letter PubMed · Publisher

• Familial pleural mesothelioma with environmental asbestos exposure: losses of DNA sequences by comparative genomic hybridization (CGH). G. Serio, A. Scattone, M. Gentile, et al. Histopathology 2004;45(6):643-5. Case report · Letter PubMed · Publisher

• Monitoring for asbestos: U.S. EPA methods. K.C. Callahan. Environmental Health Perspectives 2004;112(13):A728. Comment · Letter PubMed · Publisher · Free full text

• Overstating the consequences of radiographic abnormalities. J.J. Flynn, S. Kardos, L. Yan. Environmental Health Perspectives 2004;112(2):A84; author reply A84-5. Letter · Comment PubMed · Publisher · Free full text

• Radiographic abnormalities and asbestos exposure: Libby, Montana. B. Price. Environmental Health Perspectives 2004;112(2):A82-3, author reply A83. Letter · Comment PubMed · Publisher · Free full text

• Re: "Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003". J.H. Lange. American Journal of Epidemiology 2004;160(8):823. Comment · Letter · Review PubMed · Publisher

• RE: Asbestos in brakes: exposure and risk of disease. M.J. Teta. American Journal of Industrial Medicine 2004;46(3):312-4; author reply 315-8. Comment · Letter PubMed · Publisher

• Re: Controlled use of asbestos. D. Egilman, M. Roberts. International Journal of Occupational and Environmental Health 2004;10(1):99-103. Comment · Letter PubMed · Publisher

• Respiratory impairment due to asbestos exposure in brake-lining workers. A. Franzblau, D.H. Garabrant. Environmental Research 2004;96(1):105-6; author reply 106-8. Letter · Comment PubMed · Publisher

• Smoking trend in a high-risk group: asbestos abatement workers. J.H. Lange, G. Priolo, G. Mastrangelo. Journal of Occupational and Environmental Medicine 2004;46(12):1195. Letter · Comment PubMed

• The WTC disaster and asbestos regulations. J.H. Lange. Environmental Health Perspectives 2004;112(11):A606-7; author reply A607. Comment · Letter PubMed · Publisher · Free full text

• Trouble in Anatolia. N.R. Anthonisen. Canadian Respiratory Journal 2004;11(4):273-4. In English, French. Comment PubMed · Publisher

• Urban mesothelioma: is there an emerging risk of asbestos in place?. V. Ascoli, P. Comba, R. Pasetto. International Journal of Cancer 2004;111(6):975-6. Letter PubMed · Publisher

• Apportioning causes, targeting populations and predicting risks: population attributable fractions. N. Chatterjee, P. Hartge. European Journal of Epidemiology 2003;18(10):933-5. Comment PubMed · Publisher

• Asbestos bodies: clues to the mechanism of asbestos toxicity?. A.B. Kane. Human Pathology 2003;34(8):735-6. Comment · Editorial PubMed · Publisher

• ATS, American Bar Association, and asbestos. J.J. Renn. American Journal of Respiratory and Critical Care Medicine 2003;168(11):1399-400; discussion 1400. Letter PubMed · Publisher

• Commentary regarding the article by Fischer et al.: Fibre years, pulmonary asbestos burden and asbestosis. Int. J. Hyg. Environ. Health 205, 245-248 (2002). K. Rödelsperger, H.J. Woitowitz. International Journal of Hygiene and Environmental Health 2003;206(3):245-7; author reply 251-2. Comment · Letter PubMed · Publisher

• Commentary regarding the article by Fischer et al.: Fibre years, pulmonary asbestos burden and asbestosis. Int. J. Hyg. Environ. Health 205, 245-248 (2002). D.W. Henderson. International Journal of Hygiene and Environmental Health 2003;206(3):249-50; author reply 251-2. Comment · Letter PubMed · Publisher

• Cough and bronchial responsiveness in firefighters at the World Trade Center site. J.H. Lange. The New England Journal of Medicine 2003;348(1):76-7; author reply 76-7. Comment · Letter PubMed

• Earlier study on asbestos workers, ILO scores, and oxygenation more comprehensive. D.D. Smith. Occupational and Environmental Medicine 2003;60(8):611; author reply 611. Comment · Letter PubMed · Publisher · Free full text

• Geographic distribution of incident mesothelioma in Connecticut men, 1990-99. A.P. Polednak. International Journal of Cancer 2003;107(3):509-10. Comment · Letter PubMed · Publisher

• Lung cancer in MMVF workers--viewpoints on a null-result study. E.S. Hansen. International Journal of Occupational and Environmental Health 2003;9(4):397-8. Comment PubMed · Publisher

• Mesothelioma incidence seems to have leveled off in Sweden. K. Hemminki, X. Li. International Journal of Cancer 2003;103(1):145-6. Letter PubMed · Publisher

• Smoking prevalence of asbestos workers: a comment. J.H. Lange, K.W. Thomulka. American Journal of Industrial Medicine 2003;44(2):218-9; author reply 220-1. Comment · Letter PubMed · Publisher

• Study of lung cancer in MMVF workers. P. Boffetta, K. Kjaerheim, J. Hansen, et al. International Journal of Occupational and Environmental Health 2003;9(2):169-70. Letter · Comment PubMed · Publisher

• Toxicologic agents of concern for search-and-rescue dogs responding to urban disasters. L.A. Murphy, S.M. Gwaltney-Brant, J.C. Albretsen, et al. Journal of the American Veterinary Medical Association 2003;222(3):296-304. Comment PubMed · Publisher

• Unusual contaminant fibres on mineral analysis. R.L. Attanoos, D.M. Griffiths, A.R. Gibbs. Histopathology 2003;43(4):405-6. Case report · Letter PubMed · Publisher

• Additional techniques in serous effusions. A.G. Hanselaar. Analytical Cellular Pathology 2002;24(1):1-4. Comment · Editorial · Review PubMed · Publisher · Free full text

• Asbestos screenings. D. Egilman. American Journal of Industrial Medicine 2002;42(2):163. Letter PubMed · Publisher

• Criteria for attributing lung cancer to asbestos exposure. P.T. Cagle. American Journal of Clinical Pathology 2002;117(1):9-15. Comment · Editorial PubMed · Publisher

• Foamy cell mesothelioma. A. Cavazza, G. Pasquinelli, L. Agostini, et al. Histopathology 2002;41(4):369-71. Case report · Letter PubMed · Publisher

• How do you interpret regulations: through science or agency rules?. J.H. Lange. Toxicology and Industrial Health 2002;18(2):107-8. Comment · Letter PubMed · Publisher

• Is the ratio of pleural mesothelioma mortality to pleural cancer mortality approximately unity for Italy? Considerations from the oldest regional mesothelioma register in Italy. G. Gorini, E. Merler, E. Chellini, et al. British Journal of Cancer 2002;86(12):1970-1. Comment · Letter PubMed · Publisher · Free full text

• Joint action of smoking and asbestos exposure on lung cancer. F.D. Liddell. Occupational and Environmental Medicine 2002;59(7):494-5; author reply 495-6. Comment · Letter PubMed · Publisher · Free full text

• Mesothelioma. R. Rudd, J. Moore-Gillon, M. Muers. Thorax 2002;57(2):187. Letter PubMed · Publisher · Free full text

• One fibre or many; what causes mesothelioma?. A. Seaton. Thorax 2002;57(2):186-7. Case report · Letter PubMed · Publisher · Free full text

• Past asbestos exposure levels in foundries and cement-asbestos factories. S. Mattioli, D. Nini, G. Mancini, et al. American Journal of Industrial Medicine 2002;42(4):363. Letter · Comment PubMed · Publisher

• Peritoneal mesothelioma associated with exposure to asbestos in southeastern Turkey. H. Değertekin, K. Yalçin, R. Işik. Journal of Clinical Gastroenterology 2002;35(5):409. Letter PubMed · Publisher

• Re: Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos. M. Kottek, D. Kilpatrick. American Journal of Industrial Medicine 2002;41(6):514. Comment · Letter PubMed · Publisher

• Semantics and the application of the ILO classification: the need for recording visceral pleural manifestations separately. A. Solomon. International Journal of Occupational and Environmental Health 2002;8(3):288-9. Letter PubMed · Publisher

• Statement on malignant mesothelioma in the UK. M. Robinson, J. Wiggins. Thorax 2002;57(2):187. Letter · Comment PubMed · Publisher · Free full text

• SV40, growth factors, and mesothelioma: another piece of the puzzle. B.T. Mossman, D.C. Gruenert. American Journal of Respiratory Cell and Molecular Biology 2002;26(2):167-70. Comment PubMed · Publisher

• The "gold standard" for past asbestos exposure. J. Van Cleemput, H. De Raeve, J. Verschakelen, et al. American Journal of Respiratory and Critical Care Medicine 2002;165(1):134. Comment · Letter PubMed · Publisher

• The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure: the Wittenoom data. A. Rogers, G. Major. The Annals of Occupational Hygiene 2002;46(1):127-8; author reply 128-9. Comment · Letter PubMed · Publisher

• van Ruth S, Bronkhorst MWGA, van Coeverden F, Zoetmulder FAN. Peritoneal benign cystic mesothelioma: a case report and review of literature. Eur J Surg Oncol 2002; 28(2): 192-5. K. Sethna, F. Mohamed, P.H. Sugarbaker. European Journal of Surgical Oncology 2002;28(8):897. Comment · Letter PubMed · Publisher

• Women and mesothelioma. D.D. Smith. Chest 2002;122(6):1885-6. Comment · Editorial PubMed · Publisher

• A ban on asbestos must be based on a comparative risk assessment. M. Camus. CMAJ 2001;164(4):491-4. Comment · Review PubMed · Free full text

• A ban on asbestos: is now the time?. CMAJ 2001;164(4):453, 455. In English, French. Comment · Editorial PubMed · Free full text

• Apoptosis and asbestos-induced disease: Is there a connection?. V.C. Broaddus. The Journal of Laboratory and Clinical Medicine 2001;137(5):314-5. Comment · Editorial PubMed · Publisher

• Asbestos-related benign pleural disease. S.K. Morcos. Clinical Radiology 2001;56(1):85. Letter PubMed · Publisher

• Association between pleural plaques and coronary heart disease. B. Sjögren. Scandinavian Journal of Work, Environment & Health 2001;27(6):420-1. Comment · Letter PubMed · Publisher

• Chemoprevention or antichemoprevention? A salutary warning From the beta-carotene experience. M. Paolini, S.Z. Abdel-Rahman, G. Cantelli-Forti, et al. Journal of the National Cancer Institute 2001;93(14):1110-1. Comment · Letter PubMed · Publisher

• Cutaneous toxicity after intradermal vaccination with Mycobacterium vaccae against lung cancer and malignant mesothelioma. H.S. Pandha, P. Mortimer, B. Souberbeille, et al. The British Journal of Dermatology 2001;144(3):648-9. Case report · Letter PubMed · Publisher

• Deciduoid pleural mesothelioma. H. Monaghan, A. Al-Nafussi. Histopathology 2001;39(1):104-6. Case report · Letter PubMed · Publisher

• Detailed occupational history: the cornerstone in diagnosis of asbestos-related lung disease. R. Bégin, J.W. Christman. American Journal of Respiratory and Critical Care Medicine 2001;163(3 Pt 1):598-9. Comment · Editorial PubMed · Publisher

• Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour. B. Delahunt, J.N. Eble, J.N. Nacey, et al. Histopathology 2001;38(5):479. Letter PubMed · Publisher

• Performance of asbestos fibre counting laboratories by transmission electron microscopy. B. Préat. The Annals of Occupational Hygiene 2001;45(6):500-1. Comment · Letter PubMed · Publisher

• RE: Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am. J. Ind. Med. 2000. 37:275-282. W.J. Bailey. American Journal of Industrial Medicine 2001;39(5):513-4, 522-3; author reply 517-21. Comment · Letter PubMed · Publisher

• RE: Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am. J. Ind. Med. 2000. 37:275-282. E.R. Ludwig, L. Madeksho, D. Egilman. American Journal of Industrial Medicine 2001;39(5):524-7. Comment · Letter PubMed · Publisher

• RE: Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am. J. Ind. Med. 2000. 37:275-282. S.P. Tsai, L.C. Waddell, J.C. Ransdell. American Journal of Industrial Medicine 2001;39(5):515-21; author reply 517-21. Comment · Letter PubMed · Publisher

• Re: mortality among workers in the geothermal power plants at Larderello, Italy. Am. J. Ind. Med. 35:536-539, 2000. E. Merler, S. Silvestri, L. Mauro, et al. American Journal of Industrial Medicine 2001;39(4):436-7; author reply 438. Comment · Letter PubMed · Publisher

• Re: Researchers should talk to workers. Am. J. Ind. Med. 2000. 37:668. J.C. McDonald. American Journal of Industrial Medicine 2001;39(3):346-7. Comment · Letter PubMed · Publisher

• Should Canadian health care professionals support the call for a worldwide ban on asbestos?. J. Siemiatycki. CMAJ 2001;164(4):495-7. Comment · Review PubMed · Free full text

• Staining of malignant mesothelioma for the trefoil protein pS2. E. Murphy, S.K. Suvarna. Histopathology 2001;38(4):381-2. Letter PubMed · Publisher

• The debate on banning asbestos. D.C. Muir. CMAJ 2001;165(9):1189; author reply 1191-3. Comment · Letter PubMed · Free full text

  In plain English

  This item is a letter to the editor, not a research study, and it reported no data. The writer, David C.F. Muir, an internist at Hamilton Health Sciences Corporation in Hamilton, Ontario, was responding to a set of CMAJ editorials about calls for a ban on asbestos. He said that a few years earlier he had written to the Canadian and Quebec governments. He had suggested that asbestos be exported only to countries that could ensure it was handled with the same precautions required by law in Canada, with some form of supervision by independent experts. He said the proposal did not receive support. He was told it was not practical, that it interfered with foreign countries, and that other exporters would fill the gap. He wrote that, without assurances about how asbestos is handled in receiving countries, there is a clear moral choice to make. He added that the same issues should concern those who profit from exporting pesticides. The same page also printed separate letters by other writers, which are not covered here.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• The debate on banning asbestos. T.L. Guidotti. CMAJ 2001;165(9):1189-90; author reply 1191-3. Comment · Letter PubMed · Free full text

• The debate on banning asbestos. D. Ahmad, W.K. Morgan. CMAJ 2001;165(9):1190; author reply 1191-3. Comment · Letter PubMed · Free full text

• The debate on banning asbestos. R. Wilson, R.P. Nolan, S.G. Domnin. CMAJ 2001;165(9):1190-1; author reply 1191-3. Comment · Letter PubMed · Free full text

• The debate on banning asbestos. D. Janigan. CMAJ 2001;165(9):1190; author reply 1191-3. Comment · Letter PubMed · Free full text

• The debate on banning asbestos. D.V. Bates. CMAJ 2001;165(9):1191; author reply 1191-3. Comment · Letter PubMed · Free full text

• The debate on banning asbestos. L. Kazan-Allen. CMAJ 2001;165(9):1189; author reply 1191-3. Comment · Letter PubMed · Free full text

• Asbestos magnate to environmental guru: the morphing of Stephan Schmidheiny. D.M. Berman, A. Knoepfli. International Journal of Occupational and Environmental Health 2000;6(4):351-2. Historical article · Letter PubMed · Publisher

• Confusion about the precision of asbestos fibres counting by electron microscopy. B. Préat. The Annals of Occupational Hygiene 2000;44(1):75-6. Letter PubMed · Publisher

• Corruption of previously published asbestos research. D.S. Egilman, A. Reinert. Archives of Environmental Health 2000;55(1):75-6. Historical article · Letter PubMed · Publisher

• Deciduoid or pseudodecidual mesothelioma. A. Talerman. The American Journal of Surgical Pathology 2000;24(8):1179. Comment · Letter PubMed · Publisher

• High-resolution computed tomography in cases with environmental exposure to asbestos in Turkey. F. Topçu, H. Bayram, M. Simşek, et al. Respiration; International Review of Thoracic Diseases 2000;67(2):139-45. Comment PubMed · Publisher

• Malignant mesothelioma: predictors of prognosis and clinical trials. J.P. Steele, R.M. Rudd. Thorax 2000;55(9):725-6. Comment · Editorial PubMed · Publisher · Free full text

• Malignant pleural mesotheliomas: an environmental health risk in southeast Turkey. K.M. Müller, M. Fischer. Respiration; International Review of Thoracic Diseases 2000;67(6):608-9. Editorial · Comment PubMed · Publisher

• Mesothelial proliferations. An increasing morphologic spectrum. M.R. Wick, S.E. Mills. American Journal of Clinical Pathology 2000;113(5):619-22. Comment · Editorial · Review PubMed · Publisher

• Protective effects of green tea catechins against asbestos-induced cell injury. V.A. Kostyuk, A.I. Potapovich, E.N. Vladykovskaya, et al. Planta Medica 2000;66(8):762-4. Letter PubMed · Publisher

• Re: Call for an International Ban on Asbestos. W.J. Nicholson. American Journal of Industrial Medicine 2000;37(2):238. Comment · Letter PubMed · Publisher

• Re: Call for an International Ban on Asbestos. C. Maltoni. American Journal of Industrial Medicine 2000;37(2):230-1. Letter PubMed · Publisher

• Re: Call for an International Ban on Asbestos: Trust me, I'm a doctor. M. Greenberg. American Journal of Industrial Medicine 2000;37(2):232-4. Letter PubMed · Publisher

• RE: Call for an International Ban on Asbestos: Why asbestos should be banned. R.A. Lemen. American Journal of Industrial Medicine 2000;37(2):236-7. Comment · Letter PubMed · Publisher

• Re: Call for an International Ban on Asbestos: Why not ban asbestos?. B. Castleman. American Journal of Industrial Medicine 2000;37(2):239-40. Comment · Letter PubMed · Publisher

• Re: Call for an International Ban on Asbestos: Why not ban asbestos?. J.C. McDonald. American Journal of Industrial Medicine 2000;37(2):235. Letter PubMed · Publisher

• Researchers should talk to workers. D. Egilman. American Journal of Industrial Medicine 2000;37(6):668. Comment · Letter PubMed · Publisher

• Simian virus 40 and the human mesothelium. G. Klein. Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):9830-1. Comment PubMed · Publisher · Free full text

• South Africa asbestos ruling may bring flood of claims to London. Lloyd's of London. International Journal of Occupational and Environmental Health 2000;6(4):350-1. Comment · Letter PubMed · Publisher

• The international ban asbestos secretariat. L. Kazan-Allen. International Journal of Occupational and Environmental Health 2000;6(2):164. Letter PubMed · Publisher

• The South African asbestos trade, 1994-1999. J.S. Harington, N.D. McGlashan. American Journal of Industrial Medicine 2000;37(2):229. Letter PubMed · Publisher

• Update of the Texaco mortality study 1947-93: Part II. M.M. Finkelstein. Occupational and Environmental Medicine 2000;57(2):143-4. Comment · Letter PubMed · Publisher · Free full text

1990s

• Asbestos exposure, asbestosis, and lung cancer. D.E. Banks, M.L. Wang, J.E. Parker. Chest 1999;115(2):320-2. Comment · Editorial PubMed · Publisher

• Comments on "Comparative hazards of chrysotile asbestos and its substitutes: a European perspective". H. Savastano. Environmental Health Perspectives 1999;107(12):A596-7. Letter PubMed · Publisher · Free full text

• Globally asbestos-free automobiles. J. Rangé. International Journal of Occupational and Environmental Health 1999;5(3):242-3. Comment · Letter PubMed · Publisher

• Maintenance work and asbestos-related cancers in the refinery and petrochemical sector. M.M. Finkelstein. American Journal of Industrial Medicine 1999;36(2):326. Letter PubMed · Publisher

• Minimising health hazards associated with derogated products and in-situ materials containing chrysotile contaminated with amphibole asbestos fibres. R.M. Howie. The Annals of Occupational Hygiene 1999;43(7):493-8. Letter PubMed · Publisher

• Asbestos, ergot drugs and the pleura. P. Camus, G. Hillerdal, P. De Vuyst. The European Respiratory Journal 1998;11(6):1427. Comment · Letter PubMed · Publisher

• Asbestos--still a carcinogen. P.J. Landrigan. The New England Journal of Medicine 1998;338(22):1618-9. Comment · Editorial PubMed · Publisher

• Cancer mortality among man-made vitreous fiber production workers. C.E. Rossiter, H.G. Grimm. Epidemiology 1998;9(2):218-9; author reply 219-20. Comment · Letter PubMed · Publisher

• Cigarette smoking, asbestos exposure, lung cancer, and sample size. M.F. Petrini. American Journal of Respiratory and Critical Care Medicine 1998;158(5 Pt 1):1688. Comment · Letter PubMed · Publisher

• Diagnosing malignant pleural mesothelioma. A.S. Teirstein. Chest 1998;114(3):666-7. Editorial · Comment PubMed · Publisher

• Hazards of white asbestos. H. Demiruglu. Lancet 1998;352(9124):322-3. Comment · Letter PubMed · Publisher

• Hazards of white asbestos. A.J. Dalton. Lancet 1998;352(9124):322. Letter · Comment PubMed · Publisher

• Hyaluronate binding probe and CD44 in the differential diagnosis of malignant effusions: disappointing results in cytology material. A.C. Filie, A. Abati, P. Fetsch, et al. Diagnostic Cytopathology 1998;18(6):473-4. Letter PubMed · Publisher

• Improving surgical resection rate in lung cancer. C. Laroche, F. Wells, R. Coulden, et al. Thorax 1998;53(6):445-9. Comment PubMed · Publisher · Free full text

• Instances of sprayed asbestos use in Brazil. G. Tweedale. International Journal of Occupational and Environmental Health 1998;4(3):206. Comment · Letter PubMed · Publisher

• Invited commentary: Is it possible to investigate the quantitative relation between asbestos and mesothelioma in a community-based study?. J. Siemiatycki, P. Boffetta. American Journal of Epidemiology 1998;148(2):143-7. Comment PubMed · Publisher

• Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. B.W. Case. The New England Journal of Medicine 1998;339(14):1001; author reply 1002. Comment · Letter PubMed

• Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. H. Demiroglu. The New England Journal of Medicine 1998;339(14):999-1000; author reply 1001-2. Comment · Letter PubMed

• Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. R.W. Morgan, M. Goodman. The New England Journal of Medicine 1998;339(14):1001; author reply 1002. Comment · Letter PubMed

• Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. A. Churg. The New England Journal of Medicine 1998;339(14):999; author reply 1001-2. Comment · Letter PubMed · Publisher

• Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. A.M. Langer. The New England Journal of Medicine 1998;339(14):1000-1; author reply 1002. Comment · Letter PubMed

• Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. E. Costas, A. Garrido, V.J. Goyanes. The New England Journal of Medicine 1998;339(14):1000; author reply 1001-2. Comment · Letter PubMed

• Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. R.K. Sokas. The New England Journal of Medicine 1998;339(14):1000; author reply 1001-2. Comment · Letter PubMed

• RE main asbestos type in pleural mesothelioma. P. Dumortier, P. De Vuyst, F. Rey, et al. American Journal of Industrial Medicine 1998;33(1):94-6. Comment · Letter PubMed · Publisher

• Re: "Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry". M.J. Mirliss. American Journal of Epidemiology 1998;148(3):307-9. Comment · Letter PubMed · Publisher

• Re: "Dose-response associations of silica with nonmalignant respiratory disease and lung cancer mortality in the diatomaceous earth industry". G.W. Gibbs. American Journal of Epidemiology 1998;148(3):307; author reply 308-9. Comment · Letter PubMed · Publisher

• Salud Ocupacional. B. Castleman, J. Dement, A.L. Frank, et al. International Journal of Occupational and Environmental Health 1998;4(2):131-3. Letter PubMed · Publisher

• The diagnosis of desmoplastic malignant mesothelioma. T.V. Colby. American Journal of Clinical Pathology 1998;110(2):135-6. Comment · Editorial PubMed · Publisher

• The priority for recognizing asbestos as a multicentre carcinogen, and problems in categorizing asbestos tumours. M. Greenberg. The European Respiratory Journal 1998;11(4):996. Comment · Letter PubMed · Publisher

• Working with asbestos in Brazil. J. Rangé. International Journal of Occupational and Environmental Health 1998;4(1):56-8. Letter PubMed · Publisher

• Working with asbestos in Russia. N. Izmerov, L. Elovskaya, E. Kovalevskiy. International Journal of Occupational and Environmental Health 1998;4(1):59-61. Letter PubMed · Publisher

• Asbestos and lung cancer. R. Rudd. Thorax 1997;52(3):306. Comment · Letter PubMed

• Asbestos disease in foundrymen. A.M. Langer, R.P. Nolan. Journal of Occupational and Environmental Medicine 1997;39(8):699-700. Comment · Letter PubMed · Publisher

• Asbestos disease in foundrymen. M. Wyart-Remy. Journal of Occupational and Environmental Medicine 1997;39(8):700. Comment · Letter PubMed · Publisher

• Asbestos, ergot drugs and the pleura. P. De Vuyst, P. Pfitzenmeyer, P. Camus. The European Respiratory Journal 1997;10(12):2695-8. Comment · Editorial · Review PubMed · Publisher

• Asbestos, the mesothelial cell and malignancy: a matter of life or death. V.C. Broaddus. American Journal of Respiratory Cell and Molecular Biology 1997;17(6):657-9. Comment · Editorial PubMed · Publisher

• Asbestos-related cancer and the amphibole hypothesis. The amphibole hypothesis: neither gone nor forgotten. A.M. Langer, R.P. Nolan. American Journal of Public Health 1997;87(4):688-9; author reply 690-1. Comment · Letter PubMed · Publisher · Free full text

• Asbestos-related cancer and the amphibole hypothesis. The first documentation of the association. J.C. Wagner. American Journal of Public Health 1997;87(4):687-8. Comment · Letter PubMed · Publisher · Free full text

• Asbestos-related cancer and the amphibole hypothesis. The hypothesis is still supported by scientists and scientific data. B.T. Mossman, J.B. Gee. American Journal of Public Health 1997;87(4):689-90; author reply 690-1. Comment · Letter PubMed · Publisher · Free full text

• Asbestos-related disorders. A realistic perspective. D.M. Rosenberg. Chest 1997;111(5):1424-6. Comment PubMed · Publisher

• Detection of aneuploidy in mesothelioma cell lines by fluorescence in situ hybridization (FISH). A. Abati, J. Sanford, P. Fetsch, et al. Diagnostic Cytopathology 1997;16(4):375-7. Letter PubMed · Publisher

• Gene transfer and thoracic surgery: more to come. L.R. Kaiser, S.M. Albelda. The Annals of Thoracic Surgery 1997;63(6):1527-8. Comment · Editorial PubMed · Publisher

• History of mesothelioma. M. Greenberg. The European Respiratory Journal 1997;10(11):2690-1. Comment · Historical article · Letter PubMed · Publisher

• Increasing role of immunopathology in diagnosis of malignant mesothelioma. K. Sheibani. Human Pathology 1997;28(6):639-40. Comment · Editorial PubMed · Publisher

• Lung cancer in asbestos cement workers in Denmark. M. Greenberg. Occupational and Environmental Medicine 1997;54(2):143. Comment · Letter PubMed · Publisher · Free full text

• Magic, menace, myth and malice. F.D. Liddell. The Annals of Occupational Hygiene 1997;41(1):3-12. Comment · Editorial · Historical article PubMed · Publisher

• Mesothelioma in a community in the north of England. M. Greenberg. Occupational and Environmental Medicine 1997;54(1):67-8. Letter · Comment PubMed · Free full text

• Smooth muscle tumours of the pleura. C.A. Moran, S. Suster, M.N. Koss. Histopathology 1997;30(1):97-8. Comment · Letter PubMed · Publisher

• What every physician should know about environmental health. C. Carlsten, J. Croke. Wilderness & Environmental Medicine 1997;8(4):250-2. Letter PubMed · Publisher

• Asbestos exposure and asbestosis. J.A. Black. Journal of the Royal Society of Medicine 1996;89(4):240. Comment · Letter PubMed · Publisher · Free full text

• Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. A. Miller. American Journal of Respiratory and Critical Care Medicine 1996;154(6 Pt 1):1919-20. Letter · Comment PubMed · Publisher

• Asbestos-related cancer. J.F. Genits. CA: A Cancer Journal for Clinicians 1996;46(4):254-5. Comment · Letter PubMed · Publisher

• Asbestos-related mortality among Italian migrants to Western Australia. E. Merler, D. Balzi, E. Buiatti, et al. Epidemiology 1996;7(5):556-7. Letter PubMed · Publisher

• Carcinogens and the workplace. R. Hawkins. CA: A Cancer Journal for Clinicians 1996;46(4):255-6. Comment · Letter PubMed · Publisher

• E-cadherin in mesothelioma. M. Jeffers. Human Pathology 1996;27(11):1245-6. Comment · Letter PubMed · Publisher

• Fibrous glass insulation and cancer: response and rebuttal. P.F. Infante, L.D. Schuman, J. Huff. American Journal of Industrial Medicine 1996;30(1):113-20. Comment PubMed · Publisher

• Malignant mesothelioma in paper mill workers: where might the asbestos have come from?. M. Greenberg. American Journal of Industrial Medicine 1996;30(5):641. Comment · Letter PubMed · Publisher

• Mesothelioma: An unwarranted causal model. D.S. Egilman, A.S. Goldin, G.A. Goldin. Journal of Occupational and Environmental Medicine 1996;38(3):239-40. Comment · Letter PubMed · Publisher

• Toxic torts: are they poisoning the scientific literature?. P.E. Enterline. American Journal of Industrial Medicine 1996;30(1):121-2. Comment PubMed · Publisher

• Translocation (2;3)(p21;p26) as the sole anomaly in a benign localized fibrous mesothelioma. F. Mertens, R. Willén, R. Lillo-Gil, et al. Cancer Genetics and Cytogenetics 1996;92(1):90-1. Case report · Letter PubMed · Publisher

• Were asbestos-filtered Kent cigarettes sold in Australia?. S. Chapman, A. Heidemann, S. Woodward. Australian and New Zealand Journal of Public Health 1996;20(2):218-9. Letter PubMed · Publisher

• Airways obstruction from asbestos exposure and asbestosis revisited. K.H. Kilburn, R.H. Warshaw. Chest 1995;107(6):1730-1. Comment PubMed · Publisher

• Asbestos and idiopathic retroperitoneal fibrosis. J.C. Boulard, T. Hanslik, L.M. Doleris, et al. Lancet 1995;345(8961):1379. Case report · Letter PubMed · Publisher

• Asbestos and mesothelioma: genetic lessons from a tragedy. A. Knudson. Proceedings of the National Academy of Sciences of the United States of America 1995;92(24):10819-20. Comment · Review PubMed · Publisher · Free full text

• Asbestos: a risk too far?. W. Weiss. Lancet 1995;346(8970):305; author reply 306. Comment · Letter PubMed

• Asbestos: a risk too far?. H. Weill, J.M. Hughes, R.N. Jones. Lancet 1995;346(8970):304; author reply 306. Letter · Comment PubMed

• Asbestos: a risk too far?. E.S. Johnson. Lancet 1995;346(8970):304-5; author reply 306. Comment · Letter PubMed

• Asbestos: a risk too far?. K. Browne. Lancet 1995;346(8970):305-6. Comment · Letter PubMed

• Chrysotile, tremolite, and mesothelioma. J.C. McDonald, A.D. McDonald. Science 1995;267(5199):776-7. Comment · Letter PubMed · Publisher

• CT for asbestosis: value and limitations. D.A. Lynch. AJR. American Journal of Roentgenology 1995;164(1):69-71. Comment PubMed · Publisher

• Does welding stainless steel cause cancer?. F. Marini, M.P. Ferré, H. Gross, et al. Scandinavian Journal of Work, Environment & Health 1995;21(1):65-8. Letter PubMed · Publisher

• Fibrogenic effect of wollastonite compared with asbestos dust and dusts containing quartz. E.E. McConnell. Occupational and Environmental Medicine 1995;52(9):621. Comment · Letter PubMed · Publisher · Free full text

• Mesothelioma. H. De Vos Irvine. Lancet 1995;345(8959):1233. Comment · Letter PubMed

• Mesothelioma. R.A. Damhuis, H.T. Planteydt. Lancet 1995;345(8959):1233-4. Letter · Comment PubMed

• Mesothelioma. H. Weill, J.M. Hughes. Lancet 1995;345(8959):1234. Letter · Comment PubMed

• Mesothelioma: is asbestos exposure the only cause?. J. Leigh. The Medical Journal of Australia 1995;163(2):105-6. Comment · Letter PubMed

• Mesothelioma: is asbestos exposure the only cause?. D.J. Kilpatrick. The Medical Journal of Australia 1995;163(7):392. Comment · Letter PubMed

• Mesothelioma: is asbestos exposure the only cause?. R.T. Gun. The Medical Journal of Australia 1995;163(6):334-5. Letter PubMed

• More on thoracic neoplasms related to Lucite sphere plombage. C. Ibarra-Perez, J. Kelly-Garcia. Chest 1995;107(2):581-2. Letter PubMed · Publisher

• Non-asbestos-related mesothelioma: chance, bias, or a real phenomenon?. P. Glasziou. The Medical Journal of Australia 1995;162(8):431-2. Comment PubMed · Publisher

• Pleural mesothelioma in oil refinery workers. O. Wong. Scandinavian Journal of Work, Environment & Health 1995;21(4):301-9. Comment · Letter PubMed · Publisher

• Pleural mesothelioma with non-Hodgkin's lymphoma. P. Hughes, C.R. McGavin. Thorax 1995;50(8):915. Case report · Letter PubMed · Publisher · Free full text

• Potential public health problems of asbestos in Jamaica. H.O. Reid, I.A. Kahwa. Occupational and Environmental Medicine 1995;52(3):214. Letter PubMed · Publisher · Free full text

• Review of the Kilburn and Warshaw Chest article--airways obstruction from asbestos exposure. R.N. Jones, H.W. Glindmeyer, H. Weill. Chest 1995;107(6):1727-9. Comment PubMed · Publisher

• Trends in incidence of pleural mesothelioma in the Rotterdam area. R.A. Damhuis, H.T. Planteydt. International Journal of Cancer 1995;60(6):883. Letter PubMed · Publisher

• Asbestos-related pleural plaques and lung cancer. M. Nurminen, A. Tossavainen. Chest 1994;106(2):648-9. Comment · Letter PubMed · Publisher

• Asbestos: facts and fiction. B.T. Mossman. Environmental Health Perspectives 1994;102(5):424-5. Letter · Review PubMed · Publisher · Free full text

• Dust exposure and mortality in chrysotile mining, 1910-76. M. Greenberg. Occupational and Environmental Medicine 1994;51(6):431. Comment · Letter PubMed · Publisher · Free full text

• Exercise impairment in asbestos-induced pleural fibrosis. Is it really just interstitial fibrosis?. E.T. Mannix, W.J. Martin. Chest 1994;105(5):1312-3. Comment · Editorial PubMed · Publisher

• Fiber potency vs. importance. V.L. Roggli, P.C. Pratt, A.R. Brody. American Journal of Industrial Medicine 1994;25(4):611-2. Comment · Letter PubMed · Publisher

• Immunopathology of malignant mesothelioma. K. Sheibani. Human Pathology 1994;25(3):219-20. Comment · Editorial PubMed · Publisher

• Inconsistencies and delays in asbestos evaluations. J. Ribak. American Journal of Industrial Medicine 1994;25(3):455-6. Comment · Historical article · Letter PubMed · Publisher

• Malignant pleural mesothelioma associated with exposure to tremolite. D. Luce, P. Brochard, P. Quénel, et al. Lancet 1994;344(8939-8940):1777. Letter PubMed · Publisher

• Meningeal and brain metastases in primary malignant pericardial mesothelioma. U. Bohn, J.L. Gonzalez, L.M. Martin, et al. Annals of Oncology 1994;5(7):660-1. Case report · Letter PubMed · Publisher

• Potency versus importance in fiber pathogenicity. J.M. Hughes, H. Weill. American Journal of Industrial Medicine 1994;25(4):609-10. Comment · Letter PubMed · Publisher

• Re: Attitudes and opinions regarding asbestos and cancer, 1937-1965. D.J. Kilpatrick, M. Kottek. American Journal of Industrial Medicine 1994;25(3):461-2. Comment · Historical article · Letter PubMed · Publisher

• Regarding bias. J.B. Gee. Environmental Health Perspectives 1994;102(5):425-6. Letter PubMed · Publisher · Free full text

• Scientific objectivity and the chrysotile controversy. B.I. Castleman. Occupational and Environmental Medicine 1994;51(6):431. Comment · Letter PubMed · Publisher · Free full text

• Study of occupational lung cancer in asbestos factories in China. R.W. Morgan, K.E. Zhao. Occupational and Environmental Medicine 1994;51(10):719. Comment · Letter PubMed · Publisher · Free full text

• The removal of fibres of chrysotile asbestos from lung. A. Morgan. The Annals of Occupational Hygiene 1994;38(4):643-6. Letter PubMed · Publisher

• Unpublished data on asbestos dust continue to surface. T.F. Mancuso. American Journal of Industrial Medicine 1994;25(3):457-60. Historical article · Letter PubMed · Publisher

• Workshop on the health risks associated with chrysotile asbestos: a brief review. M. Lippmann. The Annals of Occupational Hygiene 1994;38(4):639-42. Letter PubMed · Publisher

• Additional atypical malignant mesothelioma after intraperitoneal injection of mineral fibres in rats. K. Kamino, H. Ernst, U. Mohr. Experimental and Toxicologic Pathology 1993;45(2-3):65-6. Letter PubMed · Publisher

• Asbestos and cancer: history and public policy. M. Greenberg. British Journal of Industrial Medicine 1993;50(1):95. Comment · Letter PubMed · Publisher · Free full text

• Asbestos and cancer: history and public policy. M.P. Weller. British Journal of Industrial Medicine 1993;50(7):671. Historical article · Letter PubMed · Publisher · Free full text

• Asbestos findings questioned. J.B. Gee. Environmental Health Perspectives 1993;101(7):564-5. Comment · Letter PubMed · Publisher · Free full text

• Chrysotile asbestos revisited. J. Dunnigan. British Journal of Industrial Medicine 1993;50(9):862-3. Letter PubMed · Publisher · Free full text

• Comment on "Exposure to airborne asbestos in buildings". D.R. Van Orden. Regulatory Toxicology and Pharmacology 1993;18(3):481. Comment · Letter PubMed · Publisher

• Considerations of specificity in assessing the relationship between asbestos and cancer. O. Wong. American Journal of Industrial Medicine 1993;23(3):521-3. Comment · Review PubMed · Publisher

• Early animal research on asbestos cancer. P.E. Enterline. American Journal of Industrial Medicine 1993;24(6):783-5; author reply 787-91. Letter PubMed · Publisher

• Expression of p53 in reactive mesothelium. S. Dowell, N. Derias, P.O. Wilson, et al. Histopathology 1993;22(1):96-7. Letter PubMed · Publisher

• Incidence of lung cancer by histological type among asbestos cement workers in Denmark. B. Järrholm. British Journal of Industrial Medicine 1993;50(8):767. Comment · Letter PubMed · Free full text

• Leiomyoid mesotheliomas. H. Battifora. Histopathology 1993;22(6):601; author reply 602. Comment · Letter PubMed · Publisher

• Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells. P.J. Borm, P.F. Schins. British Journal of Industrial Medicine 1993;50(6):575. Comment · Letter PubMed · Publisher · Free full text

• Pleural determinants of restrictive lung function and respiratory symptoms in an asbestos-exposed population. P.H. Wright. Chest 1993;104(4):1314-5. Comment · Letter PubMed · Publisher

• Re: "Changing attitudes and opinions regarding asbestos and cancer, 1934-1965". L.O. Meurman. American Journal of Industrial Medicine 1993;23(3):517. Comment PubMed · Publisher

• Re: "TLVs for asbestos". T.F. Mancuso. American Journal of Industrial Medicine 1993;23(6):961-5. Comment · Letter PubMed · Publisher

• Re: "TLVs for asbestos". M. Corn. American Journal of Industrial Medicine 1993;23(6):959. Comment · Letter PubMed · Publisher

• Re: "TLVs for asbestos". G.V. Coles. American Journal of Industrial Medicine 1993;23(6):955-7. Comment · Letter PubMed · Publisher

• Re: "TLVs for asbestos". G.W. Schepers. American Journal of Industrial Medicine 1993;23(6):967-9. Comment · Letter PubMed · Publisher

• Re: Asbestos and cancer, 1934-1965. H. Bohlig. American Journal of Industrial Medicine 1993;23(3):519. Comment PubMed · Publisher

• Re: Asbestos and cancer, 1934-1965. W.T. McCaughey. American Journal of Industrial Medicine 1993;23(3):503-4. Comment PubMed · Publisher

• Re: Attitudes and opinions regarding asbestos and cancer, 1934-1965. M.A. Schneiderman. American Journal of Industrial Medicine 1993;23(3):509-10. Comment PubMed · Publisher

• Re: Attitudes and opinions regarding asbestos and cancer, 1934-1965. J.M. Harrington. American Journal of Industrial Medicine 1993;23(3):505-6. Comment PubMed · Publisher

• Re: Attitudes and opinions regarding asbestos and cancer, 1934-1965. G.K. Sluis-Cremer. American Journal of Industrial Medicine 1993;23(3):511. Comment PubMed · Publisher

• Re: Historical reasons for attitudes and opinions regarding asbestos and cancer, 1934-1965. M. Corn, J.K. Corn. American Journal of Industrial Medicine 1993;23(3):513-5. Comment PubMed · Publisher

• Synthetic mineral fibers. L.D. Schuman, P.F. Infante. Journal of Occupational Medicine. 1993;35(12):1173-7. Comment · Letter PubMed

• The attribution of lung cancer to asbestos. W. Weiss. Chest 1993;103(2):654-5. Comment · Letter PubMed · Publisher

• The hazards of asbestos. Access to vital data is denied. M. Greenberg. BMJ 1993;307(6898):259. Comment · Letter PubMed · Publisher · Free full text

• The hazards of asbestos. Detailed occupational history is vital. A. Seaton. BMJ 1993;307(6898):258. Comment · Letter PubMed · Publisher · Free full text

• The hazards of asbestos. Inaccurate diagnoses distort results. F.G. Mayall. BMJ 1993;307(6898):258-9. Comment · Letter PubMed · Publisher · Free full text

• The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. L.M. Weiss, H. Battifora. Human Pathology 1993;24(4):345-6. Comment · Editorial PubMed · Publisher

• An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. R. Calisti, P. De Giuli, G.L. Ghione. British Journal of Industrial Medicine 1992;49(2):144. Case report · Comment · Letter PubMed · Publisher · Free full text

• Asbestos and cancer: history and public policy. W.K. Morgan. British Journal of Industrial Medicine 1992;49(6):451. Comment · Historical article · Letter PubMed · Publisher · Free full text

• Asbestos and cancer: history and public policy. M.P. Weller. British Journal of Industrial Medicine 1992;49(1):70-2. Comment · Historical article · Letter PubMed · Publisher · Free full text

• Asbestos and cancer: history and public policy. J.C. Kelso. British Journal of Industrial Medicine 1992;49(7):526. Comment · Historical article · Letter PubMed · Publisher · Free full text

• Asbestos exposure. D.L. Davis. Journal of the National Cancer Institute 1992;84(7):537-8. Comment · Letter PubMed · Publisher

• Asbestos exposures: known and underrecognized sources. J.L. Levin, J.M. Stocks, J.R. Shepherd, et al. American Journal of Industrial Medicine 1992;22(4):607-8. Letter PubMed · Publisher

• Asbestos-related cancer. M.A. Schneiderman. Journal of the National Cancer Institute 1992;84(14):1125. Letter PubMed · Publisher

• Asbestos: the turbulent interface between science and policy. K. Morgan. CMAJ 1992;147(7):988-9. Comment · Letter PubMed · Free full text

• Asbestos: the turbulent interface between science and policy. J.B. Gee. CMAJ 1992;146(1):14-5. Comment · Letter PubMed · Free full text

• Bone metastases in malignant mesothelioma are not uncommon. A. Dejmek. Medical and Pediatric Oncology 1992;20(1):86. Comment · Letter PubMed · Publisher

• Cellular and molecular basis of the asbestos-related diseases. A. Cosentino, M.L. Warnock. The American Review of Respiratory Disease 1992;145(1):238-9. Comment · Letter PubMed · Publisher

• Chrysotile asbestos, mesothelioma, and garage mechanics. O. Wong. American Journal of Industrial Medicine 1992;21(3):449-55. Comment · Letter PubMed · Publisher

• Clinical utility of asbestos bodies in BAL fluid. P. De Vuyst, P. Dumortier, R. Vande Weyer, et al. The American Review of Respiratory Disease 1992;145(6):1513-4. Comment · Letter PubMed · Publisher

• Commentary: environmental disease--a preventable epidemic. P.J. Landrigan. American Journal of Public Health 1992;82(7):941-3. Comment PubMed · Publisher · Free full text

• Deaths from asbestos: one physician's practice. D. Jackson. JAMA 1992;268(16):2169. Comment · Letter PubMed

• Esophageal carcinoma with asbestos bodies. J.P. Parmar. American Journal of Industrial Medicine 1992;21(4):605-8. Case report · Letter PubMed · Publisher

• Fifty-year experience in diagnosing asbestos-related cancers in Finland: progress and detours. M.S. Huuskonen, A. Tossavainen. American Journal of Industrial Medicine 1992;22(2):259-61. Comment · Historical article PubMed · Publisher

• Funding in the asbestos debate. S.W. Samuels. CMAJ 1992;146(10):1697, 1700. Comment · Letter PubMed · Free full text

• Local treatment of malignant pleural mesothelioma with intracavitary cytosine-arabinoside and cisplatin. E. Aitini, E. Pasquini, G. Cavazzini, et al. Annals of Oncology 1992;3(9):771-2. Letter PubMed · Publisher

• Merchant Marine is not such a strange place for asbestos exposure. J.E. Myers. American Journal of Industrial Medicine 1992;21(3):457. Comment · Letter PubMed · Publisher

• Mesothelioma among workers in the Québec chrysotile mining and milling industry. J.S. Harington. American Journal of Industrial Medicine 1992;22(6):925-6. Letter PubMed · Publisher

• Nucleolar organizer regions in mesothelial proliferations. M. Ramael, J. Van den Bossche, C. Buysse, et al. The Journal of Pathology 1992;167(4):435. Comment · Letter PubMed · Publisher

• On the diagnostic accuracy of asbestos-induced disease. W.K. Morgan, M. Bracken, N. Sargent, et al. Journal of Occupational Medicine. 1992;34(12):1205-6. Letter PubMed

• Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers. A. Rogers. British Journal of Industrial Medicine 1992;49(6):451-2. Comment · Letter PubMed · Publisher · Free full text

• Rapidly progressing mesothelioma in an HIV-positive patient. V. Idemyor, C.E. Cherubin. The Annals of Pharmacotherapy 1992;26(3):429. Case report · Letter PubMed · Publisher

• Re: "Attitudes and opinions regarding asbestos and cancer 1934-1965". S. Langård. American Journal of Industrial Medicine 1992;22(2):267-9. Comment PubMed · Publisher

• Re: "Attitudes and opinions regarding asbestos and cancer 1934-1965". D.O. Hourihane. American Journal of Industrial Medicine 1992;22(2):275-7. Comment PubMed · Publisher

• Re: "Attitudes and opinions: asbestos and cancer". M. Greenberg. American Journal of Industrial Medicine 1992;22(2):263-5. Comment PubMed · Publisher

• Re: "Changing attitudes and opinions regarding asbestos and cancer 1934-1965". J.E. Craighead. American Journal of Industrial Medicine 1992;22(2):271-3. Comment PubMed · Publisher

• Re: "Changing attitudes and opinions regarding asbestos and cancer 1934-1965". R. Ehrlich, J. Myers. American Journal of Industrial Medicine 1992;22(2):279-80. Comment PubMed · Publisher

• Re: "Tiger's-eye pneumoconiosis". R.S. Du Toit. American Journal of Industrial Medicine 1992;22(4):605-6. Comment · Letter PubMed · Publisher

• The health hazards of asbestos removal. L. MacDonald. JAMA 1992;267(1):52-3. Comment · Letter PubMed · Publisher

• Thrombomodulin staining of mesothelioma cells. C.L. Collins, L.M. Fink, S.M. Hsu, et al. Human Pathology 1992;23(8):966. Comment · Letter PubMed · Publisher

• TLVs for asbestos. W.A. Cook. American Journal of Industrial Medicine 1992;21(5):765-6. Letter PubMed · Publisher

• Was the literature "corrupted"?. P.C. Pratt. American Journal of Industrial Medicine 1992;22(4):609-13. Comment · Historical article · Letter PubMed · Publisher

• ACGIH TLVs: a critical analysis of the documentation. P.A. Breysse. American Journal of Industrial Medicine 1991;20(3):423-30. Comment · Letter PubMed · Publisher

• Asbestos and cancer: history and public policy. B.I. Castleman. British Journal of Industrial Medicine 1991;48(6):427-32. Comment · Letter PubMed · Publisher · Free full text

• Asbestos exposure and airways obstruction. M.G. Pearson. Respiratory Medicine 1991;85(4):344-6. Comment · Letter PubMed · Publisher

• Asbestos-related diseases. D.G. Kern, D.C. Christiani, K.T. Kelsey, et al. The New England Journal of Medicine 1991;324(3):195-7. Comment · Letter PubMed · Publisher

• Asbestos: the turbulent interface between science and policy. K. Morgan. CMAJ 1991;145(4):291-3. Comment · Letter PubMed · Free full text

• Chrysotile asbestos and mesothelioma. H.J. Woitowitz, K. Rödelsperger. American Journal of Industrial Medicine 1991;19(4):551-3. Comment · Letter PubMed · Publisher

• Comments on Chesson et al. Interpretation of airborne asbestos measurements. K.S. Crump. Risk Analysis 1991;11(3):367-71. Comment · Letter PubMed · Publisher

• Corruption of occupational medical literature: the asbestos example. H. Hardy, D. Egilman. American Journal of Industrial Medicine 1991;20(1):127-9. Letter PubMed · Publisher

• Demonstration of asbestos fibers in a ten-year-old sputum sample. D.S. Heller, R.E. Gordon. American Journal of Industrial Medicine 1991;20(3):415-9. Case report · Letter PubMed · Publisher

• Determinants of restrictive lung function in asbestos-induced pleural fibrosis. C.J. Bergin. Journal of Applied Physiology 1991;70(1):472-3. Comment · Letter PubMed · Publisher

• Environmental asbestos. K. Browne. Lancet 1991;338(8772):949. Comment · Letter PubMed · Publisher

• Malignant mesothelioma after exposure to asbestos in dental practice. A.S. Reid, B.E. Causton, J.S. Jones, et al. Lancet 1991;338(8768):696. Case report · Letter PubMed · Publisher

• Mediastinal germ cell tumour with an uncommon micropapillary architecture on histology. A. von Rohr, A. Zimmermann, K.W. Brunner, et al. Annals of Oncology 1991;2(10):771-2. Case report · Letter PubMed · Publisher

• Medical screening for occupational disease risk is not a control measure. S.M. Kennedy. American Journal of Industrial Medicine 1991;20(2):271-2. Comment · Letter PubMed · Publisher

• Mesothelioma and exposure to asbestos. W.K. Morgan. BMJ 1991;302(6785):1153. Letter PubMed · Publisher · Free full text

• Mesothelioma and non-occupational environmental exposure to asbestos. C. Magnani, G. Borgo, G.P. Betta, et al. Lancet 1991;338(8758):50. Letter PubMed · Publisher

• Occult asbestos exposure. M. Huncharek. American Journal of Industrial Medicine 1991;20(5):713-4. Case report · Comment · Letter PubMed · Publisher

• On talc, tremolite, and tergiversation. A.M. Langer, R.P. Nolan, J. Addison. British Journal of Industrial Medicine 1991;48(5):359-60. Comment · Letter PubMed · Publisher · Free full text

• On talc, tremolite, and tergiversation. Ter-gi-ver-sate: 2: to use subterfuges. B.W. Case. British Journal of Industrial Medicine 1991;48(5):357-9. Comment · Letter PubMed · Publisher · Free full text

  In plain English

  This is a letter to the editor, not a research study, and it reports no new data. B W Case wrote it in reply to a 1990 article by Reger and Morgan about "non-asbestiform" tremolite and talc. Case posed three questions: whether non-asbestiform fibres can be clearly identified, whether they occur without asbestiform fibres, and whether they tell us about the biological effects of long, thin, durable fibres. He answered no to all three. He argued that microscopic fibre shape is what counts for health. He said Reger and Morgan left out other researchers' evidence linking tremolite-actinolite to lung cancer, mesothelioma and interstitial fibrosis in vermiculite miners. He also said they left out lung fibrosis from talc, citing Merewether's 1933 report of 11 rubber tyre workers. He noted that one tremolite described as fibrous but not asbestiform produced mesothelioma in 70% of animals in Addison and Davis's work. He accepted that more work is needed. Case concluded that exempting these fibres from regulation "seems folly" until evidence shows they are easily defined, clearly separated from tremolite asbestos at work, and do not cause lung fibrosis or other health effects.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• Peritoneal mesothelioma--how a good occupational case history can best be used. R. Flechsig. Industrial Health 1991;29(2):73-6. Case report · Letter PubMed · Publisher

• Re: Meta-analysis of asbestos and gastrointestinal cancer. R.W. Morgan. American Journal of Industrial Medicine 1991;19(3):407-11. Comment · Letter · Meta-analysis PubMed · Publisher

• Respiratory cancer among mineral wool workers. Journal of Occupational Medicine. 1991;33(5):585-8. Comment · Letter PubMed

• Response to qualms about medical screening as a discriminatory tool. F.M. Kogan, E.V. Polzik. American Journal of Industrial Medicine 1991;20(2):273-4. Comment · Letter PubMed · Publisher

• The diagnosis of asbestosis. R.N. Jones. The American Review of Respiratory Disease 1991;144(3 Pt 1):477-8. Comment · Editorial PubMed · Publisher

• The relationship between respiratory impairment and asbestos-related pleural abnormality in an active work force. J.E. Cotes, B. King. The American Review of Respiratory Disease 1991;143(5 Pt 1):1197. Letter · Comment PubMed · Publisher

• Alterations in laryngeal mucosa after exposure to asbestos. D. Davies. British Journal of Industrial Medicine 1990;47(12):844. Comment · Letter PubMed · Publisher · Free full text

• Asbestos and carcinogenicity. J.C. McDonald, A.D. McDonald. Science 1990;249(4971):844. Comment · Letter PubMed · Publisher

• Asbestos and other toxins. P. Lowinger. American Journal of Public Health 1990;80(10):1274. Letter PubMed · Publisher · Free full text

• Asbestos and the Romans. K. Browne, R. Murray. Lancet 1990;336(8712):445. Historical article · Letter PubMed · Publisher

• Asbestos diseases and compensation. D.H. Yates. BMJ 1990;301(6752):609. Letter · Comment PubMed · Publisher · Free full text

• Asbestos diseases and compensation. L. Arblaster, P. Hatton, M.S. Schweiger, et al. BMJ 1990;301(6760):1101. Letter · Comment PubMed · Publisher · Free full text

• Asbestos in lung tissue. V.L. Roggli. Chest 1990;97(6):1501-2. Comment · Letter PubMed · Publisher

• Asbestos related abnormalities among United States merchant marine seamen. P.J. Barrett. British Journal of Industrial Medicine 1990;47(12):844-5. Letter · Comment PubMed · Publisher · Free full text

• Asbestos-related disease in the jewelry industry. D.G. Kern, H. Frumkin. Journal of Occupational Medicine. 1990;32(2):87. Comment · Letter PubMed

• Asbestos-related diseases. M.R. Joseph. The Medical Journal of Australia 1990;152(6):334. Letter PubMed

• Asbestos-related diseases. The New England Journal of Medicine 1990;322(2):129-31. Comment · Letter PubMed · Publisher

• Asbestos: a chronology of its origins and health effects. L. Arblaster, E. Renvoize, P. Hatton, et al. British Journal of Industrial Medicine 1990;47(11):790. Historical article · Letter PubMed · Publisher · Free full text

• Asbestos: a chronology of its origins and health effects. M. Huncharek. British Journal of Industrial Medicine 1990;47(12):845-6. Comment · Letter PubMed · Publisher · Free full text

• Cancer mortality and exposure to crocidolite. A. Rogers. British Journal of Industrial Medicine 1990;47(4):286. Letter PubMed · Publisher · Free full text

• Cancer mortality in a northern Italian cohort of rubber workers. A. Fischbein. British Journal of Industrial Medicine 1990;47(1):71-2. Comment · Letter PubMed · Publisher · Free full text

• Case 28-1989: pulmonary infiltrates and an axillary mass. E.P. Gabor. The New England Journal of Medicine 1990;322(2):131. Comment · Letter PubMed · Publisher

• Chromosome 3 and 12p rearranged in a well-differentiated peritoneal mesothelioma. H.J. Decker, F.P. Li, H.A. Bixenman, et al. Cancer Genetics and Cytogenetics 1990;46(1):135-7. Case report · Letter PubMed · Publisher

• Comparing biological effects of mineral fibres. J.M. Meijers. British Journal of Industrial Medicine 1990;47(4):286-7. Letter PubMed · Publisher · Free full text

• Crocidolite and mesothelioma. G. Berry, N.H. de Klerk. The Medical Journal of Australia 1990;152(6):330-1. Comment PubMed

• Diffuse meningeal thickening associated with pleural mesothelioma. M. Huncharek, J. Muscat. Thorax 1990;45(7):571. Case report · Comment · Letter PubMed · Publisher · Free full text

• Ear lobe oximetry was of value for assessing disability in asbestos-related lung disease. J.E. Cotes, B. King. Respiratory Medicine 1990;84(1):86. Comment · Letter PubMed · Publisher

• EPA and asbestos removal. J. Berry. Science 1990;248(4963):1595. Letter PubMed · Publisher

• Etoposide and mesothelioma. E.F. Smit, H.H. Berendsen, P.E. Postmus. Journal of Clinical Oncology 1990;8(7):1281. Case report · Letter PubMed · Publisher

• Intraoperative photodynamic therapy for malignant mesothelioma. H.I. Pass, Z. Tochner, T. DeLaney, et al. The Annals of Thoracic Surgery 1990;50(4):687-8. Case report · Comment · Letter PubMed · Publisher

• Is there a "genetic model" in the genesis of malignant pleural mesothelioma?. J.A. Precerutti, M. Mayorga, L. Dalurzo, et al. Human Pathology 1990;21(9):983. Case report · Comment · Letter PubMed · Publisher

• Pleural fluid acidosis in the malignant variant of benign pleural mesothelioma. R.D. Brandstetter, F.M. Tamarin, O.J. O'Neill, et al. Chest 1990;98(2):514-5. Case report · Letter PubMed · Publisher

• Pleural mesothelioma after asbestos exposure. A.M. Langer, R.P. Nolan. Respiratory Medicine 1990;84(6):509-10. Comment · Letter PubMed · Publisher

• Re: Asbestos and kidney cancer. American Journal of Industrial Medicine 1990;17(5):645-50. Letter PubMed · Publisher

• Re: Mesothelioma in railroad machinists. A. Churg, F. Green. American Journal of Industrial Medicine 1990;17(4):523-30. Comment · Letter PubMed · Publisher

• Relation between asbestosis and bronchial cancer in amphibole asbestos miners. R.M. Rudd. British Journal of Industrial Medicine 1990;47(3):215-6. Comment · Letter PubMed · Publisher · Free full text

• The cigarette factor in asbestosis. W. Weiss. Chest 1990;97(4):769-70. Editorial · Comment PubMed · Publisher